"...1","drugId","yearApproval.x","yearTargetDiseaseGE","yearInteractorDiseaseGE","yearTargetRelatedGE","yearInteractorRelatedGE","brandDrugName","originalDrugName","drugName","targetIds","interactorIds","targetType","sponsor","properties","therapeuticArea","indication","diseaseName","diseaseIds","relatedIds","diseaseType","diseaseClass","reviewType","hasAnyGE","hasInteractorDiseasesGE.x","hasTargetRelatedGE.x","hasInteractorRelatedGE","hasTargetDiseaseGE.x","yearApproval.y","hasAnyGE_2","yearApproval","hasInteractorDiseasesGE.y","hasTargetRelatedGE.y","hasInteractorRelatvedGE","hasTargetDiseaseGE.y"
8,"CHEMBL4297802",2018,NA,NA,NA,NA,"Palynziq","Pegvaliase","PEGVALIASE",NA,NA,"Original","BioMarin Pharmaceutical","PAL replacement therapy","No human target","Phenylketonuria","phenylketonuria","MONDO_0009861",NA,"Original","Serious","P,O,F",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
18,"CHEMBL3039514,CHEMBL2063090",2016,NA,NA,NA,NA,"Zepatier","Elbasvir, grazoprevir","ELBASVIR,GRAZOPREVIR","NA,NA",NA,"Original","Merck & Co.","NS5A inhibitor plus NS3/4A protease inhibitor","No human target","HCV genotypes 1 and 4","hepatitis C virus infection","EFO_0003047",NA,"Original","Serious","P,B",NA,NA,NA,NA,NA,2016,NA,2016,FALSE,FALSE,FALSE,NA
23,"CHEMBL1650559",2018,NA,NA,NA,NA,"Zemdri","Plazomicin","PLAZOMICIN",NA,NA,"Original","Achaogen","Aminoglycoside antibacterial","No human target","Urinary tract infections","urinary tract infection","EFO_0003103",NA,"Original","Not serious","P",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
24,"CHEMBL361497",2020,NA,NA,NA,NA,"Artesunate","Artesunate","ARTESUNATE",NA,NA,"Original","Amivas","Artemisinin antimalarial","No human target","Serious malaria","malaria","EFO_0001068",NA,"Original","Serious","P,O,B,F",NA,NA,NA,NA,NA,2020,NA,2020,FALSE,FALSE,FALSE,NA
25,"CHEMBL4297513",2021,NA,NA,NA,NA,"Brexafemme","Ibrexafungerp","Ibrexafungerp",NA,NA,"Original","Scynexis","Triterpenoid antifungal","No human target","Vulvovaginal candidiasis",NA,NA,NA,"Original",NA,"P,F",NA,NA,NA,NA,NA,2021,NA,2021,FALSE,FALSE,FALSE,NA
33,"CHEMBL3989974",2019,NA,NA,NA,NA,"Fetroja","Cefiderocol","CEFIDEROCOL",NA,NA,"Original","Shionogi","Cephalosporin antibacterial","No human target","Complicated urinary tract infections","urinary tract infection","EFO_0003103",NA,"Original","Not serious","P,F",NA,NA,NA,NA,NA,2019,NA,2019,FALSE,FALSE,FALSE,NA
45,"CHEMBL3127326,CHEMBL3391662,CHEMBL3137312,CHEMBL163",2014,NA,NA,NA,NA,"Viekira Pak","Ombitasvir, paritaprevir, dasabuvir, ritonavir","OMBITASVIR,PARITAPREVIR,DASABUVIR,RITONAVIR","NA,NA,NA,ENSG00000021461,ENSG00000160870,ENSG00000106258,ENSG00000160868",NA,"Original","AbbVie","An NS5A inhibitor plus an NS3A- and NS4A-protease inhibitor plus a non-nucleoside NS5B-palm-polymerase inhibitor plus a CYP3A inhibitor","Other indication","Chronic HCV genotype 1 infection","hepatitis C virus infection","EFO_0003047",NA,"Original","Serious","P,B,F",NA,FALSE,FALSE,FALSE,NA,2014,NA,2014,FALSE,FALSE,FALSE,NA
50,"CHEMBL2219415",2013,NA,NA,NA,NA,"Dotarem","Gadoterate meglumine","GADOTERATEMEGLUMINE",NA,NA,"Original","Guerbet","Gadolinium-based contrast agent","No human target","Contrast agent to visualize disruption of the blood-brain barrier",NA,NA,NA,"Original",NA,"P",NA,NA,NA,NA,NA,2013,NA,2013,FALSE,FALSE,FALSE,NA
53,"CHEMBL110",2017,NA,NA,NA,NA,"Benznidazole","Benznidazole","BENZNIDAZOLE",NA,NA,"Original","Chemo Research","Nitroimidazole antimicrobial","No human target","Chagas disease","Chagas disease","MONDO_0001444",NA,"Original","Serious","P,O,A",NA,NA,NA,NA,NA,2017,NA,2017,FALSE,FALSE,FALSE,NA
55,"CHEMBL1257073",2018,NA,NA,NA,NA,"TPOXX","Tecovirimat","TECOVIRIMAT",NA,NA,"Original","SIGA Technologies","Viral p37 protein inhibitor","No human target","Smallpox","smallpox","MONDO_0004651",NA,"Original","Serious","P,O,F",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
57,"CHEMBL125",2014,NA,NA,NA,NA,"Impavido","Miltefosine","MILTEFOSINE",NA,NA,"Original","Knight","MOA unknown","No human target","Leishmaniasis","Leishmaniasis","EFO_0005044",NA,"Original","Not concordant","P,O,F",NA,NA,NA,NA,NA,2014,NA,2014,FALSE,FALSE,FALSE,NA
60,"CHEMBL1257051",2014,NA,NA,NA,NA,"Sivextro","Tedizolid","TEDIZOLID",NA,NA,"Original","Cubist","Oxazolidinone-class antibacterial","No human target","ABSSSI (Acute Bacterial Skin and Skin Structure Infections)","staphylococcal skin infections","EFO_1001849",NA,"Original","Not serious","P",NA,NA,NA,NA,NA,2014,NA,2014,FALSE,FALSE,FALSE,NA
64,"CHEMBL2108670",2016,NA,NA,NA,NA,"Zinplava","Bezlotoxumab","BEZLOTOXUMAB",NA,NA,"Original","Merck & Co.","mAb against Clostridium difficile toxin","No human target","C. difficile recurrence","clostridium difficile infection","EFO_0009130",NA,"Original","Serious","P,F",NA,NA,NA,NA,NA,2016,NA,2016,FALSE,FALSE,FALSE,NA
66,"CHEMBL4298110",2019,NA,NA,NA,NA,"Accrufer","Ferric maltol","FERRICMALTOL",NA,NA,"Original","Shield Therapeutics","Iron replacement product","No human target","Iron deficiency anaemia","iron deficiency anemia","HP_0001891","EFO_0004272","Original","Not serious","S",NA,NA,NA,NA,NA,2019,NA,2019,FALSE,FALSE,FALSE,NA
70,"CHEMBL1688530",2014,NA,NA,NA,NA,"Orbactiv","Oritavancin","ORITAVANCIN",NA,NA,"Original","The Medicines Company","Semi-synthetic lipoglycopeptide","No human target","ABSSSI (Acute Bacterial Skin and Skin Structure Infections)","staphylococcal skin infections","EFO_1001849",NA,"Original","Not serious","P",NA,NA,NA,NA,NA,2014,NA,2014,FALSE,FALSE,FALSE,NA
74,"CHEMBL1908370",2014,NA,NA,NA,NA,"Xtoro","Finafloxacin","FINAFLOXACIN",NA,NA,"Original","Alcon","Fluoroquinolone antimicrobial","No human target","Acute otitis externa (swimmer's ear)","otitis externa","EFO_0009560",NA,"Original","Not serious","P",NA,NA,NA,NA,NA,2014,NA,2014,FALSE,FALSE,FALSE,NA
76,"CHEMBL4594411",2022,NA,NA,NA,NA,"Xenoview","Xenon Xe 129 hyperpolarized","XenonXe129hyperpolarized",NA,NA,"Original","Polarean","Hyperpolarized contrast agent","No human target","MRI-evaluation of lung ventilation",NA,NA,NA,"Original",NA,"S",NA,NA,NA,NA,NA,2022,NA,2022,FALSE,FALSE,FALSE,NA
77,"CHEMBL205596",2015,NA,NA,NA,NA,"Cholbam","Cholic acid","CHOLICACID",NA,NA,"Original","Retrophin","A primary bile acid","No human target","Bile acid synthesis disorders and peroxisomal disorders","peroxisomal disease; Disorder of bile acid synthesis","MONDO_0019053,Orphanet_79168",NA,"Original","Serious","P,O",NA,NA,NA,NA,NA,2015,NA,2015,FALSE,FALSE,FALSE,NA
93,"CHEMBL290960",2020,NA,NA,NA,NA,"Lampit","Nifurtimox","NIFURTIMOX",NA,NA,"Original","Bayer","Nitrofuran antiprotozoal","No human target","Chagas disease","chagas disease","MONDO_0001444",NA,"Original","Serious","P,O,A",NA,NA,NA,NA,NA,2020,NA,2020,FALSE,FALSE,FALSE,NA
95,"CHEMBL1951095",2018,NA,NA,NA,NA,"Xerava","Eravacycline","ERAVACYCLINE",NA,NA,"Original","Tetraphase Pharmaceuticals","Tetracycline antibiotic","No human target","Complicated intra-abdominal infections","infectious disease","EFO_0005741",NA,"Original","Serious","P,F",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
97,"CHEMBL3545363,CHEMBL3545123",2017,NA,NA,NA,NA,"Mavyret","Glecaprevir, pibrentasvir","GLECAPREVIR,PIBRENTASVIR","NA,NA",NA,"Original","AbbVie","NS3/4A protease inhibitor plus a NS5A inhibitor","No human target","HCV","hepatitis C virus infection","EFO_0003047",NA,"Original","Serious","P,B,F",NA,NA,NA,NA,NA,2017,NA,2017,FALSE,FALSE,FALSE,NA
101,"CHEMBL406393",2015,NA,NA,NA,NA,"Kybella","Deoxycholic acid","DEOXYCHOLICACID",NA,NA,"Original","Kythera","Cytolytic drug","No human target","Fat below the chin","body fat distribution","EFO_0004341",NA,"Original","Not serious","S",NA,NA,NA,NA,NA,2015,NA,2015,FALSE,FALSE,FALSE,NA
104,"CHEMBL127,CHEMBL3317857",2017,NA,NA,NA,NA,"Vabomere","Meropenem, vaborbactam","MEROPENEM,VABORBACTAM","NA,NA",NA,"Original","The Medicines Company/Rempex Pharmaceuticals","Carbapenem antimicrobial plus a ‚Äö√¢√†‚àö‚â†‚Äö√Ñ√∂‚àö¬¢¬¨√ü-lactamase inhibitor","No human target","Complicated urinary tract infections","urinary tract infection","EFO_0003103",NA,"Original","Not serious","P,F",NA,NA,NA,NA,NA,2017,NA,2017,FALSE,FALSE,FALSE,NA
120,"CHEMBL498847",2017,NA,NA,NA,NA,"Solosec","Secnidazole","SECNIDAZOLE",NA,NA,"Original","Lupin","Nitroimidazole antimicrobial","No human target","Bacterial vaginosis","bacterial vaginosis","EFO_0003932",NA,"Original","Not serious","P,F",NA,NA,NA,NA,NA,2017,NA,2017,FALSE,FALSE,FALSE,NA
125,"CHEMBL1661",2020,NA,NA,NA,NA,"Pizensy","Lactitol","LACTITOL",NA,NA,"Original","Braintree Labs","Osmotic laxative","No human target","Chronic idiopathic constipation","Chronic constipation","HP_0012450",NA,"Original","Not serious","S",NA,NA,NA,NA,NA,2020,NA,2020,FALSE,FALSE,FALSE,NA
127,"CHEMBL437765",2018,NA,NA,NA,NA,"Aemcolo","Rifamycin","RIFAMYCIN",NA,NA,"Original","Cosmo Technologies","Ansamycin antibacterial","No human target","Travellers diarrhoea","Diarrhea","HP_0002014",NA,"Original","Not serious","P,F",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
137,"CHEMBL501849",2013,NA,NA,NA,NA,"Olysio","Simeprevir","SIMEPREVIR",NA,NA,"Original","Janssen","HCV NS3/4A protease inhibitor","No human target","Chronic HCV infection, as a component of a combination antiviral treatment regimen","hepatitis C virus infection","EFO_0003047",NA,"Original","Serious","P,F",NA,NA,NA,NA,NA,2013,NA,2013,FALSE,FALSE,FALSE,NA
141,"CHEMBL1259059,CHEMBL3545062,CHEMBL3707372",2017,NA,NA,NA,NA,"Vosevi","Sofosbuvir, velpatasvir, voxilaprevir","SOFOSBUVIR,VELPATASVIR,VOXILAPREVIR","NA,NA,NA",NA,"Original","Gilead Sciences","Nucleotide analogue NS5B polymerase inhibitor plus an NS5A inhibitor plus an NS3/4A protease inhibitor","No human target","HCV","hepatitis C virus infection","EFO_0003047",NA,"Original","Serious","P,B",NA,NA,NA,NA,NA,2017,NA,2017,FALSE,FALSE,FALSE,NA
145,"CHEMBL3989866,CHEMBL885,CHEMBL2107825",2018,NA,NA,NA,NA,"Biktarvy","Bictegravir, emtricitabine, tenofovir alafenamide","BICTEGRAVIR,EMTRICITABINE,TENOFOVIRALAFENAMIDE","NA,NA,NA",NA,"Original","Gilead Sciences","HIV-1 integrase inhibitor and HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors","No human target","HIV","hiv infection","EFO_0000764",NA,"Original","Serious","P",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
146,"CHEMBL2104415",2018,NA,NA,NA,NA,"Moxidectin","Moxidectin","MOXIDECTIN",NA,NA,"Original","Medicines Development for Global Health","Antihelmintic GABA receptor and glutamate channel modulator","No human target","River blindness","ocular onchocerciasis","EFO_0007398",NA,"Original","Not concordant","P,O",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
169,"CHEMBL298470",2018,NA,NA,NA,NA,"Krintafel","Tafenoquine","TAFENOQUINE",NA,NA,"Original","Medicines for Malaria Venture/GlaxoSmithKline","8-Aminoquinoline antimalarial","No human target","Plasmodium vivax malaria","Plasmodium vivax malaria","EFO_0007445",NA,"Original","Serious","P,O,B,F",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
171,"CHEMBL2364608",2018,NA,NA,NA,NA,"Pifeltro","Doravirine","DORAVIRINE",NA,NA,"Original","Merck & Co.","NNRTI","No human target","HIV","hiv infection","EFO_0000764",NA,"Original","Serious","S",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
177,"CHEMBL1689063,CHEMBL44354",2015,NA,NA,NA,NA,"Avycaz","Avibactam, ceftazidime","AVIBACTAM,CEFTAZIDIME","NA,NA",NA,"Original","Allergan","A beta-lactamase inhibitor and a cephalosporin","No human target","Complicated intra-abdominal infections and complicated urinary tract infections","infection","EFO_0000544","Orphanet_169142","Original","Serious","P,F",NA,NA,NA,NA,NA,2015,NA,2015,FALSE,FALSE,FALSE,NA
181,"CHEMBL3301594",2020,NA,NA,NA,NA,"Rukobia","Fostemsavir","FOSTEMSAVIR",NA,NA,"Original","ViiV Healthcare","Attachment inhibitor","No human target","HIV","hiv infection","EFO_0000764",NA,"Original","Serious","P,B,F",NA,NA,NA,NA,NA,2020,NA,2020,FALSE,FALSE,FALSE,NA
185,"CHEMBL443052",2014,NA,NA,NA,NA,"Kerydin","Tavaborole","TAVABOROLE",NA,NA,"Original","Anacor","Oxaborole antifungal","No human target","Onychomycosis of the toenails","paronychia","EFO_0007421",NA,"Original","Not serious","S",NA,NA,NA,NA,NA,2014,NA,2014,FALSE,FALSE,FALSE,NA
186,"CHEMBL204656,CHEMBL2095208,CHEMBL885,CHEMBL483",2015,NA,NA,NA,NA,"Genvoya","Elvitegravir, cobicistat, emtricitabine, tenofovir","ELVITEGRAVIR,COBICISTAT,EMTRICITABINE,TENOFOVIR","NA,ENSG00000160870,ENSG00000106258,ENSG00000160868,ENSG00000021461,NA,NA",NA,"Original","Gilead","An INSTI plus a CYP3A inhibitor plus two nucleoside analogue reverse transcriptase inhibitors","No human target","HIV","HIV infection","EFO_0000764",NA,"Original","Serious","S,F",NA,FALSE,FALSE,FALSE,NA,2015,NA,2015,FALSE,FALSE,FALSE,NA
189,"CHEMBL4297634",2022,NA,NA,NA,NA,"Elucirem","Gadopiclenol","Gadopiclenol",NA,NA,"Original","Guerbet","Gadolinium-based contrast agent","No human target","Lesions with abnormal vascularity",NA,NA,NA,"Original",NA,"P",NA,NA,NA,NA,NA,2022,NA,2022,FALSE,FALSE,FALSE,NA
193,"CHEMBL2103872,CHEMBL404",2014,NA,NA,NA,NA,"Zerbaxa","Ceftolozane, tazobactam","CEFTOLOZANE,TAZOBACTAM","NA,NA",NA,"Original","Cubist","A cephalosporin antibacterial plus a beta-lactamase inhibitor","No human target","Complicated intra-abdominal infections and complicated urinary tract infections","infection","EFO_0000544","Orphanet_169142","Original","Serious","P,F",NA,NA,NA,NA,NA,2014,NA,2014,FALSE,FALSE,FALSE,NA
198,"CHEMBL1689772",2018,NA,NA,NA,NA,"Nuzyra","Omadacycline","OMADACYCLINE",NA,NA,"Original","Paratek Pharmaceuticals","Tetracycline antibiotic","No human target","CABP and ABSSSI","bacterial pneumonia; skin disease caused by bacterial infection","EFO_1001272,MONDO_0024295",NA,"Original","Serious","P,F",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
211,"CHEMBL290916",2017,NA,NA,NA,NA,"Radicava","Edaravone","EDARAVONE",NA,NA,"Original","Mitsubishi Tanabe","Unknown (radical scavenger)","No human target","ALS (amyotrophic lateral sclerosis)","amyotrophic lateral sclerosis","MONDO_0004976",NA,"Original","Serious","S,O",NA,NA,NA,NA,NA,2017,NA,2017,FALSE,FALSE,FALSE,NA
212,"CHEMBL4297620",2019,NA,NA,NA,NA,"Sunosi","Solriamfetol","SOLRIAMFETOL",NA,NA,"Original","Jazz","Dopamine and noradrenaline reuptake inhibitor","No human target","Excessive sleepiness due to narcolepsy or obstructive sleep apnoea","hypersomnia; narcolepsy; obstructive sleep apnea","EFO_0005246,MONDO_0021107,EFO_0003918",NA,"Original","Serious","S,O",NA,NA,NA,NA,NA,2019,NA,2019,FALSE,FALSE,FALSE,NA
215,"CHEMBL4594438",2022,NA,NA,NA,NA,"Sunlenca","Lenacapavir","Lenacapavir",NA,NA,"Original","Gilead","HIV-1 capsid inhibitor","No human target","HIV-1 infection","HIV-1 infection","EFO_0000180",NA,"Original",NA,"P,B,F",NA,NA,NA,NA,NA,2022,NA,2022,FALSE,FALSE,FALSE,NA
222,"CHEMBL2403238,CHEMBL175691",2021,NA,NA,NA,NA,"Cabenuva Kit","Cabotegravir, rilpivirine","Cabotegravir,rilpivirine","NA,NA",NA,"Original","ViiV","INSTI and an NNRTI","No human target","HIV-1 infection",NA,NA,NA,"Original",NA,"P,F",NA,NA,NA,NA,NA,2021,NA,2021,FALSE,FALSE,FALSE,NA
225,"CHEMBL3544996",2015,NA,NA,NA,NA,"Praxbind","Idarucizumab","IDARUCIZUMAB",NA,NA,"Original","Boehringer Ingelheim","Dabigatran-binding mAb fragment","No human target","Reversal of anticoagulant effects of dabigatran","response to anticoagulant","GO_0061476",NA,"Original","Not serious","P,O,B,A",NA,NA,NA,NA,NA,2015,NA,2015,FALSE,FALSE,FALSE,NA
226,"CHEMBL766,CHEMBL148,CHEMBL3301605",2019,NA,NA,NA,NA,"Recarbrio","Cilastatin, imipenem, relebactam","CILASTATIN,IMIPENEM,RELEBACTAM","ENSG00000015413,NA,NA",NA,"Original","Merck & Co.","A renal dehydropeptidase inhibitor, a penem antibacterial and a beta-lactamase inhibitor","No human target","Complicated urinary tract and complicated intra-abdominal infections","urinary tract infection","EFO_0003103",NA,"Original","Not serious","P,F",NA,FALSE,FALSE,FALSE,NA,2019,NA,2019,FALSE,FALSE,FALSE,NA
233,"CHEMBL4594388",2020,NA,NA,NA,NA,"Ebanga","Ansuvimab","ANSUVIMAB",NA,NA,"Original","Ridgeback","Ebola glycoprotein-directed mAb","No human target","Ebola virus","Ebola hemorrhagic fever","EFO_0007243",NA,"Original","Serious","P,O,B",NA,NA,NA,NA,NA,2020,NA,2020,FALSE,FALSE,FALSE,NA
239,"CHEMBL1086440",2019,NA,NA,NA,NA,"Egaten","Triclabendazole","TRICLABENDAZOLE",NA,NA,"Original","Novartis","Anthelmintic","No human target","Fascioliasis","fascioliasis","EFO_1001324",NA,"Original","Not concordant","P,O,F",NA,NA,NA,NA,NA,2019,NA,2019,FALSE,FALSE,FALSE,NA
240,"CHEMBL2205807",2020,NA,NA,NA,NA,"Xeglyze","Abametapir","ABAMETAPIR",NA,NA,"Original","Dr Reddy‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö¬¥‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ¬¨¬®‚Äö√Ñ¬¢s","Metalloproteinase inhibitor","No human target","Head lice","lice infestation","MONDO_0003472",NA,"Original","Not serious","S",NA,NA,NA,NA,NA,2020,NA,2020,FALSE,FALSE,FALSE,NA
242,"CHEMBL4065616",2020,NA,NA,NA,NA,"Veklury","Remdesivir","REMDESIVIR",NA,NA,"Original","Gilead","Nucleotide analogue RNA polymerase inhibitor","No human target","COVID-19","covid-19","MONDO_0100096",NA,"Original","Serious","P,F",NA,NA,NA,NA,NA,2020,NA,2020,FALSE,FALSE,FALSE,NA
245,"CHEMBL4297503",2018,NA,NA,NA,NA,"Xofluza","Baloxavir marboxil","BALOXAVIRMARBOXIL",NA,NA,"Original","Shionogi/Roche","Polymerase acidic endonuclease inhibitor","No human target","Acute uncomplicated influenza","influenza","EFO_0007328",NA,"Original","Not serious","P",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
249,"CHEMBL3291398",2019,NA,NA,NA,NA,"Xenleta","Lefamulin","LEFAMULIN",NA,NA,"Original","Nabriva","Pleuromutilin antibacterial","No human target","CABP","bacterial pneumonia","EFO_1001272",NA,"Original","Serious","P,F",NA,NA,NA,NA,NA,2019,NA,2019,FALSE,FALSE,FALSE,NA
257,"CHEMBL3989402,CHEMBL139367",2014,NA,NA,NA,NA,"Rapivab","Peramivir","PERAMIVIR,PERAMIVIR","NA,NA",NA,"Original","BioCryst","Neuraminidase inhibitor","No human target","Influenza infection","influenza","EFO_0007328",NA,"Original","Not serious","S,F",NA,NA,NA,NA,NA,2014,NA,2014,FALSE,FALSE,FALSE,NA
263,"CHEMBL100259",2015,NA,NA,NA,NA,"Xuriden","Uridine","URIDINE",NA,NA,"Original","Wellstat","Pyrimidine analogue","No human target","Hereditary orotic aciduria","Hereditary orotic aciduria","Orphanet_30",NA,"Original","Serious","P,O,B",NA,NA,NA,NA,NA,2015,NA,2015,FALSE,FALSE,FALSE,NA
266,"CHEMBL515408",2021,NA,NA,NA,NA,"Livtencity","Maribavir","Maribavir",NA,NA,"Original","Takeda","CMV pUL97 kinase inhibitor","No human target","Post-transplant CMV infection",NA,NA,NA,"Original",NA,"P,O,B",NA,NA,NA,NA,NA,2021,NA,2021,FALSE,FALSE,FALSE,NA
267,"CHEMBL2107816",2013,NA,NA,NA,NA,"Xofigo","Radium RA 223 dichloride","RADIUMRA223DICHLORIDE",NA,NA,"Original","Bayer","Alpha particle-emitting radioactive therapeutic","No human target","Castration-resistant prostate cancer","prostate cancer","MONDO_0008315",NA,"Original","Serious","P,F",NA,NA,NA,NA,NA,2013,NA,2013,FALSE,FALSE,FALSE,NA
280,"CHEMBL1259059",2013,NA,NA,NA,NA,"Sovaldi","Sofosbuvir","SOFOSBUVIR",NA,NA,"Original","Gilead","HCV nucleotide analogue NS5B polymerase inhibitor","No human target","Chronic HCV infection, as a component of a combination antiviral treatment regimen","hepatitis C virus infection","EFO_0003047",NA,"Original","Serious","P,B,F",NA,NA,NA,NA,NA,2013,NA,2013,FALSE,FALSE,FALSE,NA
282,"CHEMBL2364632",2018,NA,NA,NA,NA,"Seysara","Sarecycline","SARECYCLINE",NA,NA,"Original","Allergan","Tetracycline antibiotic","No human target","Serious acne vulgaris","acne","EFO_0003894",NA,"Original","Not serious","S",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
284,"CHEMBL2111107",2015,NA,NA,NA,NA,"Bridion","Sugammadex","SUGAMMADEX",NA,NA,"Original","Merck & Co.","A modified gamma cyclodextrin","No human target","Reversal of neuromuscular blockade during surgery","neuromuscular disease","EFO_1001902",NA,"Original","Serious","P",NA,NA,NA,NA,NA,2015,NA,2015,FALSE,FALSE,FALSE,NA
288,"CHEMBL3400972",2019,NA,NA,NA,NA,"Fluorodopa F-18","Fluorodopa F-18","FLUORODOPAF-18",NA,NA,"Original","Feinstein Institutes","Radioactive diagnostic","No human target","Diagnosis of parkinsonian syndromes","Parkinson disease","MONDO_0005180",NA,"Original","Serious","S",NA,NA,NA,NA,NA,2019,NA,2019,FALSE,FALSE,FALSE,NA
294,"CHEMBL3301592",2018,NA,NA,NA,NA,"Lokelma","Sodium zirconium cyclosilicate","SODIUMZIRCONIUMCYCLOSILICATE",NA,NA,"Original","AstraZeneca","Potassium binder","No human target","Hyperkalaemia","hyperkalemia","HP_0002153",NA,"Original","Not concordant","S",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
297,"CHEMBL2105637",2017,NA,NA,NA,NA,"Baxdela","Delafloxacin","DELAFLOXACIN",NA,NA,"Original","Melinta Therapeutics","Fluoroquinolone antibacterial","No human target","Acute bacterial skin and skin structure infections","staphylococcal skin infections","EFO_1001849",NA,"Original","Not serious","P,F",NA,NA,NA,NA,NA,2017,NA,2017,FALSE,FALSE,FALSE,NA
305,"CHEMBL450449",2015,NA,NA,NA,NA,"Yondelis","Trabectedin","TRABECTEDIN",NA,NA,"Original","Johnson & Johnson","Alkylating drug",NA,"Liposarcoma or leiomyosarcoma","liposarcoma; leiomyosarcoma","EFO_0000569,EFO_0000564",NA,"Original","Serious","P,O",NA,NA,NA,NA,NA,2015,NA,2015,FALSE,FALSE,FALSE,NA
307,"CHEMBL3301669",2014,NA,NA,NA,NA,"Dalvance","Dalbavancin","DALBAVANCIN",NA,NA,"Original","Durata","Semisynthetic lipoglycopeptide","No human target","ABSSSI (Acute Bacterial Skin and Skin Structure Infections)","staphylococcal skin infections","EFO_1001849",NA,"Original","Not serious","P,F",NA,NA,NA,NA,NA,2014,NA,2014,FALSE,FALSE,FALSE,NA
309,"CHEMBL4298183,CHEMBL4298188,CHEMBL4298184",2020,NA,NA,NA,NA,"Inmazeb","Atoltivimab, odesivimab, maftivimab","ATOLTIVIMAB,ODESIVIMAB,MAFTIVIMAB","NA,NA,NA",NA,"Original","Regeneron","Cocktail of Ebola glycoprotein-directed mAbs","No human target","Ebola virus","Ebola hemorrhagic fever","EFO_0007243",NA,"Original","Serious","P,O,B",NA,NA,NA,NA,NA,2020,NA,2020,FALSE,FALSE,FALSE,NA
316,"CHEMBL2107840",2015,NA,NA,NA,NA,"Veltassa","Patiromer sorbitex","PATIROMERSORBITEX",NA,NA,"Original","Relypsa","Potassium binder","No human target","Hyperkalaemia","Hyperkalemia","HP_0002153",NA,"Original","Not concordant","S",NA,NA,NA,NA,NA,2015,NA,2015,FALSE,FALSE,FALSE,NA
317,"CHEMBL3311228",2022,NA,NA,NA,NA,"Vivjoa","Oteseconazole","Oteseconazole",NA,NA,"Original","Mycovia","Azole antifungal","No human target","Vulvovaginal candidiasis","vulvovaginal candidiasis","EFO_0007543",NA,"Original",NA,"P,F",NA,NA,NA,NA,NA,2022,NA,2022,FALSE,FALSE,FALSE,NA
318,"CHEMBL4594264",2019,NA,NA,NA,NA,"ExEm Foam","Air polymer-type A","AIRPOLYMER-TYPEA",NA,NA,"Original","Giskit","Ultrasound contrast agent","No human target","Assess fallopian tube patency in women with known or suspected infertility","infertility","EFO_0000545",NA,"Original","Not serious","S",NA,NA,NA,NA,NA,2019,NA,2019,FALSE,FALSE,FALSE,NA
319,"CHEMBL4297535",2018,NA,NA,NA,NA,"Omegaven","Fish oil triglycerides","FISHOILTRIGLYCERIDES",NA,NA,"Original","Fresenius","Mixture of fatty acids","No human target","Parenteral nutrition-associated cholestasis","cholestasis","MONDO_0001751",NA,"Original","Serious","P,O,F",NA,NA,NA,NA,NA,2018,NA,2018,FALSE,FALSE,FALSE,NA
321,"CHEMBL3990047",2017,NA,NA,NA,NA,"Xepi","Ozenoxacin","OZENOXACIN",NA,NA,"Original","Ferrer Internacional","Quinolone antimicrobial","No human target","Impetigo due to Staphylococcus aureus or Streptococcus pyogenes","impetigo","EFO_1000714",NA,"Original","Not serious","S",NA,NA,NA,NA,NA,2017,NA,2017,FALSE,FALSE,FALSE,NA
328,"CHEMBL1229211",2013,NA,NA,NA,NA,"Tivicay","Dolutegravir","DOLUTEGRAVIR",NA,NA,"Original","ViiV","HIV1 integrase strand transfer inhibitor","No human target","HIV1 infection in adults and children, in combination with other antiretroviral agents","HIV infection","EFO_0000764",NA,"Original","Serious","P,F",NA,NA,NA,NA,NA,2013,NA,2013,FALSE,FALSE,FALSE,NA
334,NA,2022,NA,NA,NA,NA,"NexoBrid","Anacaulase","Anacaulase",NA,NA,"Original","Mediwound","Proteolytic enzymes from pineapple plants","No human target","Eschar removal after thermal burns",NA,NA,NA,"Original",NA,"S,O",NA,NA,NA,NA,NA,2022,NA,2022,FALSE,FALSE,FALSE,NA
335,"CHEMBL1746,CHEMBL272427",2022,NA,NA,NA,NA,"Relyvrio","Sodium phenylbutyrate, taurursodiol","Sodiumphenylbutyrate,taurursodiol","NA,NA",NA,"Original","Amylyx","Mechanism unknown","No human target","Amyotrophic lateral sclerosis","amyotrophic lateral sclerosis","MONDO_0004976",NA,"Original","Serious","P,O",NA,NA,NA,NA,NA,2022,NA,2022,FALSE,FALSE,FALSE,NA
341,"CHEMBL2023898",2015,NA,NA,NA,NA,"Daklinza","Daclatasvir","DACLATASVIR",NA,NA,"Original","Bristol-Myers Squibb","NS5A inhibitor","No human target","HCV","hepatitis C virus infection","EFO_0003047",NA,"Original","Serious","P,F",NA,NA,NA,NA,NA,2015,NA,2015,FALSE,FALSE,FALSE,NA
343,"CHEMBL3544926",2016,NA,NA,NA,NA,"Anthim","Obiltoxaximab","OBILTOXAXIMAB",NA,NA,"Original","Elusys Therapeutics","mAb against anthrax toxin","No human target","Anthrax","anthrax infection","EFO_0000778",NA,"Original","Serious","S,O,F",NA,NA,NA,NA,NA,2016,NA,2016,FALSE,FALSE,FALSE,NA
347,"CHEMBL227875",2019,NA,NA,NA,NA,"Pretomanid","Pretomanid","PRETOMANID",NA,NA,"Original","Pfizer/Mylan","Antimycobacterial","No human target","Tuberculosis","tuberculosis","MONDO_0018076",NA,"Original","Serious","P,O,F",NA,NA,NA,NA,NA,2019,NA,2019,FALSE,FALSE,FALSE,NA
352,"CHEMBL4303060",2021,NA,NA,NA,NA,"Pepaxto","Melphalan flufenamide","Melphalanflufenamide",NA,NA,"Original","Oncopeptides","Peptide-conjugated alkylating drug",NA,"Multiple myeloma","multiple myeloma","EFO_0001378","MONDO_0004095","Original","Serious","P,O,A",NA,NA,NA,NA,NA,2021,NA,2021,FALSE,FALSE,FALSE,NA
375,"CHEMBL4297585",2020,NA,NA,NA,NA,"Dojolvi","Triheptanoin","TRIHEPTANOIN",NA,NA,"Original","Ultragenyx","Medium-chain triglyceride","No human target","LC-FAODs","inherited fatty acid metabolism disorder","MONDO_0037858",NA,"Original","Serious","S,O,F",NA,NA,NA,NA,NA,2020,NA,2020,FALSE,FALSE,FALSE,NA
377,"CHEMBL2079130,CHEMBL1082,CHEMBL1741",2022,NA,NA,NA,NA,"Voquezna Triple Pak","Vonoprazan, amoxicillin, clarithromycin","Vonoprazan,amoxicillin,clarithromycin","ENSG00000186009,ENSG00000105675,NA,NA",NA,"Original","Phathom","Potassium-competitive acid blocker plus a penicillin class antibacterial plus a macrolide antimicrobial","Other indication","Helicobacter pylori infection","Helicobacter pylori infectious disease","EFO_1000961",NA,"Original","Not serious","P,F",NA,FALSE,FALSE,FALSE,NA,2022,NA,2022,FALSE,FALSE,FALSE,NA
380,"CHEMBL1863514",2021,NA,NA,NA,NA,"Rylaze","Asparaginase erwinia chrysanthemi","Asparaginaseerwiniachrysanthemi",NA,NA,"Original","Jazz","Recombinant asparagine-specific enzyme",NA,"ALL and LBL, in patients allergic to E. coli-derived products","acute lymphoblastic leukemia; lymphoblastic lymphoma","EFO_0000220,MONDO_0000873",NA,"Original","Serious","S,O,F",NA,NA,NA,NA,NA,2021,NA,2021,FALSE,FALSE,FALSE,NA
384,"CHEMBL1256391",2014,NA,NA,NA,NA,"Esbriet","Pirfenidone","PIRFENIDONE",NA,NA,"Original","InterMune","MOA unknown","No human target","IPF (idiopathic pulmonary fibrosis)","idiopathic pulmonary fibrosis","EFO_0000768",NA,"Original","Serious","P,O,B,F",NA,NA,NA,NA,NA,2014,NA,2014,FALSE,FALSE,FALSE,NA
390,"CHEMBL2103877",2014,NA,NA,NA,NA,"Jublia","Efinaconazole","EFINACONAZOLE",NA,NA,"Original","Dow","Azole antifungal","No human target","Onychomycosis of the toenails","paronychia","EFO_0007421",NA,"Original","Not serious","S",NA,NA,NA,NA,NA,2014,NA,2014,FALSE,FALSE,FALSE,NA
393,"CHEMBL2374220,CHEMBL1259059",2014,NA,NA,NA,NA,"Harvoni","Ledipasvir, sofosbuvir","LEDIPASVIR,SOFOSBUVIR","NA,NA",NA,"Original","Gilead Sciences","An NS5A inhibitor plus an HCV nucleotide-analogue NS5B-polymerase inhibitor","No human target","Genotype 1 HCV","hepatitis C virus infection","EFO_0003047",NA,"Original","Serious","P,B,F",NA,NA,NA,NA,NA,2014,NA,2014,FALSE,FALSE,FALSE,NA
396,"CHEMBL1631694",2021,NA,NA,NA,NA,"Fexinidazole","Fexinidazole","Fexinidazole",NA,NA,"Original","Sanofi/DNDi","Nitroimidazole antimicrobial","No human target","Sleeping sickness",NA,NA,NA,"Original",NA,"P,O",NA,NA,NA,NA,NA,2021,NA,2021,FALSE,FALSE,FALSE,NA
397,"CHEMBL2105689",2013,NA,NA,NA,NA,"Luzu","Luliconazole","LULICONAZOLE",NA,NA,"Original","Medicis","Azole antifungal","No human target","Interdigital tinea pedis, tinea cruris and tinea corporis caused by Trichophyton rubrum and Epidermophyton floccosum","tinea","EFO_0007510",NA,"Original","Not serious","S",NA,NA,NA,NA,NA,2013,NA,2013,FALSE,FALSE,FALSE,NA
408,"CHEMBL4297984",2020,NA,NA,NA,NA,"Danyelza","Naxitamab","NAXITAMAB",NA,NA,"Original","Y-mAbs Therapeutics","GD2-directed mAb",NA,"High-risk neuroblastoma","neuroblastoma","EFO_0000621",NA,"Original","Serious","P,O,B,A",NA,NA,NA,NA,NA,2020,NA,2020,FALSE,FALSE,FALSE,NA
410,"CHEMBL3137342",2015,NA,NA,NA,NA,"Unituxin","Dinutuximab","DINUTUXIMAB",NA,NA,"Original","United Therapeutics","GD2-binding mAb",NA,"Neuroblastoma","neuroblastoma","EFO_0000621",NA,"Original","Serious","P,O",NA,NA,NA,NA,NA,2015,NA,2015,FALSE,FALSE,FALSE,NA
411,"CHEMBL4297516",2020,NA,NA,NA,NA,"Zepzelca","Lurbinectedin","LURBINECTEDIN",NA,NA,"Original","Jazz","Alkylating drug",NA,"Small-cell lung cancer","small cell lung carcinoma","EFO_0000702",NA,"Original","Serious","P,O,A",NA,NA,NA,NA,NA,2020,NA,2020,FALSE,FALSE,FALSE,NA
415,"CHEMBL1259059,CHEMBL3545062",2016,NA,NA,NA,NA,"Epclusa","Sofosbuvir, velpatasvir","SOFOSBUVIR,VELPATASVIR","NA,NA",NA,"Original","Gilead Sciences","A nucleotide analogue NS5B polymerase inhibitor plus an HCV NS5A inhibitor","No human target","genotype 1, 2, 3 or 4 chronic hepatitis C virus (HCV)","hepatitis C virus infection","EFO_0003047",NA,"Original","Serious","P,B,F",NA,NA,NA,NA,NA,2016,NA,2016,FALSE,FALSE,FALSE,NA
417,"CHEMBL1183349",2015,NA,NA,NA,NA,"Cresemba","Isavuconazonium","ISAVUCONAZONIUM",NA,NA,"Original","Astellas","Azole antifungal","No human target","Antifungal","aspergillosis; mucormycosis","EFO_0007157,EFO_0007380",NA,"Original","Serious","P,O",NA,NA,NA,NA,NA,2015,NA,2015,FALSE,FALSE,FALSE,NA
420,"CHEMBL4173394",2019,NA,NA,NA,NA,"Tissueblue","Brilliant Blue G","BRILLIANTBLUEG",NA,NA,"Original","Dutch Ophthalmic Research","Brilliant Blue G dye","No human target","Staining the internal limiting membrane",NA,NA,NA,"Original",NA,"P,O",NA,NA,NA,NA,NA,2019,NA,2019,FALSE,FALSE,FALSE,NA
423,NA,2014,NA,NA,NA,NA,"Lumason","Sulfur hexafluoride lipid-type A microspheres","SULFURHEXAFLUORIDELIPID-TYPEAMICROSPHERES",NA,NA,"Original","Bracco","Ultrasound contrast agent","No human target","Cardiovascular imaging",NA,NA,NA,"Original",NA,"S",NA,NA,NA,NA,NA,2014,NA,2014,FALSE,FALSE,FALSE,NA
426,"CHEMBL1241951",2017,NA,NA,NA,NA,"Prevymis","Letermovir","LETERMOVIR",NA,NA,"Original","Merck & Co.","CMV DNA terminase complex inhibitor","No human target","Prophylaxis of CMV (cytomegalovirus)","cytomegalovirus infection","EFO_0001062",NA,"Original","Serious","P,O,B,F",NA,NA,NA,NA,NA,2017,NA,2017,FALSE,FALSE,FALSE,NA
15,"CHEMBL17860",2018,NA,NA,NA,NA,"Lucemyra","Lofexidine","LOFEXIDINE","ENSG00000150594,ENSG00000274286,ENSG00000184160",NA,"Original","US WorldMeds","beta2-adrenoceptor agonist","Other indication","Opioid withdrawal","opioid dependence","EFO_0005611",NA,"Original","Not serious","P,F",FALSE,FALSE,FALSE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
26,"CHEMBL1201891",2017,NA,NA,NA,NA,"Emflaza","Deflazacort","DEFLAZACORT","ENSG00000113580",NA,"Original","PTC Therapeutics","Corticosteroid","Other indication","Duchenne muscular dystrophy","Duchenne muscular dystrophy","MONDO_0010679",NA,"Original","Serious","P,O,F",FALSE,FALSE,FALSE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
36,"CHEMBL206253,CHEMBL1189679",2014,NA,NA,NA,NA,"Akynzeo","Netupitant, palonosetron","NETUPITANT,PALONOSETRON","ENSG00000115353,ENSG00000166736",NA,"Original","Helsinn","An NK1-receptor antagonist plus a 5-HT3-receptor antagonist","Other indication","Chemotherapy-related nausea","Chemotherapy-induced nausea and vomiting","EFO_0006911",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
46,"CHEMBL3304485",2019,NA,NA,NA,NA,"Ibsrela","Tenapanor","TENAPANOR","ENSG00000066230",NA,"Original","Ardelyx","NHE3 inhibitor","Other indication","IBS with constipation","irritable bowel syndrome","EFO_0000555",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
54,"CHEMBL2107826",2020,NA,NA,NA,NA,"Gemtesa","Vibegron","VIBEGRON","ENSG00000188778",NA,"Original","Urovant Sciences","Beta-3 adrenergic receptor agonist","Other indication","Overactive bladder","overactive bladder","EFO_1000781",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
73,"CHEMBL2159122",2015,NA,NA,NA,NA,"Viberzi","Eluxadoline","ELUXADOLINE","ENSG00000112038",NA,"Original","Allergan","Mu-opioid receptor agonist","Other indication","Irritable bowel syndrome","irritable bowel syndrome","EFO_0000555",NA,"Original","Not serious","P,F",FALSE,FALSE,FALSE,FALSE,FALSE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
89,"CHEMBL4297551",2021,NA,NA,NA,NA,"Vyvgart","Efgartigimod alfa","Efgartigimodalfa","ENSG00000104870",NA,"Original","Argenx","FcRn-binding Fc fragment","Other indication","Myasthenia gravis","Myasthenia gravis","EFO_0004991",NA,"Original","Serious","S,O,F",FALSE,FALSE,FALSE,FALSE,FALSE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
91,"CHEMBL2108041",2017,NA,NA,NA,NA,"Ocrevus","Ocrelizumab","OCRELIZUMAB","ENSG00000156738",NA,"Original","Roche/Genentech","CD20-directed cytolytic antibody","Other indication","Relapsing or primary progressive forms of multiple sclerosis","chronic progressive multiple sclerosis","EFO_0003840",NA,"Original","Serious","P,B,F",FALSE,FALSE,FALSE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
96,"CHEMBL2048028",2016,NA,NA,NA,NA,"Xiidra","Lifitegrast","LIFITEGRAST","ENSG00000160255,ENSG00000005844",NA,"Original","Shire Pharmaceuticals","LFA1 antagonist","Other indication","Dry eye disease","dry eye syndrome","EFO_1000906",NA,"Original","Not serious","P",FALSE,FALSE,FALSE,FALSE,FALSE,2016,FALSE,2016,FALSE,FALSE,FALSE,FALSE
106,"CHEMBL4297229",2019,NA,NA,NA,NA,"Jeuveau","Prabotulinumtoxin A","PRABOTULINUMTOXINA","ENSG00000132639",NA,"Original","Evolus","Acetylcholine release inhibitor and a neuromuscular blocking agent","Other indication","Glabellar lines associated with corrugator and/or procerus muscle activity","Facial wrinkling","HP_0009762",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
112,"CHEMBL3707313",2019,NA,NA,NA,NA,"Aklief","Trifarotene","TRIFAROTENE","ENSG00000172819",NA,"Original","Galderma","Retinoic acid receptor agonist","Other indication","Acne vulgaris","acne","EFO_0003894",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
116,"CHEMBL2219418",2014,NA,NA,NA,NA,"Movantik","Naloxegol","NALOXEGOL","ENSG00000112038",NA,"Original","AstraZeneca","Opioid-receptor antagonist","Other indication","Opioid-induced constipation","Constipation","HP_0002019",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
119,"CHEMBL4594250",2017,NA,NA,NA,NA,"Rhopressa","Netarsudil","NETARSUDIL","ENSG00000134318,ENSG00000067900",NA,"Original","Aerie Pharmaceuticals","RHO kinase inhibitor","Other indication","Open-angle glaucoma or ocular hypertension","open-angle glaucoma; ocular hypertension","EFO_0004190,EFO_1001069",NA,"Original","Serious","P",FALSE,FALSE,FALSE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
123,"CHEMBL243712",2020,NA,NA,NA,NA,"Barhemsys","Amisulpride","AMISULPRIDE","ENSG00000151577,ENSG00000149295,ENSG00000164270,ENSG00000157219,ENSG00000158748,ENSG00000166736,ENSG00000186090,ENSG00000178084,ENSG00000102468,ENSG00000149305,ENSG00000179097,ENSG00000135914,ENSG00000178394,ENSG00000168830,ENSG00000147246,ENSG00000186038,ENSG00000148680,ENSG00000135312,ENSG00000179546",NA,"Original","Acacia","Dopamine receptors D2 & D3 antagonist","Other indication","Nausea and vomiting after surgery","Nausea and vomiting","HP_0002017",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
126,"CHEMBL3348963",2017,NA,NA,NA,NA,"Xermelo","Telotristat etiprate","TELOTRISTATETIPRATE","ENSG00000129167,ENSG00000139287",NA,"Original","Lexicon Pharmaceuticals","Tryptophan hydroxylase inhibitor","Other indication","Carcinoid syndrome diarrhoea","carcinoid syndrome; Diarrhea","EFO_1000852,HP_0002014",NA,"Original","Not serious","P,O,F",FALSE,FALSE,FALSE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
139,"CHEMBL4297760",2019,NA,NA,NA,NA,"Givlaari","Givosiran","GIVOSIRAN","ENSG00000023330",NA,"Original","Alnylam","ALAS1-directed siRNA","Other indication","Acute hepatic porphyria","acute hepatic porphyria","Orphanet_95157",NA,"Original","Serious","P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
142,"CHEMBL1743079",2020,NA,NA,NA,NA,"Tepezza","Teprotumumab","TEPROTUMUMAB","ENSG00000140443",NA,"Original","Horizon Therapeutics","IGF1R-directed mAb","Other indication","Thyroid eye disease","Graves disease","EFO_0004237",NA,"Original","Not concordant","P,O,B,F",FALSE,FALSE,FALSE,FALSE,FALSE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
143,"CHEMBL2364612",2017,NA,NA,NA,NA,"Vyzulta","Latanoprostene bunod","LATANOPROSTENEBUNOD","ENSG00000122420",NA,"Original","Bausch and Lomb/Valeant Pharmaceuticals","Prostaglandin analogue","Other indication","Intraocular pressure","intraocular pressure measurement","EFO_0004695",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
144,"CHEMBL2108728",2018,NA,NA,NA,NA,"Asparlas","Calaspargase pegol","CALASPARGASEPEGOL","ENSG00000166183",NA,"Original","Servier","Asparagine specific enzyme","Oncology","ALL","acute lymphoblastic leukemia","EFO_0000220",NA,"Original","Serious","S,O",FALSE,FALSE,FALSE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
150,"CHEMBL354077",2018,NA,NA,NA,NA,"Firdapse","Amifampridine","AMIFAMPRIDINE","ENSG00000130037,ENSG00000182255,ENSG00000173826,ENSG00000111262,ENSG00000178342,ENSG00000131398,ENSG00000140015,ENSG00000055118,ENSG00000168418,ENSG00000143473,ENSG00000183960,ENSG00000151079,ENSG00000184408,ENSG00000116396,ENSG00000171126,ENSG00000168263,ENSG00000026559,ENSG00000170745,ENSG00000185760,ENSG00000135519,ENSG00000184156,ENSG00000075043,ENSG00000117013,ENSG00000158445,ENSG00000166006,ENSG00000129159,ENSG00000124134,ENSG00000156486,ENSG00000143105,ENSG00000182674,ENSG00000053918,ENSG00000089558,ENSG00000177301,ENSG00000162975,ENSG00000102057,ENSG00000184611,ENSG00000171385,ENSG00000177272,ENSG00000104848,ENSG00000164794",NA,"Original","Catalyst Pharmaceuticals","Potassium channel blocker","Other indication","Lambert-Eaton myasthenic syndrome","Lambert-Eaton myasthenic syndrome","Orphanet_43393",NA,"Original","Serious","P,O",FALSE,FALSE,FALSE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
161,"CHEMBL1742991",2017,NA,NA,NA,NA,"Fasenra","Benralizumab","BENRALIZUMAB","ENSG00000091181",NA,"Original","AstraZeneca","IL-5Ralpha-directed monoclonal antibody","Other indication","Serious asthma","Status Asthmaticus","EFO_0008590","MONDO_0004979,MONDO_0004979","Original","Serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
180,"CHEMBL2103867",2017,NA,NA,NA,NA,"Trulance","Plecanatide","PLECANATIDE","ENSG00000070019",NA,"Original","Synergy Pharmaceuticals","Guanylate cyclase C agonist","Other indication","Chronic idiopathic constipation","Chronic constipation","HP_0012450",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
187,"CHEMBL2108738",2014,NA,NA,NA,NA,"Opdivo","Nivolumab","NIVOLUMAB","ENSG00000188389",NA,"Original","Bristol-Myers Squibb","PD1 inhibitor","Oncology","Unresectable or metastatic melanoma","metastatic melanoma","EFO_0002617","EFO_0000756","Original","Serious","P,O,B,A,F",FALSE,FALSE,FALSE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
188,"CHEMBL4297911",2022,NA,NA,NA,NA,"Spevigo","Spesolimab","Spesolimab","ENSG00000115598,ENSG00000196083",NA,"Original","Boehringer Ingelheim","IL-36R-targeted mAb","Other indication","Generalized pustular psoriasis flares","psoriasis 14, pustular","MONDO_0013626",NA,"Original","Not concordant","P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
195,"CHEMBL1743068",2015,NA,NA,NA,NA,"Cosentyx","Secukinumab","SECUKINUMAB","ENSG00000112115",NA,"Original","Novartis","IL-17A antagonist","Other indication","Plaque psoriasis, *psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders.","psoriasis vulgaris","EFO_1001494","EFO_0000676","Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
199,"CHEMBL4297334",2021,NA,NA,NA,NA,"Pylarify","Piflufolastat F-18","PiflufolastatF-18","ENSG00000086205",NA,"Original","Progenics","Radiolabelled PSMA imaging agent","Other indication","Prostate cancer imaging","prostate carcinoma","EFO_0001663",NA,"Original","Serious","P",FALSE,FALSE,FALSE,FALSE,FALSE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
206,"CHEMBL2005186",2021,NA,NA,NA,NA,"Rezurock","Belumosudil","Belumosudil","ENSG00000134318,ENSG00000067900",NA,"Original","Kadmon","ROCK2 kinase inhibitor","Other indication","Chronic GVHD","graft versus host disease","MONDO_0013730",NA,"Original","Serious","P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
217,"CHEMBL2108726",2013,NA,NA,NA,NA,"Lymphoseek kit","Technetium TC 99m tilmanocept","TECHNETIUMTC99MTILMANOCEPT","ENSG00000260314",NA,"Original","Navidea","Radioactive diagnostic agent","Other indication","Lymphatic mapping in patients with breast cancer or melanoma","breast cancer; melanoma","MONDO_0007254,EFO_0000756",NA,"Original","Serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
224,"CHEMBL4594271",2020,NA,NA,NA,NA,"Orladeyo","Berotralstatc","BEROTRALSTAT","ENSG00000164344",NA,"Original","BioCryst","Plasma kallikrein inhibitor","#N/A","Hereditary angioedema","hereditary angioedema","MONDO_0019623",NA,"Original","Serious","S,O,F",FALSE,NA,NA,NA,FALSE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
231,"CHEMBL334966",2015,NA,NA,NA,NA,"Kengreal","Cangrelor","CANGRELOR","ENSG00000169313",NA,"Original","Medicines Company","P2Y12 platelet inhibitor","Other indication","Myocardial infarction, repeat coronary revascularization, and stent thrombosis","myocardial infarction","EFO_0000612",NA,"Original","Serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
234,"CHEMBL2443262",2020,NA,NA,NA,NA,"Olinvyk","Oliceridine","OLICERIDINE","ENSG00000112038",NA,"Original","Trevena","Opioid receptor agonist","Other indication","Acute pain","pain","EFO_0003843",NA,"Original","Not serious","S,F",FALSE,FALSE,FALSE,FALSE,FALSE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
235,"CHEMBL2108354",2022,NA,NA,NA,NA,"Briumvi","Ublituximab","Ublituximab","ENSG00000156738",NA,"Original","TG Therapeutics","CD20-targeted mAb","Other indication","Relapsing forms of multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929","MONDO_0005301","Original","Serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
238,"CHEMBL3707359",2022,NA,NA,NA,NA,"Daxxify","DaxibotulinumtoxinA","DaxibotulinumtoxinA","ENSG00000132639",NA,"Original","Revance","Botulinum toxin","Other indication","Glabellar lines","Facial wrinkling","HP_0009762",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
268,"CHEMBL2108677",2014,NA,NA,NA,NA,"Plegridy","Peginterferon beta-1A","PEGINTERFERONBETA-1A","ENSG00000159110,ENSG00000142166",NA,"Original","Biogen Idec","Long-acting interferon-beta1A","Other indication","Relapsing multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929","MONDO_0005301","Original","Serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
276,"CHEMBL3989871",2021,NA,NA,NA,NA,"Tavneos","Avacopan","Avacopan","ENSG00000197405",NA,"Original","ChemoCentryx","Complement 5a receptor antagonist","Other indication","ANCA-associated vasculitis","Anti-neutrophil cytoplasmic antibody-associated vasculitis","MONDO_0015492",NA,"Original","Serious","S,O",FALSE,FALSE,FALSE,FALSE,FALSE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
289,"CHEMBL2336071",2019,NA,NA,NA,NA,"Mayzent","Siponimod","SIPONIMOD","ENSG00000170989",NA,"Original","Novartis","S1P receptor modulator","Other indication","Relapsing forms of multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929","MONDO_0005301","Original","Serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
290,"CHEMBL117287",2018,NA,NA,NA,NA,"Motegrity","Prucalopride","PRUCALOPRIDE","ENSG00000164270",NA,"Original","Shire/Takeda","5-HT4-receptor agonist","Other indication","Chronic idiopathic constipation","constipation disorder","MONDO_0002203",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
296,"CHEMBL3137343",2014,NA,NA,NA,NA,"Keytruda","Pembrolizumab","PEMBROLIZUMAB","ENSG00000188389",NA,"Original","Merck & Co.","PD1-specific antibody","Oncology","Metastatic melanoma *and others (2021 approval)","metastatic melanoma","EFO_0002617","EFO_0000756","Original","Serious","P,O,B,A",FALSE,FALSE,FALSE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
298,"CHEMBL4297990",2022,NA,NA,NA,NA,"Kimmtrak","Tebentafusp","Tebentafusp","ENSG00000185664",NA,"Original","Immunocore","gp100 peptide HLA _ CD3 bispecific T-cell engager","Oncology","Uveal melanoma","Uveal Melanoma","EFO_1000616",NA,"Original","Serious","P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
313,"CHEMBL1743034",2016,NA,NA,NA,NA,"Taltz","Ixekizumab","IXEKIZUMAB","ENSG00000112115",NA,"Original","Eli Lilly","IL-17A antagonist","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","EFO_0000676","Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2016,FALSE,2016,FALSE,FALSE,FALSE,FALSE
314,"CHEMBL4297832",2022,NA,NA,NA,NA,"Enjaymo","Sutimlimab","Sutimlimab","ENSG00000182326",NA,"Original","Bioverativ","C1s-targeted mAb","Other indication","RBC transfusion due to haemolysis in CAD (cold agglutinin disease)","Anemia, Hemolytic, Autoimmune","EFO_1001264",NA,"Original","Serious","P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
323,"CHEMBL3707331",2015,NA,NA,NA,NA,"Varubi","Rolapitant","ROLAPITANT","ENSG00000115353",NA,"Original","Tesaro","Neurokinin 1 receptor antagonist","Other indication","Nausea and vomiting associated with chemotherapy","Chemotherapy-induced nausea and vomiting","EFO_0006911",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
324,"CHEMBL4297734",2019,NA,NA,NA,NA,"Adakveo","Crizanlizumab","CRIZANLIZUMAB","ENSG00000174175",NA,"Original","Novartis","P-selectin blocker","Other indication","Painful complications of SCD","sickle cell disease and related diseases","MONDO_0017146",NA,"Original","Serious","P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
326,"CHEMBL3545189",2018,NA,NA,NA,NA,"Takhzyro","Lanadelumab","LANADELUMAB","ENSG00000164344",NA,"Original","Dyax/Shire","Kallikrein antibody","Other indication","Hereditary angioedema","hereditary angioedema","MONDO_0019623",NA,"Original","Serious","P,O,B,F",FALSE,FALSE,FALSE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
329,"CHEMBL462605",2019,NA,NA,NA,NA,"Wakix","Pitolisant","PITOLISANT","ENSG00000101180",NA,"Original","Harmony","H3-receptor antagonist/inverse agonist","Other indication","Excessive sleepiness due to narcolepsy","narcolepsy","MONDO_0021107",NA,"Original","Serious","P,O,F",FALSE,FALSE,FALSE,FALSE,FALSE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
330,"CHEMBL298734",2020,NA,NA,NA,NA,"Zokinvy","Lonafarnib","LONAFARNIB","ENSG00000257365,ENSG00000168522",NA,"Original","Eiger","Farnesyltransferase inhibitor","Other indication","HGPS","hutchinson-gilford progeria syndrome","MONDO_0008310",NA,"Original","Serious","P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
331,"CHEMBL231068",2015,NA,NA,NA,NA,"Addyi","Flibanserin","FLIBANSERIN","ENSG00000178394,ENSG00000102468,ENSG00000069696",NA,"Original","Sprout","Serotonin receptor modulator","Other indication","Hypoactive sexual desire disorder","sexual dysfunction","EFO_0004714","EFO_0008343,EFO_0008343","Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
332,"CHEMBL2135460",2022,NA,NA,NA,NA,"Terlivaz","Terlipressin","Terlipressin","ENSG00000166148",NA,"Original","Mallinckrodt","Vasopressin receptor agonist","Other indication","Kidney function in hepatorenal syndrome","Hepatorenal syndrome","MONDO_0001382","HP_0006554","Original","Serious","P,O,F",FALSE,FALSE,FALSE,FALSE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
342,"CHEMBL2109334",2020,NA,NA,NA,NA,"Uplizna","Inebilizumab","INEBILIZUMAB","ENSG00000177455",NA,"Original","Viela Bio","CD19-directed mAb","Other indication","NMOSD","neuromyelitis optica","EFO_0004256","MONDO_0000568","Original","Serious","S,O,B",FALSE,FALSE,FALSE,FALSE,FALSE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
348,"CHEMBL493982",2014,NA,NA,NA,NA,"Zontivity","Vorapaxar","VORAPAXAR","ENSG00000181104",NA,"Original","Merck & Co.","Protease-activated receptor 1 antagonist","Other indication","Thrombotic cardiovascular events (after myocardial infarction or with peripheral arterial disease*)","myocardial infarction; peripheral arterial disease","EFO_0000612,EFO_0004265",NA,"Original","Serious","S,F",FALSE,FALSE,FALSE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
351,"CHEMBL4297412",2021,NA,NA,NA,NA,"Cytalux","Pafolacianine","Pafolacianine","ENSG00000110195",NA,"Original","On Target Labs","Fluorescent FR imaging agent","Other indication","Ovarian cancer imaging","ovarian carcinoma","EFO_0001075",NA,"Original","Serious","P,O,F",FALSE,FALSE,FALSE,FALSE,FALSE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
360,"CHEMBL1189679,CHEMBL3989917",2018,NA,NA,NA,NA,"Akynzeo IV","Palonosetron, fosnetupitant","PALONOSETRON,FOSNETUPITANT","ENSG00000166736,ENSG00000115353",NA,"Original","Helsinn Group","5-HT3-receptor antagonist and NK1-receptor antagonist","Other indication","Chemotherapy-induced emesis","Chemotherapy-induced nausea and vomiting","EFO_0006911",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
361,"CHEMBL3039520",2019,NA,NA,NA,NA,"Reyvow","Lasmiditan","LASMIDITAN","ENSG00000179097",NA,"Original","Eli Lilly","Serotonin (5-HT) 1F receptor agonist","Other indication","Migraine with or without aura","migraine disorder","MONDO_0005277",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
376,"CHEMBL3545313",2020,NA,NA,NA,NA,"Nexletol","Bempedoic acid","BEMPEDOICACID","ENSG00000131473",NA,"Original","Esperion Therapeutics","ACL inhibitor","Other indication","HeFH or atherosclerotic cardiovascular disease","atherosclerosis; familial hypercholesterolemia","EFO_0003914,EFO_0004911",NA,"Original","Serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
381,"CHEMBL4297741",2021,NA,NA,NA,NA,"Zegalogue","Dasiglucagon","Dasiglucagon","ENSG00000215644",NA,"Original","Zealand Pharma","Glucagon receptor agonist","Other indication","Serious hypoglycaemia","GCGR-related hyperglucagonemia","EFO_0001360",NA,"Original","Serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
386,"CHEMBL2105755",2017,NA,NA,NA,NA,"Symproic","Naldemedine","NALDEMEDINE","ENSG00000112038",NA,"Original","Shionogi","Opioid antagonist","Other indication","Opioid-induced constipation","Constipation","HP_0002019",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
387,"CHEMBL238804",2015,NA,NA,NA,NA,"Uptravi","Selexipag","SELEXIPAG","ENSG00000160013",NA,"Original","Actelion","Prostacyclin receptor agonist","Other indication","Pulmonary arterial hypertension","pulmonary arterial hypertension","EFO_0001361","EFO_0000537","Original","Serious","S,O",FALSE,FALSE,FALSE,FALSE,FALSE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
394,"CHEMBL306700",2021,NA,NA,NA,NA,"Qelbree","Viloxazine","Viloxazine","ENSG00000103546",NA,"Original","Supernus","SNRI","Other indication","ADHD","attention deficit hyperactivity disorder","EFO_0003888",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
404,"CHEMBL4297573",2018,NA,NA,NA,NA,"Elzonris","Tagraxofusp","TAGRAXOFUSP","ENSG00000167658,ENSG00000185291",NA,"Original","Stemline Therapeutics","IL-3 and diphtheria toxin fusion protein","Oncology","Blastic plasmacytoid dendritic cell neoplasm","blastic plasmacytoid dendritic cell neoplasm","EFO_0010580",NA,"Original","Serious","P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
407,"CHEMBL3989915",2021,NA,NA,NA,NA,"Korsuva","Difelikefalin","Difelikefalin","ENSG00000082556",NA,"Original","Cara Therapeutics","kappa-Opioid receptor agonist","Other indication","Pruritus associated with CKD","chronic kidney disease","EFO_0003884","HP_0012594","Original","Serious","P,B",FALSE,FALSE,FALSE,FALSE,FALSE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
409,"CHEMBL4297666",2022,NA,NA,NA,NA,"Omlonti","Omidenepag isopropyl","Omidenepagisopropyl","ENSG00000125384",NA,"Original","Santen","Prostaglandin E2 receptor agonist","Other indication","Intraocular pressure in open-angle glaucoma or ocular hypertension","ocular hypertension, open-angle glaucoma","EFO_1001069,EFO_0004190",NA,"Original","Serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
422,"CHEMBL2110588",2014,NA,NA,NA,NA,"Cerdelga","Eliglustat","ELIGLUSTAT","ENSG00000148154",NA,"Original","Genzyme","Glucosylceramide-synthase inhibitor","Other indication","Gaucher's disease","Gaucher disease","MONDO_0018150",NA,"Original","Serious","P,O",FALSE,FALSE,FALSE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
427,"CHEMBL4297779",2020,NA,NA,NA,NA,"Oxlumo","Lumasiran","LUMASIRAN","ENSG00000101323",NA,"Original","Alnylam","HAO1-directed siRNA","Other indication","Hyperoxaluria type 1","primary hyperoxaluria type 1","MONDO_0009823",NA,"Original","Serious","P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
0,"CHEMBL2146883",2015,2011,2002,NA,NA,"Cotellic","Cobimetinib","COBIMETINIB","ENSG00000126934,ENSG00000169032","ENSG00000132155,ENSG00000157764,ENSG00000078061,ENSG00000100030,ENSG00000108953,ENSG00000102882,ENSG00000109971,ENSG00000137693,ENSG00000141068,ENSG00000142192,ENSG00000166913,ENSG00000172530","Original","Genentech","MEK inhibitor","Oncology","Melanoma with BRAFV600E/K mutations","melanoma","EFO_0000756",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
1,"CHEMBL1096146",2021,NA,2013,NA,NA,"Ponvory","Ponesimod","Ponesimod","ENSG00000170989","ENSG00000110848","Interactor","J&J","S1P receptor modulator","Other indication","Relapsing multiple sclerosis","multiple sclerosis","MONDO_0005301",NA,"Original","Serious","S",TRUE,TRUE,FALSE,FALSE,FALSE,2021,TRUE,2021,TRUE,FALSE,FALSE,FALSE
2,"CHEMBL1983268",2019,2000,1975,NA,NA,"Rozlytrek","Entrectinib","ENTRECTINIB","ENSG00000148053,ENSG00000198400,ENSG00000140538,ENSG00000047936,ENSG00000171094","ENSG00000105976,ENSG00000146648,ENSG00000165731,ENSG00000171094,ENSG00000198400,ENSG00000081237,ENSG00000096384,ENSG00000111679,ENSG00000124181,ENSG00000127329,ENSG00000135333,ENSG00000140538,ENSG00000145675,ENSG00000162733,ENSG00000206503,ENSG00000160691,ENSG00000006125,ENSG00000071537,ENSG00000127947,ENSG00000134259,ENSG00000142192,ENSG00000149177","Original","Roche","TRKA, TRKB, TRKC, ROS1 and ALK inhibitor","Oncology","NTRK fusion-positive solid tumours and ROS1-positive NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
3,"CHEMBL4297774",2021,1975,1975,NA,NA,"Rybrevant","Amivantamab","Amivantamab","ENSG00000105976,ENSG00000146648","ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000178568,ENSG00000010671,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000080824,ENSG00000081237,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000135605,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000140538,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000152894,ENSG00000153707,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000182866,ENSG00000185338,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000007264,ENSG00000010017,ENSG00000011485,ENSG00000019991,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000070159,ENSG00000071051,ENSG00000071537,ENSG00000074966,ENSG00000087586,ENSG00000088930,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115290,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000134215,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000141738,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000160293,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000198753,ENSG00000213658,ENSG00000253729","Original","J&J","EGFRxMETR bispecific antibody","Oncology","EGFR exon 20-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
4,"CHEMBL1743047",2015,1975,1975,NA,NA,"Portrazza","Necitumumab","NECITUMUMAB","ENSG00000146648","ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000178568,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000080824,ENSG00000081237,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000153707,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000011485,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000071051,ENSG00000071537,ENSG00000087586,ENSG00000088930,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000213658,ENSG00000253729","Original","Eli Lilly","EGFR antagonist","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","S,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2015,TRUE,2015,FALSE,FALSE,FALSE,TRUE
5,"CHEMBL3183409",2018,1984,1984,NA,NA,"Erleada","Apalutamide","APALUTAMIDE","ENSG00000169083","ENSG00000169083,ENSG00000005339,ENSG00000010671,ENSG00000084676,ENSG00000089280,ENSG00000097007,ENSG00000101213,ENSG00000106462,ENSG00000109685,ENSG00000110092,ENSG00000118058,ENSG00000124181,ENSG00000129514,ENSG00000136504,ENSG00000136826,ENSG00000140396,ENSG00000141027,ENSG00000141867,ENSG00000141968,ENSG00000143322,ENSG00000145675,ENSG00000157554,ENSG00000159388,ENSG00000165025,ENSG00000167548,ENSG00000168036,ENSG00000179295,ENSG00000182511,ENSG00000182866,ENSG00000184634,ENSG00000197122,ENSG00000204209,ENSG00000254087,ENSG00000125686,ENSG00000142515,ENSG00000145715,ENSG00000160691,ENSG00000266412","Original","Johnson & Johnson","Androgen receptor inhibitor","Oncology","Prostate cancer","prostate cancer","MONDO_0008315",NA,"Original","Serious","P,F",TRUE,FALSE,FALSE,FALSE,TRUE,2018,TRUE,2018,FALSE,FALSE,FALSE,TRUE
6,"CHEMBL3707290",2020,1993,1993,NA,NA,"Sogroya","Somapacitan","SOMAPACITAN","ENSG00000112964","ENSG00000112964,ENSG00000196396","Original","Novo Nordisk","Growth hormone analogue","Other indication","Growth hormone deficiency","short stature due to partial GHR deficiency","MONDO_0011420",NA,"Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2020,TRUE,2020,FALSE,FALSE,FALSE,TRUE
7,"CHEMBL3833320",2020,NA,1998,NA,NA,"Vyepti","Eptinezumab","EPTINEZUMAB","ENSG00000110680,ENSG00000175868","ENSG00000157087,ENSG00000110680","Original","Lundbeck","CGRP-directed mAb","Other indication","Migraine","migraine disorder","MONDO_0005277",NA,"Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
9,"CHEMBL4297839",2022,1996,2016,1996,NA,"Mounjaro","Tirzepatide","Tirzepatide","ENSG00000010310,ENSG00000112164","NA,ENSG00000159224","Original","Eli Lilly","GIP receptor and GLP1 receptor agonist","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","HP_0003076,Orphanet_79161","Original","Not concordant","S",TRUE,FALSE,FALSE,FALSE,TRUE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
10,"CHEMBL3545184",2017,1982,1982,NA,NA,"Parsabiv","Etelcalcetide","VELCALCETIDE","ENSG00000036828","ENSG00000036828","Original","Amgen/Kai Pharmaceuticals","Calcium-sensing receptor agonist","Other indication","Secondary hyperparathyroidism in patients with chronic kidney disease on haemodialysis","hyperparathyroidism","EFO_0008506",NA,"Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2017,TRUE,2017,FALSE,FALSE,FALSE,TRUE
11,"CHEMBL4297522",2020,2017,NA,NA,NA,"Pemazyre","Pemigatinib","PEMIGATINIB","ENSG00000066468,ENSG00000068078,ENSG00000077782","ENSG00000066468,ENSG00000065361,ENSG00000145675","Original","Incyte","FGFR1-3 kinase inhibitor","Oncology","Cholangiocarcinoma","cholangiocarcinoma","EFO_0005221",NA,"Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
12,"CHEMBL3402762",2021,2005,1975,NA,NA,"Tepmetko","Tepotinib","Tepotinib","ENSG00000105976","ENSG00000105976,ENSG00000146648,ENSG00000010671,ENSG00000081237,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000135605,ENSG00000140538,ENSG00000143322,ENSG00000145675,ENSG00000152894,ENSG00000165025,ENSG00000179295,ENSG00000182511,ENSG00000182866,ENSG00000185338,ENSG00000197122,ENSG00000254087,ENSG00000160691,ENSG00000177885,ENSG00000101336,ENSG00000136205,ENSG00000000938,ENSG00000007264,ENSG00000010017,ENSG00000019991,ENSG00000070159,ENSG00000071051,ENSG00000074966,ENSG00000105647,ENSG00000115290,ENSG00000117461,ENSG00000127947,ENSG00000131746,ENSG00000134215,ENSG00000141738,ENSG00000145715,ENSG00000149177,ENSG00000158092,ENSG00000160293,ENSG00000176105,ENSG00000197943,ENSG00000198753","Original","EMD Serono","MET kinase inhibitor","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,O,A",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
13,"CHEMBL3545311",2017,1975,1975,NA,NA,"Alunbrig","Brigatinib","BRIGATINIB","ENSG00000171094,ENSG00000146648","ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000171094,ENSG00000178568,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000080824,ENSG00000081237,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000153707,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000011485,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000071051,ENSG00000071537,ENSG00000087586,ENSG00000088930,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000213658,ENSG00000253729","Original","Ariad Pharmaceuticals/Takeda","ALK inhibitor","Oncology","ALK-positive NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
14,"CHEMBL3237547,CHEMBL1201129",2020,2011,1978,NA,NA,"Inqovi","Cedazuridine, decitabine","CEDAZURIDINE,DECITABINE","ENSG00000158825,ENSG00000119772,ENSG00000130816","ENSG00000106462,ENSG00000119772,ENSG00000163041,ENSG00000109101,ENSG00000198945","Original","Otsuka","Cytidine deaminase inhibitor; nucleoside metabolic inhibitor","Other indication","Myelodysplastic syndromes","myelodysplastic syndrome","EFO_0000198",NA,"Original","Serious","P,O",TRUE,FALSE,FALSE,FALSE,TRUE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
16,"CHEMBL3707357",2019,2013,2011,NA,NA,"Beovu","Brolucizumab","BROLUCIZUMAB","ENSG00000112715","ENSG00000099250,ENSG00000112715","Original","Novartis","VEGF inhibitor","Other indication","Wet age-related macular degeneration","macular degeneration","EFO_0009606",NA,"Original","Not concordant","S",TRUE,FALSE,FALSE,FALSE,TRUE,2019,TRUE,2019,FALSE,FALSE,FALSE,TRUE
17,"CHEMBL1089318",2020,NA,2005,NA,NA,"Ongentys","Opicapone","OPICAPONE","ENSG00000093010","ENSG00000103266,ENSG00000109501,ENSG00000099377","Original","Neurocrine","COMT inhibitor","Other indication","Parkinson disease","parkinson disease","MONDO_0005180",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2020,TRUE,2020,FALSE,FALSE,FALSE,TRUE
19,"CHEMBL2105720",2015,2017,NA,NA,NA,"Zurampic","Lesinurad","LESINURAD","ENSG00000197891",NA,"Original","AstraZeneca","URAT1 inhibitor","Other indication","Gout","gout","EFO_0004274",NA,"Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2015,TRUE,2015,FALSE,FALSE,FALSE,TRUE
20,"CHEMBL4298124",2021,NA,2017,NA,NA,"Jemperli","Dostarlimab","Dostarlimab","ENSG00000188389","ENSG00000120217,ENSG00000179295,ENSG00000197646,ENSG00000006125","Original","GlaxoSmithKline","PD1-targeted mAb","Oncology","Endometrial cancer","endometrial cancer","MONDO_0011962",NA,"Original","Serious","P,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
21,"CHEMBL1269025",2015,NA,2021,NA,NA,"Savaysa","Edoxaban","EDOXABAN","ENSG00000126218","ENSG00000117601,NA","Original","Daiichi Sankyo","Factor Xa inhibitor","Other indication","Risk of stroke and systemic embolism in NVAF, and deep vein thrombosis","atrial fibrillation; deep vein thrombosis","EFO_0000275,EFO_0003907",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
22,"CHEMBL1743029",2018,NA,1996,NA,NA,"Trogarzo","Ibalizumab","IBALIZUMAB","ENSG00000010610","ENSG00000160791","Interactor","TaiMed Biologics/Theratechnologies","CD4 antibody","Other indication","HIV","hiv infection","EFO_0000764",NA,"Original","Serious","P,O,B,F",TRUE,TRUE,FALSE,FALSE,FALSE,2018,TRUE,2018,TRUE,FALSE,FALSE,FALSE
27,"CHEMBL2364639",2017,1997,1994,NA,NA,"Ingrezza","Valbenazine","VALBENAZINE","ENSG00000165646","ENSG00000173250,ENSG00000139514,ENSG00000180871,NA","Original","Neurocrine Biosciences","VMAT2 inhibitor","Other indication","Tardive dyskinesia","movement disorder","EFO_0004280",NA,"Original","Not concordant","P,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2017,TRUE,2017,FALSE,FALSE,FALSE,TRUE
28,"CHEMBL3989868",2020,2010,2010,NA,NA,"Tukysa","Tucatinib","TUCATINIB","ENSG00000141736","ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000085832,ENSG00000096384,ENSG00000097007,ENSG00000101213,ENSG00000111252,ENSG00000113263,ENSG00000123983,ENSG00000124181,ENSG00000127329,ENSG00000135605,ENSG00000141736,ENSG00000141968,ENSG00000143322,ENSG00000145675,ENSG00000146648,ENSG00000152894,ENSG00000153201,ENSG00000157168,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000168610,ENSG00000178568,ENSG00000179295,ENSG00000197122","Original","Seagen","HER2 kinase inhibitor","Oncology","HER2-positive breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2020,TRUE,2020,FALSE,FALSE,FALSE,TRUE
29,"CHEMBL2108675",2017,1998,1975,1998,1975,"Dupixent","Dupilumab","DUPILUMAB","ENSG00000077238","ENSG00000077238,ENSG00000111679,ENSG00000113520,ENSG00000131724,ENSG00000166888","Original","Regeneron/Sanofi","IL-4Ralpha antagonist","Other indication","Atopic dermatitis","atopic eczema","EFO_0000274","HP_0000964,MONDO_0002406","Original","Not serious","P,B",TRUE,FALSE,FALSE,FALSE,TRUE,2017,TRUE,2017,FALSE,FALSE,FALSE,TRUE
30,"CHEMBL3545262",2020,2017,2017,NA,NA,"Trodelvy","Sacituzumab govitecan","SACITUZUMABGOVITECAN","ENSG00000198900,ENSG00000184292","ENSG00000091831,ENSG00000097007,ENSG00000122566,ENSG00000136997,ENSG00000147140,ENSG00000181163","Original","Immunomedics/Gilead","TROP2-directed ADC, with topoisomerase inhibitor","Oncology","Triple-negative breast cancer (and advanced or metastatic urothelial cancer (mUC)*)","triple-negative breast cancer; urothelial carcinoma","EFO_0005537,EFO_0008528",NA,"Original","Serious","P,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
31,"CHEMBL3813873",2019,NA,NA,2021,NA,"Turalio","Pexidartinib","PEXIDARTINIB","ENSG00000182578,ENSG00000122025,ENSG00000157404",NA,"Original","Daiichi Sankyo","CSF1R, KIT and FLT3 inhibitor","Oncology","Tenosynovial giant cell tumour","Tenosynovial Giant Cell Tumor","EFO_1000562","MONDO_0002171","Related","Serious","P,O,B",TRUE,FALSE,TRUE,FALSE,FALSE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
32,"CHEMBL3301610",2017,NA,NA,2008,2015,"Verzenio","Abemaciclib","ABEMACICLIB","ENSG00000105810,ENSG00000135446","ENSG00000110092,ENSG00000179750","Interactor","Eli Lilly","CDK4/6 inhibitor","Oncology","HR-positive, HER2-negative breast cancer","HER2 negative breast carcinoma","EFO_0009780","EFO_0000305","Related","Serious","P,B,F",TRUE,TRUE,TRUE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
34,"CHEMBL3353410",2015,1975,1975,NA,NA,"Tagrisso","Osimertinib","OSIMERTINIB","ENSG00000146648","ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000178568,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000080824,ENSG00000081237,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000153707,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000011485,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000071051,ENSG00000071537,ENSG00000087586,ENSG00000088930,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000213658,ENSG00000253729","Original","AstraZeneca","EGFR inhibitor","Oncology","NSCLC with EGFRT790M mutations","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2015,TRUE,2015,FALSE,FALSE,FALSE,TRUE
35,"CHEMBL4585668",2021,NA,1993,2017,1993,"Welireg","Belzutifan","Belzutifan","ENSG00000116016","ENSG00000134086","Interactor","Merck & Co.","HIF-2alpha inhibitor","Oncology","von Hippel-Lindau disease","von Hippel-Lindau disease","MONDO_0008667","EFO_0000681","Related","Serious","P,O",TRUE,TRUE,TRUE,FALSE,FALSE,2021,TRUE,2021,TRUE,TRUE,FALSE,FALSE
37,"CHEMBL426084,CHEMBL715",2021,1997,1994,NA,NA,"Lybalvi","Olanzapine, samidorphan","samidorphan,Olanzapine","ENSG00000112038,ENSG00000116329,ENSG00000082556,ENSG00000102468,ENSG00000147246,ENSG00000151577,ENSG00000069696,ENSG00000149295","ENSG00000162975,ENSG00000078369,ENSG00000102468,ENSG00000118432,ENSG00000128271,ENSG00000142192,ENSG00000142319,ENSG00000147246,ENSG00000147955,ENSG00000162946,ENSG00000164082,ENSG00000180720,ENSG00000103042,ENSG00000132965,ENSG00000174437,ENSG00000205279,ENSG00000134640,ENSG00000149295,NA","Original","Alkermes","Atypical antipsychotic and opioid antagonist","Other indication","Schizophrenia and bipolar I disorder","Schizophrenia; bipolar I disorder","MONDO_0005090,EFO_0009963",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
38,"CHEMBL190461",2018,NA,NA,2001,NA,"Epidiolex","Cannabidiol","CANNABIDIOL","ENSG00000118432",NA,"Original","GW Pharmaceuticals","Cannabinoid","Other indication","Dravet syndrome and Lennox-Gastaut syndrome","Dravet syndrome; Lennox-Gastaut syndrome","Orphanet_33069,MONDO_0016532","MONDO_0020072","Related","Serious","P,O,F",TRUE,FALSE,TRUE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
39,"CHEMBL4101807",2019,1996,1996,NA,NA,"Oxbryta","Voxelotor","VOXELOTOR","ENSG00000206172,ENSG00000244734,ENSG00000188536","ENSG00000244734,ENSG00000130656,ENSG00000169877,ENSG00000176155,ENSG00000188536,ENSG00000206172,ENSG00000196565,ENSG00000213931","Original","Global Blood Therapeutics","Haemoglobin S polymerization inhibitor","Other indication","SCD (sickle cell disease)","sickle cell anemia","MONDO_0011382",NA,"Original","Serious","P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
40,"CHEMBL2105719",2018,1975,1975,NA,NA,"Vizimpro","Dacomitinib","DACOMITINIB","ENSG00000178568,ENSG00000146648,ENSG00000141736","ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000178568,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000085832,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000123983,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000135605,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000152894,ENSG00000153201,ENSG00000153707,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000185338,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000075624,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000007264,ENSG00000010810,ENSG00000011485,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000070159,ENSG00000071051,ENSG00000071537,ENSG00000074966,ENSG00000078747,ENSG00000087586,ENSG00000088930,ENSG00000090776,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000132535,ENSG00000134215,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138095,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000141738,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000160293,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000173406,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000213658,ENSG00000253729","Original","Pfizer","EGFR inhibitor","Oncology","EGFR-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,O",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
41,"CHEMBL2035187",2022,1995,1995,NA,NA,"Vonjo","Pacritinib","Pacritinib","ENSG00000096968,ENSG00000122025","ENSG00000096968,ENSG00000097007,ENSG00000117400,ENSG00000122025,ENSG00000179295","Original","CTI Biopharma","JAK2 inhibitor","Oncology","Myelofibrosis","myelofibrosis","MONDO_0044903",NA,"Original","Serious","P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
42,"CHEMBL3894860",2021,2017,1989,NA,NA,"Cosela","Trilaciclib","Trilaciclib","ENSG00000135446,ENSG00000105810","ENSG00000096384,ENSG00000106462,ENSG00000110092,ENSG00000111087,ENSG00000111276,ENSG00000112576,ENSG00000118689,ENSG00000118971,ENSG00000119866,ENSG00000123080,ENSG00000124762,ENSG00000136754,ENSG00000136997,ENSG00000137497,ENSG00000139687,ENSG00000140464,ENSG00000143379,ENSG00000147130,ENSG00000147889,ENSG00000148516,ENSG00000159216,ENSG00000161405,ENSG00000161547,ENSG00000171843,ENSG00000065328,ENSG00000103479","Original","G1 Therapeutics","CDK4 and CDK6 kinase inhibitor","Oncology","Chemotherapy-induced myelosuppression","myelosuppression; small cell lung carcinoma","EFO_0007053,EFO_0000702",NA,"Original","Serious","P,B",TRUE,FALSE,FALSE,FALSE,TRUE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
43,"CHEMBL4298047",2020,NA,NA,1995,NA,"Monjuvi","Tafasitamab","TAFASITAMAB","ENSG00000177455",NA,"Original","MorphoSys","CD19-directed mAb","Oncology","DLBCL","diffuse large b-cell lymphoma","EFO_0000403","EFO_1001938","Related","Serious","P,O,B,A,F",TRUE,FALSE,TRUE,FALSE,FALSE,2020,TRUE,2020,FALSE,TRUE,FALSE,FALSE
44,"CHEMBL2364655",2015,NA,2020,NA,NA,"Repatha","Evolocumab","EVOLOCUMAB","ENSG00000169174","ENSG00000130164","Interactor","Amgen","PCSK9 inhibitor","Other indication","LDL lowering","LDL cholesterol change measurement","EFO_0007804",NA,"Original","Not serious","S,O",TRUE,TRUE,FALSE,FALSE,FALSE,2015,TRUE,2015,TRUE,FALSE,FALSE,FALSE
47,"CHEMBL2105737",2015,1998,1996,NA,NA,"Odomzo","Sonidegib","SONIDEGIB","ENSG00000128602","ENSG00000185920","Original","Novartis","Smoothened inhibitor","Oncology","Basal cell carcinoma","basal cell carcinoma","EFO_0004193",NA,"Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2015,TRUE,2015,FALSE,FALSE,FALSE,TRUE
48,"CHEMBL502835",2014,NA,1975,NA,NA,"Ofev","Nintedanib","NINTEDANIB","ENSG00000102755,ENSG00000037280,ENSG00000128052,ENSG00000066468,ENSG00000077782,ENSG00000160867,ENSG00000134853,ENSG00000113721,ENSG00000068078","ENSG00000102678,ENSG00000111679,ENSG00000125968,ENSG00000197461,ENSG00000140320","Interactor","Boehringer Ingelheim","Kinase inhibitor against PDGFRs, FGFRs, VEGFRs and FLT3","Other indication","IPF (idiopathic pulmonary fibrosis)","idiopathic pulmonary fibrosis","EFO_0000768",NA,"Original","Serious","P,O,B,F",TRUE,TRUE,FALSE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
49,"CHEMBL3989986",2018,NA,2007,NA,NA,"Ultomiris","Ravulizumab","RAVULIZUMAB","ENSG00000106804","ENSG00000244414","Interactor","Alexion","Complement inhibitor","Other indication","Paroxysmal nocturnal haemoglobinuria, atypical hemolytic uremic syndrome (*), generalized myasthenia gravis AChR+ (*)","paroxysmal nocturnal hemoglobinuria, atypical hemolytic-uremic syndrome, Myasthenia gravis","MONDO_0100244,MONDO_0016244,EFO_0004991",NA,"Related","Serious","S,O",TRUE,FALSE,TRUE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
51,"CHEMBL1743081",2021,1998,2003,1998,2003,"Adbry","Tralokinumab","Tralokinumab","ENSG00000169194","ENSG00000123496,ENSG00000131724,NA","Original","LEO Pharma","IL-13-targeted mAb","Other indication","Atopic dermatitis","atopic eczema","EFO_0000274","HP_0000964,MONDO_0002406","Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
52,"CHEMBL4297566",2021,1988,NA,NA,NA,"Amondys 45","Casimersen","Casimersen","ENSG00000198947","ENSG00000101400,NA","Original","Sarepta","Exon 45-skipping ASO","Other indication","DMD","Duchenne muscular dystrophy","MONDO_0010679",NA,"Original","Serious","P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
56,"CHEMBL4297526",2020,NA,NA,2019,NA,"Byfavo","Remimazolam","REMIMAZOLAM","ENSG00000102287,ENSG00000163288,ENSG00000186297,ENSG00000145864,ENSG00000113327,ENSG00000011677,ENSG00000094755,ENSG00000163285,ENSG00000151834,ENSG00000109158,ENSG00000268089,ENSG00000187730,ENSG00000182256,ENSG00000022355,ENSG00000145863,ENSG00000166206",NA,"Original","Acacia","Benzodiazepine","Other indication","Procedural sedation","sedation","EFO_0009868","EFO_0003843","Related","Not serious","S",TRUE,FALSE,TRUE,FALSE,FALSE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
58,"CHEMBL3990033",2021,2018,2018,NA,NA,"Leqvio","Inclisiran","Inclisiran","ENSG00000169174","ENSG00000130164,ENSG00000169174","Original","Novartis/Alnylam","PCSK9-targeted siRNA","Other indication","HeFH or ASCVD","coronary atherosclerosis","MONDO_0021661",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
59,"CHEMBL180022",2017,2010,2010,NA,NA,"Nerlynx","Neratinib","NERATINIB","ENSG00000178568,ENSG00000146648,ENSG00000141736","ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000085832,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000105976,ENSG00000110395,ENSG00000111252,ENSG00000113263,ENSG00000123983,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000134853,ENSG00000135605,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141736,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000146648,ENSG00000152894,ENSG00000153201,ENSG00000153707,ENSG00000157168,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000165731,ENSG00000168036,ENSG00000168610,ENSG00000178568,ENSG00000179295,ENSG00000197122,ENSG00000198561,ENSG00000254087","Original","Puma Biotechnology","EGFR, HER2 and HER4 irreversible kinase inhibitor","Oncology","HER2-overexpressed breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
61,"CHEMBL3544914,CHEMBL4298128,CHEMBL2010601",2019,1990,1990,NA,NA,"Trikafta","Tezacaftor, elexacaftor, ivacaftor","TEZACAFTOR,ELEXACAFTOR,IVACAFTOR","ENSG00000001626,ENSG00000001626,ENSG00000001626","ENSG00000001626,ENSG00000001626,ENSG00000001626,ENSG00000170421,ENSG00000253729,ENSG00000170421,ENSG00000253729,ENSG00000170421,ENSG00000253729,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972","Original","Vertex","Two CFTR correctors and a CFTR potentiator","Other indication","Most common gene mutation that causes cystic fibrosis","cystic fibrosis","MONDO_0009061",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
62,"CHEMBL4650319",2021,1975,1975,NA,NA,"Exkivity","Mobocertinib","Mobocertinib","ENSG00000146648","ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000178568,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000080824,ENSG00000081237,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000153707,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000011485,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000071051,ENSG00000071537,ENSG00000087586,ENSG00000088930,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000213658,ENSG00000253729","Original","Takeda","EGFR kinase inhibitor","Oncology","EGFR exon 20-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
63,"CHEMBL2105760",2015,2006,1997,NA,NA,"Rexulti","Brexpiprazole","BREXPIPRAZOLE","ENSG00000149295,ENSG00000178394,ENSG00000102468","ENSG00000078369,ENSG00000102468,ENSG00000118432,ENSG00000128271,ENSG00000142319,ENSG00000147246,ENSG00000147955,ENSG00000162946,ENSG00000164082,ENSG00000077782,ENSG00000149295","Original","Otsuka","Atypical antipsychotic","Other indication","MDD and schizophrenia","major depressive disorder; schizophrenia","MONDO_0002009,MONDO_0005090",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
65,"CHEMBL2107831",2018,1994,1998,NA,NA,"Mulpleta","Lusutrombopag","LUSUTROMBOPAG","ENSG00000117400","NA,ENSG00000096968","Original","Shionogi","Thrombopoietin receptor agonist","Other indication","Thrombocytopenia","thrombocytopenia","HP_0001873",NA,"Original","Not concordant","P,F",TRUE,FALSE,FALSE,FALSE,TRUE,2018,TRUE,2018,FALSE,FALSE,FALSE,TRUE
67,"CHEMBL4297339",2020,NA,2013,NA,NA,"Copper dotatate Cu-64","Copper dotatate Cu-64","COPPERDOTATATECU-64","ENSG00000180616","ENSG00000145675","Interactor","Radiomedix","Radioactive diagnostic","Other indication","Imaging, cancer","neuroendocrine neoplasm","EFO_1001901",NA,"Original","Serious","P,O,F",TRUE,TRUE,FALSE,FALSE,FALSE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
68,"CHEMBL2103873",2013,NA,NA,2021,NA,"Opsumit","Macitentan","MACITENTAN","ENSG00000136160,ENSG00000151617",NA,"Original","Actelion","Endothelin receptor antagonist","Other indication","Pulmonary arterial hypertension","pulmonary arterial hypertension","EFO_0001361","EFO_0000537","Related","Serious","S,O",TRUE,FALSE,TRUE,FALSE,FALSE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
69,"CHEMBL4594505",2022,NA,1997,1998,1997,"Tecvayli","Teclistamab","Teclistamab","ENSG00000048462,ENSG00000160654,ENSG00000198851,ENSG00000167286","ENSG00000126777,ENSG00000115085,ENSG00000213658,ENSG00000158092,ENSG00000169550","Interactor","J&J","BCMA _ CD3 bispecific antibody","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","MONDO_0004095","Related","Serious","P,O,B,A",TRUE,TRUE,TRUE,TRUE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
71,"CHEMBL2010601,CHEMBL2103870",2015,1990,1990,NA,NA,"Orkambi","Ivacaftor, lumacaftor","IVACAFTOR,LUMACAFTOR","ENSG00000001626,ENSG00000001626","ENSG00000001626,ENSG00000001626,ENSG00000170421,ENSG00000253729,ENSG00000170421,ENSG00000253729,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972","Original","Vertex","CFTR potentiator plus CFTR corrector","Other indication","Cystic fibrosis in patients with homozygous DF508 CFTR mutation","cystic fibrosis","MONDO_0009061",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
72,"CHEMBL3301582",2019,2011,1994,2001,1983,"Polivy","Polatuzumab vedotin","POLATUZUMABVEDOTIN","ENSG00000198033,ENSG00000167552,ENSG00000261456,ENSG00000176014,ENSG00000258947,ENSG00000123416,ENSG00000101162,ENSG00000188229,ENSG00000152086,ENSG00000007312,ENSG00000137285,ENSG00000167553,ENSG00000196230,ENSG00000137267,ENSG00000127824,ENSG00000104833","ENSG00000007312,ENSG00000065361,ENSG00000080824,ENSG00000083799,ENSG00000091831,ENSG00000126934,ENSG00000130779,ENSG00000133124,ENSG00000136997,ENSG00000146648,ENSG00000177606,ENSG00000179218","Original","Roche","CD79b-directed ADC","Oncology","Diffuse large B-cell lymphoma","diffuse large b-cell lymphoma","EFO_0000403","EFO_1001938","Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
75,"CHEMBL259571",2022,NA,NA,2016,NA,"Vtama","Tapinarof","Tapinarof","ENSG00000106546",NA,"Original","Dermavant","Aryl hydrocarbon receptor agonist","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","EFO_0000676","Related","Not serious","S",TRUE,FALSE,TRUE,FALSE,FALSE,2022,TRUE,2022,FALSE,TRUE,FALSE,FALSE
78,"CHEMBL2141296",2015,NA,1994,2007,1983,"Ninlaro","Ixazomib","IXAZOMIB","ENSG00000165916,ENSG00000240065,ENSG00000159377,ENSG00000108671,ENSG00000100804,ENSG00000161057,ENSG00000154611,ENSG00000159352,ENSG00000100902,ENSG00000013275,ENSG00000173692,ENSG00000101182,ENSG00000103035,ENSG00000129084,ENSG00000142507,ENSG00000222028,ENSG00000197170,ENSG00000175166,ENSG00000205220,ENSG00000100764,ENSG00000277791,ENSG00000136930,ENSG00000099341,ENSG00000163636,ENSG00000185627,ENSG00000127922,ENSG00000115233,ENSG00000087191,ENSG00000108344,ENSG00000204264,ENSG00000100519,ENSG00000100567,ENSG00000143106,ENSG00000126067,ENSG00000130706,ENSG00000106588,ENSG00000008018,ENSG00000041357","ENSG00000068078,ENSG00000136997,ENSG00000072062,ENSG00000073584,ENSG00000076242,ENSG00000084676,ENSG00000089280,ENSG00000091831,ENSG00000099956,ENSG00000100644,ENSG00000113916,ENSG00000124762,ENSG00000135363,ENSG00000136936,ENSG00000139618,ENSG00000139687,ENSG00000140262,ENSG00000141985,ENSG00000146648,ENSG00000161405,ENSG00000163161,ENSG00000163513,ENSG00000171723,ENSG00000179218,ENSG00000179348,ENSG00000185811,ENSG00000186575,ENSG00000204713,ENSG00000204843,ENSG00000082512,ENSG00000112182,ENSG00000123143,ENSG00000124508,ENSG00000134504,ENSG00000142192,ENSG00000162924,ENSG00000167604,ENSG00000197943,ENSG00000100906,ENSG00000131323,ENSG00000057663,ENSG00000168404,ENSG00000013275,ENSG00000087191,ENSG00000100567,ENSG00000101182,ENSG00000138443,ENSG00000147010,ENSG00000148082,ENSG00000150991,ENSG00000161057,ENSG00000186153,ENSG00000197170,ENSG00000240065,ENSG00000276293","Original","Takeda","Oral proteasome inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","MONDO_0004095","Original","Serious","P,O",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
79,"CHEMBL3545131",2020,NA,NA,2007,NA,"Sarclisa","Isatuximab","ISATUXIMAB","ENSG00000004468",NA,"Original","Sanofi","CD38-directed mAb","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","MONDO_0004095","Related","Serious","S,O",TRUE,FALSE,TRUE,FALSE,FALSE,2020,TRUE,2020,FALSE,TRUE,FALSE,FALSE
80,"CHEMBL3545191",2021,2002,1995,2010,2021,"Evkeeza","Evinacumab","Evinacumab","ENSG00000132855","ENSG00000175445","Original","Regeneron","ANGPTL3-targeted mAb","Other indication","HoFH","homozygous familial hypercholesterolemia","MONDO_0018328","EFO_0004611","Original","Serious","P,O,B",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
81,"CHEMBL110458",2018,1989,NA,NA,NA,"Galafold","Migalastat","MIGALASTAT","ENSG00000102393",NA,"Original","Amicus Therapeutics","beta-galactosidase regulator","Other indication","Fabry disease","fabry disease","MONDO_0010526",NA,"Original","Serious","P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2018,TRUE,2018,FALSE,FALSE,FALSE,TRUE
82,"CHEMBL1173655",2013,1975,1975,NA,NA,"Gilotrif","Afatinib","AFATINIB","ENSG00000141736,ENSG00000146648,ENSG00000178568","ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000178568,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000085832,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000123983,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000135605,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000152894,ENSG00000153201,ENSG00000153707,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000185338,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000075624,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000007264,ENSG00000010810,ENSG00000011485,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000070159,ENSG00000071051,ENSG00000071537,ENSG00000074966,ENSG00000078747,ENSG00000087586,ENSG00000088930,ENSG00000090776,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000132535,ENSG00000134215,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138095,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000141738,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000160293,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000173406,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000213658,ENSG00000253729","Original","Boehringer Ingelheim","EGFR (ERBB1), HER2 (ERBB2), and HER4 (ERRB4) kinase inhibitor","Oncology","First-line treatment of patients with metastatic NSCLC whose tumours have EGFR exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
83,"CHEMBL43452",2013,2014,1995,2014,1994,"Pomalyst","Pomalidomide","POMALIDOMIDE","ENSG00000167986,ENSG00000139842,ENSG00000113851,ENSG00000100387","ENSG00000113851,ENSG00000106462,ENSG00000138081,ENSG00000185811,ENSG00000113712,ENSG00000130725,ENSG00000109320,ENSG00000115415","Original","Celgene","Immunomodulatory antineoplastic agent","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","MONDO_0004095","Original","Serious","S,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
84,"CHEMBL2106615,CHEMBL1201649",2013,NA,2018,NA,NA,"Duavee","Bazedoxifene acetate, oestrogens","BAZEDOXIFENEACETATE,ESTROGENS,CONJUGATED","ENSG00000091831,ENSG00000140009,ENSG00000140009,ENSG00000091831","ENSG00000012048,ENSG00000171490,ENSG00000012048,ENSG00000171490","Interactor","Pfizer","Conjugated oestrogens with an oestrogen receptor modulator","Other indication","Moderate to Serious vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis","menopause; postmenopausal osteoporosis","EFO_0003922,EFO_0003854",NA,"Original","Not serious","S",TRUE,TRUE,FALSE,FALSE,FALSE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
85,"CHEMBL2108336",2016,1996,NA,NA,NA,"Adlyxin","Lixisenatide","LIXISENATIDE","ENSG00000112164",NA,"Original","Sanofi","GLP1 receptor agonist","Other indication","Diabetes","diabetes mellitus","EFO_0000400",NA,"Original","Not concordant","S",TRUE,FALSE,FALSE,FALSE,TRUE,2016,TRUE,2016,FALSE,FALSE,FALSE,TRUE
86,"CHEMBL4298209",2020,NA,1994,NA,1983,"Blenrep","Belantamab mafodotin","BELANTAMABMAFODOTIN","ENSG00000048462,ENSG00000152086,ENSG00000167553,ENSG00000188229,ENSG00000137267,ENSG00000176014,ENSG00000261456,ENSG00000127824,ENSG00000123416,ENSG00000137285,ENSG00000258947,ENSG00000167552,ENSG00000198033,ENSG00000196230,ENSG00000104833,ENSG00000101162","ENSG00000136997,ENSG00000065361,ENSG00000083799,ENSG00000091831,ENSG00000126934,ENSG00000130779,ENSG00000133124,ENSG00000146648,ENSG00000179218,ENSG00000204843,ENSG00000084774,ENSG00000133112,ENSG00000142192,ENSG00000114416,ENSG00000163468","Original","GlaxoSmithKline","BCMA-directed ADC, with microtubule inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","MONDO_0004095","Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
87,"CHEMBL3137326",2017,1997,NA,NA,NA,"Austedo","Deutetrabenazine","DUTETRABENAZINE","ENSG00000165646",NA,"Original","Teva","VMAT2 inhibitor","Other indication","Chorea associated with Huntington disease","chorea; Huntington disease","EFO_0004152,MONDO_0007739",NA,"Original","Serious","S,O",TRUE,FALSE,FALSE,FALSE,TRUE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
88,"CHEMBL483254",2015,NA,1992,NA,1983,"Farydak","Panobinostat","PANOBINOSTAT","ENSG00000100429,ENSG00000196591,ENSG00000163517,ENSG00000061273,ENSG00000068024,ENSG00000048052,ENSG00000116478,ENSG00000108840,ENSG00000094631,ENSG00000171720,ENSG00000147099","ENSG00000136997,ENSG00000065361,ENSG00000073614,ENSG00000083799,ENSG00000091831,ENSG00000100697,ENSG00000108654,ENSG00000109906,ENSG00000110092,ENSG00000111642,ENSG00000113916,ENSG00000121741,ENSG00000135363,ENSG00000139687,ENSG00000141027,ENSG00000141510,ENSG00000141736,ENSG00000146648,ENSG00000147130,ENSG00000148400,ENSG00000168036,ENSG00000179348,ENSG00000181163,ENSG00000196498,ENSG00000198795,ENSG00000204209,ENSG00000204713,ENSG00000204843,ENSG00000169554,ENSG00000198176,ENSG00000068024,ENSG00000172936,ENSG00000174197,ENSG00000276903,ENSG00000278677,ENSG00000105287,ENSG00000109320,ENSG00000128340,ENSG00000131910,ENSG00000142599,ENSG00000162924,ENSG00000167604,ENSG00000169083,ENSG00000150991,ENSG00000163468","Original","Novartis","Histone deacetylase inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","MONDO_0004095","Original","Serious","P,O,A",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
90,"CHEMBL1743082",2013,2010,2010,NA,NA,"Kadcyla","Ado-trastuzumab emtansine","TRASTUZUMABEMTANSINE","ENSG00000167553,ENSG00000196230,ENSG00000137285,ENSG00000123416,ENSG00000176014,ENSG00000137267,ENSG00000101162,ENSG00000258947,ENSG00000261456,ENSG00000188229,ENSG00000104833,ENSG00000127824,ENSG00000198033,ENSG00000167552,ENSG00000152086,ENSG00000141736","ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000083799,ENSG00000085832,ENSG00000091831,ENSG00000096384,ENSG00000097007,ENSG00000101213,ENSG00000111252,ENSG00000113263,ENSG00000123983,ENSG00000124181,ENSG00000126934,ENSG00000127329,ENSG00000130779,ENSG00000135605,ENSG00000136997,ENSG00000141736,ENSG00000141968,ENSG00000143322,ENSG00000145675,ENSG00000146648,ENSG00000152894,ENSG00000153201,ENSG00000157168,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000168610,ENSG00000178568,ENSG00000179295,ENSG00000197122,ENSG00000204843","Original","Genentech","HER2-targeted antibody and microtubule inhibitor conjugate","Oncology","HER2-positive metastatic breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294",NA,"Original","Serious","P,F",TRUE,FALSE,FALSE,FALSE,TRUE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
92,"CHEMBL4297590",2022,NA,NA,2003,NA,"Quviviq","Daridorexant","Daridorexant","ENSG00000137252,ENSG00000121764",NA,"Original","Idorsia","Orexin receptor antagonist","Other indication","Insomnia","insomnia","EFO_0004698","EFO_0008568,EFO_0005271","Related","Not serious","S",TRUE,FALSE,TRUE,FALSE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
94,"CHEMBL3414621",2020,NA,NA,2014,NA,"Tazverik","Tazemetostat","TAZEMETOSTAT","ENSG00000106462",NA,"Original","Epizyme","EZH2 inhibitor","Oncology","Epithelioid sarcoma","epithelioid sarcoma","MONDO_0017387","EFO_1001968","Related","Serious","P,O,A,F",TRUE,FALSE,TRUE,FALSE,FALSE,2020,TRUE,2020,FALSE,TRUE,FALSE,FALSE
98,"CHEMBL3989987",2018,1977,1977,NA,NA,"Onpattro","Patisiran","PATISIRAN","ENSG00000118271","ENSG00000118271","Original","Alnylam Pharmaceuticals","TTR-directed small interfering RNA","Other indication","Hereditary TTR-mediated amyloidosis","hereditary ATTR amyloidosis","MONDO_0017132",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2018,TRUE,2018,FALSE,FALSE,FALSE,TRUE
99,"CHEMBL1568698",2022,2013,2013,NA,NA,"Ztalmy","Ganaxolone","Ganaxolone","ENSG00000094755,ENSG00000163288,ENSG00000102287,ENSG00000166206,ENSG00000145863,ENSG00000022355,ENSG00000113327,ENSG00000187730,ENSG00000011677,ENSG00000268089,ENSG00000145864,ENSG00000151834,ENSG00000186297,ENSG00000182256,ENSG00000109158,ENSG00000163285","ENSG00000166206,ENSG00000022355","Original","Marinus","GABAA receptor positive allosteric modulator","Other indication","Seizures associated with CDD","Epileptic encephalopathy","HP_0200134",NA,"Original","Serious","P,O",TRUE,FALSE,FALSE,FALSE,TRUE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
100,"CHEMBL4594217,CHEMBL2048484",2013,NA,NA,2002,NA,"Invokana","Canagliflozin","CANAGLIFLOZIN,CANAGLIFLOZIN","ENSG00000140675,ENSG00000140675",NA,"Original","Janssen","SGLT2 inhibitor","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","HP_0003076,Orphanet_79161","Related","Not concordant","S",TRUE,FALSE,TRUE,FALSE,FALSE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
102,"CHEMBL4299940",2022,1995,NA,NA,NA,"Pyrukynd","Mitapivat","Mitapivat","ENSG00000143627",NA,"Original","Agios","Pyruvate kinase activator","Other indication","Haemolytic anaemia due to PK deficiency","hemolytic anemia","EFO_0005558",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
103,"CHEMBL2107841",2014,1996,NA,1996,NA,"Tanzeum","Albiglutide","ALBIGLUTIDE","ENSG00000112164",NA,"Original","GlaxoSmithKline","GLP1-receptor agonist","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","HP_0003076,Orphanet_79161","Original","Not concordant","S",TRUE,FALSE,FALSE,FALSE,TRUE,2014,TRUE,2014,FALSE,FALSE,FALSE,TRUE
105,"CHEMBL3301587",2017,2017,2020,NA,NA,"Imfinzi","Durvalumab","DURVALUMAB","ENSG00000120217","ENSG00000197646","Original","AstraZeneca","PDL1-blocking antibody","Oncology","Urothelial carcinoma","urothelial carcinoma","EFO_0008528",NA,"Original","Serious","P,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2017,TRUE,2017,FALSE,FALSE,FALSE,TRUE
107,"CHEMBL3039537",2015,1995,NA,NA,NA,"Kanuma","Sebelipase alfa","SEBELIPASEALFA","ENSG00000107798",NA,"Original","Alexion","Enzyme replacement therapy","Other indication","LAL deficiency","lysosomal acid lipase deficiency","MONDO_0010204",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
108,"CHEMBL2396661",2019,2004,2004,NA,NA,"Piqray","Alpelisib","ALPELISIB","ENSG00000121879","ENSG00000121879,ENSG00000065361,ENSG00000145675,ENSG00000117461,ENSG00000124788,ENSG00000169047,ENSG00000066427,ENSG00000100368,ENSG00000177885","Original","Novartis","PI3K inhibitor","Oncology","Breast cancer","breast cancer","MONDO_0007254",NA,"Original","Serious","P",TRUE,FALSE,FALSE,FALSE,TRUE,2019,TRUE,2019,FALSE,FALSE,FALSE,TRUE
109,"CHEMBL3544914,CHEMBL2010601",2018,1990,1990,NA,NA,"Symdeko","Tezacaftor, ivacaftor","TEZACAFTOR,IVACAFTOR","ENSG00000001626,ENSG00000001626","ENSG00000001626,ENSG00000001626,ENSG00000170421,ENSG00000253729,ENSG00000170421,ENSG00000253729,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972","Original","Vertex Pharmaceuticals","CFTR corrector and CFTR potentiator","Other indication","Cystic fibrosis","cystic fibrosis","MONDO_0009061",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
110,"CHEMBL1743087",2014,2017,2017,NA,NA,"Entyvio","Vedolizumab","VEDOLIZUMAB","ENSG00000115232,ENSG00000139626","ENSG00000139626,ENSG00000115232,ENSG00000136754","Original","Takeda","Integrin-receptor antagonist","Other indication","Ulcerative colitis and Crohn's disease","ulcerative colitis; Crohn's disease","EFO_0000729,EFO_0000384",NA,"Original","Serious","P,F",TRUE,FALSE,FALSE,FALSE,TRUE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
111,"CHEMBL3590187",2020,NA,2022,NA,NA,"Winlevi","Clascoterone","CLASCOTERONE","ENSG00000169083","ENSG00000107338,ENSG00000110092,ENSG00000116288","Interactor","Cassiopea SpA","Androgen receptor inhibitor","Other indication","Acne vulgaris","acne","EFO_0003894",NA,"Original","Not serious","S",TRUE,TRUE,FALSE,FALSE,FALSE,2020,TRUE,2020,TRUE,FALSE,FALSE,FALSE
113,"CHEMBL1743070",2014,NA,NA,NA,NA,"Sylvant","Siltuximab","SILTUXIMAB","ENSG00000136244",NA,"Original","Janssen Biotech","IL-6-specific antibody","Other indication","Multicentric Castleman's disease","Castleman disease","MONDO_0015564",NA,"Original","Serious","P,O",FALSE,FALSE,FALSE,FALSE,FALSE,2014,TRUE,2014,FALSE,FALSE,FALSE,TRUE
114,"CHEMBL2181927",2021,NA,NA,2019,NA,"Kerendia","Finerenone","Finerenone","ENSG00000151623",NA,"Original","Bayer","Non-steroidal MR antagonist","Other indication","CKD with type 2 diabetes","chronic kidney disease","EFO_0003884","HP_0012594","Related","Serious","P,F",TRUE,FALSE,TRUE,FALSE,FALSE,2021,TRUE,2021,FALSE,TRUE,FALSE,FALSE
115,"CHEMBL521686",2014,NA,1991,NA,NA,"Lynparza","Olaparib","OLAPARIB","ENSG00000143799,ENSG00000041880,ENSG00000129484","ENSG00000141510,ENSG00000082805,ENSG00000091831,ENSG00000100030,ENSG00000148737,ENSG00000154767,ENSG00000156052,ENSG00000157554,ENSG00000164305,ENSG00000165392,ENSG00000168036,ENSG00000198900,ENSG00000245848,ENSG00000286522,ENSG00000004700,ENSG00000101412,ENSG00000148702,ENSG00000073050,ENSG00000092847,ENSG00000118518,ENSG00000131747,ENSG00000143799,ENSG00000147874,ENSG00000150991,ENSG00000166884,ENSG00000189403,ENSG00000196419,ENSG00000253729","Original","AstraZeneca","PARP inhibitor","Oncology","Advanced BRCA-mutated ovarian cancer","ovarian cancer","MONDO_0008170",NA,"Original","Serious","P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
117,"CHEMBL827,CHEMBL4301162",2021,1996,2021,NA,NA,"Azstarys","Dexmethylphenidate, serdexmethylphenidate","Dexmethylphenidate,serdexmethylphenidate","ENSG00000103546,ENSG00000142319,ENSG00000142319,ENSG00000103546","NA,NA,ENSG00000149295,ENSG00000152214,ENSG00000149295,ENSG00000152214","Original","Commave Therapeutics","CNS stimulant","Other indication","ADHD","attention deficit hyperactivity disorder","EFO_0003888",NA,"Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
118,"CHEMBL2364649",2020,2010,2010,NA,NA,"Margenza","Margetuximab","MARGETUXIMAB","ENSG00000141736","ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000085832,ENSG00000096384,ENSG00000097007,ENSG00000101213,ENSG00000111252,ENSG00000113263,ENSG00000123983,ENSG00000124181,ENSG00000127329,ENSG00000135605,ENSG00000141736,ENSG00000141968,ENSG00000143322,ENSG00000145675,ENSG00000146648,ENSG00000152894,ENSG00000153201,ENSG00000157168,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000168610,ENSG00000178568,ENSG00000179295,ENSG00000197122","Original","MacroGenics","HER2-directed mAb","Oncology","HER2-positive breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294",NA,"Original","Serious","S,F",TRUE,FALSE,FALSE,FALSE,TRUE,2020,TRUE,2020,FALSE,FALSE,FALSE,TRUE
121,"CHEMBL2216870",2014,2002,2016,NA,NA,"Zydelig","Idelalisib","IDELALISIB","ENSG00000171608","ENSG00000145675,NA","Original","Gilead Sciences","PI3K‚Äöp110-delta subunit inhibitor","Other indication","CLL, B-cell non-Hodgkin lymphoma and SLL","chronic lymphocytic leukemia; B-cell non-Hodgkins lymphoma","EFO_0000095,EFO_1001938",NA,"Original","Serious","P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
122,"CHEMBL2219425",2015,2006,1997,NA,NA,"Aristada","Aripiprazole lauroxil","ARIPIPRAZOLELAUROXIL","ENSG00000102468,ENSG00000178394,ENSG00000149295","ENSG00000078369,ENSG00000102468,ENSG00000118432,ENSG00000128271,ENSG00000142319,ENSG00000147246,ENSG00000147955,ENSG00000162946,ENSG00000164082,ENSG00000077782,ENSG00000149295","Original","Alkermes","Extended release atypical antipsychotic","Other indication","Schizophrenia","schizophrenia","MONDO_0005090",NA,"Original","Not concordant","S",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
124,"CHEMBL1742992",2014,NA,NA,1995,NA,"Blincyto","Blinatumomab","BLINATUMOMAB","ENSG00000177455,ENSG00000160654,ENSG00000167286,ENSG00000198851",NA,"Original","Amgen","CD19- and CD3-bispecific antibody","Oncology","B-ALL","precursor B-cell acute lymphoblastic leukemia","MONDO_0020511","EFO_1001938","Related","Serious","P,O,B,A",TRUE,FALSE,TRUE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
128,"CHEMBL3137301,CHEMBL1069",2015,NA,2014,NA,NA,"Entresto","Sacubitril, valsartan","SACUBITRIL,VALSARTAN","ENSG00000196549,ENSG00000144891","ENSG00000134817","Interactor","Novartis","A neprilysin inhibitor plus an angiotensin II receptor blocker","Other indication","Chronic heart failure","congestive heart failure","EFO_0000373",NA,"Original","Serious","P,F",TRUE,TRUE,FALSE,FALSE,FALSE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
129,"CHEMBL3707276",2021,2007,NA,2012,NA,"Voxzogo","Vosoritide","Vosoritide","ENSG00000159899",NA,"Original","Biomarin","CNP analogue","Other indication","Achondroplasia","achondroplasia","MONDO_0007037","EFO_0004339,Orphanet_329191","Original","Not serious","P,O,A",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
130,"CHEMBL1289494",2021,2004,1999,NA,NA,"Fotivda","Tivozanib","Tivozanib","ENSG00000102755,ENSG00000128052,ENSG00000037280,ENSG00000157404,ENSG00000113721","ENSG00000037280,ENSG00000081237,ENSG00000096384,ENSG00000097007,ENSG00000100311,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000124181,ENSG00000127329,ENSG00000128052,ENSG00000134853,ENSG00000135605,ENSG00000143322,ENSG00000145675,ENSG00000152894,ENSG00000165025,ENSG00000171862,ENSG00000179295,ENSG00000182511,ENSG00000182866,ENSG00000197122,ENSG00000254087,ENSG00000134215,ENSG00000010810,ENSG00000094796,ENSG00000101336,ENSG00000164916,ENSG00000177885,ENSG00000186432,ENSG00000205439","Original","Aveo","VEGFR kinase inhibitor","Oncology","Renal cell carcinoma","renal cell carcinoma","EFO_0000681",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
131,"CHEMBL4594350",2022,1990,1990,NA,NA,"Krazati","Adagrasib","Adagrasib","ENSG00000133703","ENSG00000078061,ENSG00000133703,ENSG00000157764,ENSG00000067560,ENSG00000132155,ENSG00000142192,ENSG00000143398","Original","Mirati","KRAS-G12C inhibitor","Oncology","KRASG12C-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","S,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2022,TRUE,2022,FALSE,FALSE,FALSE,TRUE
132,"CHEMBL3990029",2019,2018,2018,2009,2009,"Skyrizi","Risankizumab","RISANKIZUMAB","ENSG00000110944,ENSG00000113302","ENSG00000110944,ENSG00000113302,ENSG00000162594","Original","AbbVie","IL-23 antagonist","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","EFO_0000676","Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
133,"CHEMBL408513",2014,NA,1993,NA,NA,"Beleodaq","Belinostat","BELINOSTAT","ENSG00000108840,ENSG00000147099,ENSG00000061273,ENSG00000068024,ENSG00000171720,ENSG00000094631,ENSG00000163517,ENSG00000048052,ENSG00000100429,ENSG00000196591,ENSG00000116478","ENSG00000065361,ENSG00000100697,ENSG00000107485,ENSG00000113916,ENSG00000127152,ENSG00000141027,ENSG00000141510,ENSG00000141736,ENSG00000146648,ENSG00000147130,ENSG00000148400,ENSG00000162367,ENSG00000168036,ENSG00000169083,ENSG00000177565,ENSG00000181163,ENSG00000181449","Interactor","Spectrum","Histone-deacetylase inhibitor","Other indication","Peripheral T-cell lymphoma","unspecified peripheral T-cell lymphoma","EFO_0000211",NA,"Original","Serious","P,O,A,F",TRUE,TRUE,FALSE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
134,"CHEMBL512351",2017,NA,2021,NA,NA,"Bevyxxa","Betrixaban","BETRIXABAN","ENSG00000126218","ENSG00000117601,NA","Original","Portola Pharmaceuticals","FXa inhibitor","Other indication","Prophylaxis of venous thromboembolism","venous thromboembolism","EFO_0004286",NA,"Original","Serious","P,F",TRUE,FALSE,FALSE,FALSE,TRUE,2017,TRUE,2017,FALSE,FALSE,FALSE,TRUE
135,"CHEMBL4297788",2022,NA,NA,1998,NA,"Lunsumio","Mosunetuzumab","Mosunetuzumab","ENSG00000167286,ENSG00000156738,ENSG00000198851,ENSG00000160654",NA,"Original","Roche/Genentech","CD20 _ CD3 bispecific antibody","Oncology","Follicular lymphoma","follicular lymphoma","MONDO_0018906","EFO_0000183","Related","Serious","P,O,B,A",TRUE,FALSE,TRUE,FALSE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
136,"CHEMBL4594261",2020,NA,2004,NA,NA,"Fluoroestradiol F-18","Fluoroestradiol F-18","FLUOROESTRADIOLF-18","ENSG00000186868","ENSG00000096384,ENSG00000108953,ENSG00000110367,ENSG00000118515,ENSG00000142208,ENSG00000146648,ENSG00000153944,ENSG00000197122,ENSG00000204843,ENSG00000075624,ENSG00000109971,ENSG00000134516,ENSG00000135097,ENSG00000186868,ENSG00000082701,ENSG00000105723,ENSG00000004478,ENSG00000010810,ENSG00000100784,ENSG00000108443,ENSG00000117676,ENSG00000142192,ENSG00000142330,ENSG00000164885,ENSG00000164924,ENSG00000165732,ENSG00000166033,ENSG00000167552,ENSG00000170027,ENSG00000175166,ENSG00000175203,ENSG00000175793,ENSG00000177189,ENSG00000185624,ENSG00000188906","Original","Zionexa","Radioactive diagnostic","Other indication","Imaging, breast cancer","breast carcinoma","EFO_0000305",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
138,"CHEMBL4435170",2022,2021,NA,2012,2009,"Sotyktu","Deucravacitinib","Deucravacitinib","ENSG00000105397","ENSG00000170581","Original","Bristol Myers Squibb","TYK2 inhibitor","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","EFO_0000676","Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2022,TRUE,2022,FALSE,FALSE,FALSE,TRUE
140,"CHEMBL3833393",2017,NA,1984,NA,NA,"Hemlibra","Emicizumab","EMICIZUMAB","ENSG00000126218,ENSG00000101981","ENSG00000185010,ENSG00000117601","Original","Roche/Genentech","Bispecific FIX and FX-directed antibody","Other indication","Haemophilia A","hemophilia A","MONDO_0010602",NA,"Original","Serious","P,O,B",TRUE,FALSE,FALSE,FALSE,TRUE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
147,"CHEMBL4297335",2020,2008,1984,NA,NA,"PSMA-11 Ga-68","PSMA-11 Ga-68","PSMA-11GA-68","ENSG00000142515","ENSG00000169083","Original","UCLA","Radioactive diagnostic","Other indication","Imaging, prostate cancer","prostate carcinoma","EFO_0001663",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
148,"CHEMBL4594511",2022,1977,1977,NA,NA,"Amvuttra","Vutrisiran","Vutrisiran","ENSG00000118271","ENSG00000118271","Original","Alnylam","TTR-targeted siRNA","Other indication","Polyneuropathy of hereditary TTR-mediated amyloidosis","familial amyloid neuropathy","EFO_0004129",NA,"Original","Serious","S,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
149,"CHEMBL2104993",2013,1998,NA,NA,NA,"Brintellix","Vortioxetine","VORTIOXETINE","ENSG00000178394,ENSG00000108576,ENSG00000166736",NA,"Original","Takeda","Serotonin reuptake inhibitor","Other indication","Major depressive disorder","major depressive disorder","MONDO_0002009",NA,"Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
151,"CHEMBL3990026",2018,1975,NA,NA,NA,"Revcovi","Elapegademase","ELAPEGADEMASE","ENSG00000196839",NA,"Original","Leadiant Biosciences","Recombinant adenosine deaminase","Other indication","ADA-SCID","Serious combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency","MONDO_0007064",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
152,"CHEMBL3301612",2018,2002,1989,NA,NA,"Braftovi","Encorafenib","ENCORAFENIB","ENSG00000157764","ENSG00000126934,ENSG00000132155,ENSG00000157764,ENSG00000169032,ENSG00000213281,ENSG00000078061,ENSG00000095015,ENSG00000096384,ENSG00000108953,ENSG00000133703,ENSG00000174775,ENSG00000105401,ENSG00000109971,ENSG00000166913,ENSG00000171132","Original","Array BioPharma","BRAF inhibitor","Oncology","BRAF-mutated melanoma","melanoma","EFO_0000756",NA,"Original","Serious","S,O",TRUE,FALSE,FALSE,FALSE,TRUE,2018,TRUE,2018,FALSE,FALSE,FALSE,TRUE
153,"CHEMBL2107830",2014,NA,NA,2002,NA,"Jardiance","Empagliflozin","EMPAGLIFLOZIN","ENSG00000140675",NA,"Original","Boehringer Ingelheim","SGLT2 inhibitor","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","HP_0003076,Orphanet_79161","Related","Not concordant","S,F",TRUE,FALSE,TRUE,FALSE,FALSE,2014,TRUE,2014,FALSE,TRUE,FALSE,FALSE
154,"CHEMBL1743043",2018,NA,2014,NA,NA,"Lumoxiti","Moxetumomab pasudotox","MOXETUMOMABPASUDOTOX","ENSG00000167658,ENSG00000012124","ENSG00000111679,ENSG00000165025","Interactor","AstraZeneca","CD22-directed antibody‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂¬¨¬Ædrug conjugate","Oncology","Hairy cell leukaemia","hairy cell leukemia","EFO_1000956",NA,"Original","Serious","P,O,F",TRUE,TRUE,FALSE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
155,"CHEMBL4297844",2019,2010,2010,NA,NA,"Enhertu","Trastuzumab deruxtecan","TRASTUZUMABDERUXTECAN","ENSG00000141736,ENSG00000198900","ENSG00000015285,ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000085832,ENSG00000091831,ENSG00000096384,ENSG00000097007,ENSG00000101213,ENSG00000111252,ENSG00000113263,ENSG00000116560,ENSG00000122566,ENSG00000123983,ENSG00000124181,ENSG00000127329,ENSG00000135605,ENSG00000136997,ENSG00000141736,ENSG00000141968,ENSG00000143322,ENSG00000145675,ENSG00000146648,ENSG00000147140,ENSG00000152894,ENSG00000153201,ENSG00000157168,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000168610,ENSG00000178568,ENSG00000179295,ENSG00000181163,ENSG00000197122","Original","Daiichi Sankyo/AstraZeneca","HER2-directed ADC","Oncology","HER2-positive breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294",NA,"Original","Serious","P,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
156,"CHEMBL2108730",2017,2014,NA,NA,NA,"Kevzara","Sarilumab","SARILUMAB","ENSG00000160712","NA,ENSG00000136244","Original","Sanofi/Regeneron","IL-6 receptor antagonist","Other indication","Rheumatoid arthritis","rheumatoid arthritis","EFO_0000685",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2017,TRUE,2017,FALSE,FALSE,FALSE,TRUE
157,"CHEMBL3301622",2018,1995,1994,NA,NA,"Xospata","Gilteritinib","GILTERITINIB","ENSG00000122025,ENSG00000167601","ENSG00000122025,ENSG00000096384,ENSG00000097007,ENSG00000124181,ENSG00000143322,ENSG00000145675,ENSG00000146648,ENSG00000165025,ENSG00000179295,ENSG00000182866,ENSG00000145715,ENSG00000106070","Original","Astellas","FLT3 inhibitor","Oncology","FLT3-positive AML","acute myeloid leukemia","EFO_0000222",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
158,"CHEMBL2103875",2013,NA,NA,2011,NA,"Mekinist","Trametinib","TRAMETINIB","ENSG00000169032,ENSG00000126934",NA,"Original","GSK","MEK1 and MEK2 kinase inhibitor","Oncology","Unresectable or metastatic melanoma with BRAF(V600E) mutation as detected by an FDA-approved test","metastatic melanoma","EFO_0002617","EFO_0000756","Related","Serious","S,O,F",TRUE,FALSE,TRUE,FALSE,FALSE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
159,"CHEMBL1473,CHEMBL1198857",2013,1995,NA,NA,NA,"Breo Ellipta","Fluticasone, vilanterol","FLUTICASONE,VILANTEROL","ENSG00000113580,ENSG00000169252","ENSG00000204388,ENSG00000204389,NA,ENSG00000113369,ENSG00000163485,ENSG00000080824,ENSG00000175793","Original","GSK","Corticosteroid plus LABA","Other indication","Chronic obstructive pulmonary disease","chronic obstructive pulmonary disease","EFO_0000341",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
160,"CHEMBL3655081",2022,NA,2008,1998,2000,"Cibinqo","Abrocitinib","Abrocitinib","ENSG00000162434","ENSG00000134352,ENSG00000115415,ENSG00000159110","Interactor","Pfizer","JAK inhibitor","Other indication","Atopic dermatitis","atopic eczema","EFO_0000274","HP_0000964,MONDO_0002406","Related","Not serious","P,B",TRUE,TRUE,TRUE,TRUE,FALSE,2022,TRUE,2022,TRUE,TRUE,TRUE,FALSE
162,"CHEMBL1743048",2013,NA,2015,NA,NA,"Gazyva","Obinutuzumab","OBINUTUZUMAB","ENSG00000156738","ENSG00000157613,ENSG00000168685","Interactor","Genentech","Humanized CD20-specific monoclonal antibody","Oncology","Previously untreated chronic lymphocytic leukaemia","chronic lymphocytic leukemia","EFO_0000095",NA,"Original","Serious","P,O,B",TRUE,TRUE,FALSE,FALSE,FALSE,2013,TRUE,2013,TRUE,FALSE,FALSE,FALSE
163,"CHEMBL2178422",2020,NA,2018,NA,NA,"Nurtec ODT","Rimegepant","RIMEGEPANT","ENSG00000064989","ENSG00000110680","Interactor","Biohaven","CGRP receptor antagonist","Other indication","Migraine","migraine disorder","MONDO_0005277",NA,"Original","Not serious","S",TRUE,TRUE,FALSE,FALSE,FALSE,2020,TRUE,2020,TRUE,FALSE,FALSE,FALSE
164,"CHEMBL3545185",2019,NA,1992,2011,1992,"Xpovio","Selinexor","SELINEXOR","ENSG00000082898","ENSG00000141510,ENSG00000141736,NA","Original","Karyopharm Therapeutics","XPO1 inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","MONDO_0004095","Original","Serious","P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2019,TRUE,2019,FALSE,FALSE,FALSE,TRUE
165,"CHEMBL2108611",2017,NA,NA,1996,NA,"Besponsa","Inotuzumab ozogamicin","INOTUZUMABOZOGAMICIN","ENSG00000012124",NA,"Original","Pfizer","CD22-directed antibody‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂¬¨¬Ædrug conjugate","Oncology","B cell precursor ALL","precursor B-cell acute lymphoblastic leukemia","MONDO_0020511","EFO_1001938","Related","Serious","P,O,B",TRUE,FALSE,TRUE,FALSE,FALSE,2017,TRUE,2017,FALSE,TRUE,FALSE,FALSE
166,"CHEMBL1743010",2015,NA,2001,NA,2001,"Empliciti","Elotuzumab","ELOTUZUMAB","ENSG00000026751","ENSG00000183918","Interactor","Bristol-Myers Squibb","SLAMF7-directed mAb","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","MONDO_0004095","Original","Serious","P,O,B",TRUE,TRUE,FALSE,FALSE,FALSE,2015,TRUE,2015,TRUE,FALSE,FALSE,FALSE
167,"CHEMBL1983350",2018,1999,2011,1999,2001,"Diacomit","Stiripentol","STIRIPENTOL","ENSG00000022355","ENSG00000113327,NA","Original","Biocodex","GABA reuptake inhibitor","Other indication","Dravet syndrome","dravet syndrome","Orphanet_33069","MONDO_0020072,MONDO_0020072","Original","Serious","P,O",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
168,"CHEMBL1201605",2016,2007,2013,NA,NA,"Zinbryta","Daclizumab","DACLIZUMAB","ENSG00000134460,ENSG00000100385,ENSG00000147168","ENSG00000134470,ENSG00000244411","Original","Biogen","IL-2-targeted mAb","Other indication","Multiple sclerosis","multiple sclerosis","MONDO_0005301",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2016,FALSE,2016,FALSE,FALSE,FALSE,FALSE
170,"CHEMBL3188267",2020,2005,1975,NA,NA,"Tabrecta","Capmatinib","CAPMATINIB","ENSG00000105976","ENSG00000105976,ENSG00000146648,ENSG00000010671,ENSG00000081237,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000135605,ENSG00000140538,ENSG00000143322,ENSG00000145675,ENSG00000152894,ENSG00000165025,ENSG00000179295,ENSG00000182511,ENSG00000182866,ENSG00000185338,ENSG00000197122,ENSG00000254087,ENSG00000160691,ENSG00000177885,ENSG00000101336,ENSG00000136205,ENSG00000000938,ENSG00000007264,ENSG00000010017,ENSG00000019991,ENSG00000070159,ENSG00000071051,ENSG00000074966,ENSG00000105647,ENSG00000115290,ENSG00000117461,ENSG00000127947,ENSG00000131746,ENSG00000134215,ENSG00000141738,ENSG00000145715,ENSG00000149177,ENSG00000158092,ENSG00000160293,ENSG00000176105,ENSG00000197943,ENSG00000198753","Original","Novartis","MET kinase inhibitor","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2020,TRUE,2020,FALSE,FALSE,FALSE,TRUE
172,"CHEMBL4297762",2019,1988,NA,NA,NA,"Vyondys 53","Golodirsen","GOLODIRSEN","ENSG00000198947","ENSG00000101400,NA","Original","Sarepta","Exon 53 skipping antisense","Other indication","Duchenne muscular dystrophy","duchenne muscular dystrophy","MONDO_0010679",NA,"Original","Serious","P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2019,TRUE,2019,FALSE,FALSE,FALSE,TRUE
173,"CHEMBL3707358",2022,1991,NA,NA,NA,"Xenpozyme","Olipudase alfa","Olipudasealfa","ENSG00000166311",NA,"Original","Sanofi/Genzyme","Acid sphingomyelinase ERT","Other indication","Acid sphingomyelinase deficiency","acid sphingomyelinase deficiency","MONDO_0100464",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
174,"CHEMBL3545132",2022,NA,2008,NA,NA,"Elahere","Mirvetuximab soravtansine","Mirvetuximabsoravtansine","ENSG00000110195,ENSG00000127824,ENSG00000152086,ENSG00000261456,ENSG00000101162,ENSG00000188229,ENSG00000104833,ENSG00000258947,ENSG00000123416,ENSG00000198033,ENSG00000167553,ENSG00000137285,ENSG00000167552,ENSG00000176014,ENSG00000137267,ENSG00000196230","ENSG00000065361,ENSG00000080824,ENSG00000083799,ENSG00000091831,ENSG00000126934,ENSG00000130779,ENSG00000133124,ENSG00000136997,ENSG00000146648,ENSG00000177606,ENSG00000179218,ENSG00000204843,ENSG00000123349","Interactor","ImmunoGen","FR_-targeted antibody-drug conjugate","Oncology","Ovarian cancer","ovarian carcinoma","EFO_0001075",NA,"Original","Serious","P,O,A,F",TRUE,TRUE,FALSE,FALSE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
175,"CHEMBL3989977",2018,1993,1993,NA,NA,"Gamifant","Emapalumab","EMAPALUMAB","ENSG00000111537","ENSG00000027697","Original","Novimmune","Interferon-‚Äö√¢√†‚àö‚â†‚Äö√Ñ√∂‚àö¬¢‚Äö√Ñ¬¢-blocking antibody","Other indication","Primary haemophagocytic lymphohistiocytosis","genetic hemophagocytic lymphohistiocytosis","MONDO_0015541",NA,"Original","Serious","P,O,B",TRUE,FALSE,FALSE,FALSE,TRUE,2018,TRUE,2018,FALSE,FALSE,FALSE,TRUE
176,"CHEMBL4297185",2019,1984,1984,NA,NA,"Nubeqa","Darolutamide","DAROLUTAMIDE","ENSG00000169083","ENSG00000169083,ENSG00000005339,ENSG00000010671,ENSG00000084676,ENSG00000089280,ENSG00000097007,ENSG00000101213,ENSG00000106462,ENSG00000109685,ENSG00000110092,ENSG00000118058,ENSG00000124181,ENSG00000129514,ENSG00000136504,ENSG00000136826,ENSG00000140396,ENSG00000141027,ENSG00000141867,ENSG00000141968,ENSG00000143322,ENSG00000145675,ENSG00000157554,ENSG00000159388,ENSG00000165025,ENSG00000167548,ENSG00000168036,ENSG00000179295,ENSG00000182511,ENSG00000182866,ENSG00000184634,ENSG00000197122,ENSG00000204209,ENSG00000254087,ENSG00000125686,ENSG00000142515,ENSG00000145715,ENSG00000160691,ENSG00000266412","Original","Bayer","Androgen receptor inhibitor","Oncology","Prostate cancer","prostate cancer","MONDO_0008315",NA,"Original","Serious","P,F",TRUE,FALSE,FALSE,FALSE,TRUE,2019,TRUE,2019,FALSE,FALSE,FALSE,TRUE
178,"CHEMBL471737",2015,2007,NA,NA,NA,"Corlanor","Ivabradine","IVABRADINE","ENSG00000138622","ENSG00000138622","Original","Amgen","Hyperpolarization-activated cyclic nucleotide-gated channel blocker","Other indication","Chronic heart failure","Abnormality of the cardiovascular system","HP_0001626",NA,"Original","Serious","P,F",TRUE,FALSE,FALSE,FALSE,TRUE,2015,TRUE,2015,FALSE,FALSE,FALSE,TRUE
179,"CHEMBL566752",2014,1991,1985,NA,NA,"Neuraceq","Florbetaben-F18","FLORBETABEN-F18","ENSG00000142192","ENSG00000080815,ENSG00000130203,ENSG00000137642,ENSG00000137845,ENSG00000142192,ENSG00000143801,ENSG00000186868,ENSG00000070808,ENSG00000132535,ENSG00000007047,ENSG00000073060,ENSG00000120885,ENSG00000120899,ENSG00000121653,ENSG00000128482,ENSG00000129219,ENSG00000131042,ENSG00000138613,ENSG00000139318,ENSG00000163879,ENSG00000165916,ENSG00000168077","Original","Piramal Imaging","Radioactive diagnostic agent","Other indication","Imaging of the brain to estimate density of neuritic amyloid-beta plaques","neuritic plaque measurement; Alzheimer disease","EFO_0006798,MONDO_0004975",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
182,"CHEMBL3545376",2019,2001,2000,NA,NA,"Balversa","Erdafitinib","ERDAFITINIB","ENSG00000077782,ENSG00000066468,ENSG00000160867,ENSG00000068078","ENSG00000065361,ENSG00000068078,ENSG00000002834,ENSG00000039068,ENSG00000066468,ENSG00000077782,ENSG00000096384,ENSG00000099956,ENSG00000102145,ENSG00000106462,ENSG00000107485,ENSG00000123388,ENSG00000124181,ENSG00000124762,ENSG00000127914,ENSG00000136997,ENSG00000139219,ENSG00000145675,ENSG00000147548,ENSG00000160867,ENSG00000165731,ENSG00000168036,ENSG00000168769,ENSG00000177606,ENSG00000178104,ENSG00000179094,ENSG00000179295,ENSG00000179348,ENSG00000184937,ENSG00000197157,ENSG00000106615","Original","Janssen /J&J","FGFR inhibitor","Oncology","Bladder cancer","urinary bladder carcinoma","MONDO_0004986",NA,"Original","Serious","P,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
183,"CHEMBL4216467",2020,1990,1977,NA,NA,"Qinlock","Ripretinib","RIPRETINIB","ENSG00000157404,ENSG00000134853","NA,ENSG00000111252,ENSG00000113721,ENSG00000146648,ENSG00000049130","Original","Deciphera","KIT and PDGFRA kinase inhibitor","Oncology","GIST","gastrointestinal stromal tumor","MONDO_0011719",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
184,"CHEMBL1094636",2017,NA,1991,NA,NA,"Zejula","Niraparib","NIRAPARIB","ENSG00000129484,ENSG00000143799","ENSG00000141510,ENSG00000082805,ENSG00000091831,ENSG00000100030,ENSG00000148737,ENSG00000154767,ENSG00000156052,ENSG00000157554,ENSG00000164305,ENSG00000165392,ENSG00000168036,ENSG00000198900,ENSG00000245848,ENSG00000286522,ENSG00000101412,ENSG00000148702","Interactor","Tesaro","PARP inhibitor","Oncology","Epithelial ovarian, fallopian tube or primary peritoneal cancer","fallopian tube cancer; ovarian epithelial tumor; primary peritoneal carcinoma","MONDO_0002158,MONDO_0002229,MONDO_0015686",NA,"Original","Serious","P,O,B,F",TRUE,TRUE,FALSE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
190,"CHEMBL3622821",2019,1995,1995,NA,NA,"Rinvoq","Upadacitinib","UPADACITINIB","ENSG00000162434,ENSG00000096968,ENSG00000105397,ENSG00000105639","ENSG00000096968,ENSG00000100368,ENSG00000105639,ENSG00000134352,ENSG00000162434,ENSG00000065361,ENSG00000106541,ENSG00000115415,ENSG00000131196,ENSG00000142166,ENSG00000168610,ENSG00000183386","Original","AbbVie","JAK inhibitor","Other indication","Rheumatoid arthritis","rheumatoid arthritis","EFO_0000685",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
191,"CHEMBL3989931",2017,2010,2010,NA,NA,"Idhifa","Enasidenib mesylate","ENASIDENIBMESYLATE","ENSG00000182054","ENSG00000182054","Original","Celgene/Agios","IDH2 inhibitor","Oncology","IDH2-mutated AML","acute myeloid leukemia","EFO_0000222",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2017,TRUE,2017,FALSE,FALSE,FALSE,TRUE
192,"CHEMBL3948730",2021,NA,1990,1991,1996,"Ukoniq","Umbralisib","Umbralisib","ENSG00000171608,ENSG00000097007,ENSG00000213923","ENSG00000078674,ENSG00000122025,ENSG00000141736,ENSG00000145675,ENSG00000149311,ENSG00000153707,ENSG00000157404,ENSG00000134982,ENSG00000197822","Interactor","TG Therapeutics","PI3Kdelta and CK1epsilon inhibitor","Oncology","MZL, follicular lymphoma","MZL; follicular lymphoma","EFO_1000630,MONDO_0018906","EFO_0000183","Related","Serious","P,O,B,A",TRUE,TRUE,TRUE,TRUE,FALSE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
194,"CHEMBL2107884",2016,NA,NA,2016,NA,"Cinqair","Reslizumab","RESLIZUMAB","ENSG00000113525",NA,"Original","Teva","IL-5 antagonist","Other indication","Serious asthma","Status Asthmaticus","EFO_0008590","MONDO_0004979,MONDO_0004979","Related","Serious","S",TRUE,FALSE,TRUE,FALSE,FALSE,2016,TRUE,2016,FALSE,TRUE,FALSE,FALSE
196,"CHEMBL3707328",2018,NA,1998,NA,NA,"Emgality","Galcanezumab","GALCANEZUMAB","ENSG00000175868,ENSG00000110680","ENSG00000157087,ENSG00000110680","Original","Eli Lilly","CGRP antibody","Other indication","Migraine","migraine disorder","MONDO_0005277",NA,"Original","Not serious","S,F",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
197,"CHEMBL2108078",2015,2006,1986,NA,NA,"Natpara","Parathyroid hormone","PARATHYROIDHORMONE","ENSG00000160801","ENSG00000152266,ENSG00000087494,ENSG00000168036","Original","NPS Pharma","Hormonal injection","Other indication","Hypocalcaemia in patients with hypoparathyroidism","hypoparathyroidism; Hypocalcemia","EFO_0009451,HP_0002901",NA,"Original","Not concordant","S,O",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
200,"CHEMBL3989949",2019,1999,1999,NA,NA,"Xcopri","Cenobamate","CENOBAMATE","ENSG00000168356,ENSG00000196876,ENSG00000185313,ENSG00000144285,ENSG00000153253,ENSG00000183873,ENSG00000136531,ENSG00000169432,ENSG00000136546,ENSG00000007314,ENSG00000186297,ENSG00000151834,ENSG00000011677,ENSG00000187730,ENSG00000109158,ENSG00000022355,ENSG00000166206,ENSG00000182256,ENSG00000145864,ENSG00000268089,ENSG00000145863,ENSG00000094755,ENSG00000163288,ENSG00000113327,ENSG00000102287,ENSG00000163285","ENSG00000022355,ENSG00000102466,ENSG00000105711,ENSG00000113327,ENSG00000114279,ENSG00000166206,NA","Original","SK Life Science","Unknown","Other indication","Partial onset seizures","seizure","HP_0001250",NA,"Original","Not concordant","S",TRUE,FALSE,FALSE,FALSE,TRUE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
201,"CHEMBL408403",2017,NA,2019,NA,NA,"Giapreza","Angiotensin II","ANGIOTENSINII","ENSG00000144891","ENSG00000134817,ENSG00000139053,ENSG00000143153","Interactor","La Jolla Pharmaceutical Company","Synthetic human angiotensin","Other indication","Blood pressure in adults with septic or other distributive shock","septic shock; blood pressure","EFO_0006834,EFO_0004325",NA,"Original","Serious","P",TRUE,TRUE,FALSE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
202,"CHEMBL3286830",2018,2005,2005,NA,NA,"Lorbrena","Lorlatinib","LORLATINIB","ENSG00000171094,ENSG00000143924","ENSG00000165731,ENSG00000171094,ENSG00000096384,ENSG00000107882,ENSG00000127329,ENSG00000149177","Original","Pfizer","ALK and ROS1 inhibitor","Oncology","ALK-positive NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
203,"CHEMBL3544921",2017,1997,NA,NA,NA,"Brineura","Cerliponase alfa","CERLIPONASEALFA","ENSG00000166340",NA,"Original","BioMarin Pharmaceutical","Tripeptidyl peptidase","Other indication","Tripeptidyl peptidase 1 deficiency (neuronal ceroid lipofuscinosis type 2*)","neuronal ceroid lipofuscinosis 2","MONDO_0008769",NA,"Original","Serious","P,O,B",TRUE,FALSE,FALSE,FALSE,TRUE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
204,"CHEMBL3301624",2020,2000,NA,NA,NA,"Imcivree","Setmelanotide","SETMELANOTIDE","ENSG00000166603",NA,"Original","Rhythm","Melanocortin receptor 4 agonist","Other indication","Rare genetic diseases of obesity","Bardet-Biedl syndrome","MONDO_0015229",NA,"Original","Serious","P,O,B",TRUE,FALSE,FALSE,FALSE,TRUE,2020,TRUE,2020,FALSE,FALSE,FALSE,TRUE
205,"CHEMBL3301589",2019,NA,2015,NA,NA,"Padcev","Enfortumab vedotin","ENFORTUMABVEDOTIN","ENSG00000143217,ENSG00000101162,ENSG00000167552,ENSG00000261456,ENSG00000127824,ENSG00000123416,ENSG00000258947,ENSG00000198033,ENSG00000188229,ENSG00000152086,ENSG00000137267,ENSG00000104833,ENSG00000167553,ENSG00000137285,ENSG00000196230,ENSG00000176014","ENSG00000065361,ENSG00000080824,ENSG00000083799,ENSG00000091831,ENSG00000126934,ENSG00000130779,ENSG00000133124,ENSG00000136997,ENSG00000146648,ENSG00000177606,ENSG00000179218,ENSG00000204843","Interactor","Astellas","Nectin-4-directed ADC","Oncology","Urothelial cancers","urothelial neoplasm","MONDO_0024337",NA,"Original","Serious","P,B,A",TRUE,TRUE,FALSE,FALSE,FALSE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
207,"CHEMBL4297756",2018,NA,1998,NA,NA,"Ajovy","Fremanezumab","FREMANEZUMAB","ENSG00000110680,ENSG00000175868","ENSG00000157087,ENSG00000110680","Original","Teva","CGRP antibody","Other indication","Migraine","migraine disorder","MONDO_0005277",NA,"Original","Not serious","P",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
208,"CHEMBL4298185",2021,NA,NA,2021,2021,"Skytrofa","Lonapegsomatropin","Lonapegsomatropin","ENSG00000112964","ENSG00000112964","Original","Ascendis Pharma","PEGylated human growth hormone","Other indication","Growth failure due to GHD","Growth delay","HP_0001510","EFO_0004339","Original","Not serious","S,O",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
209,"CHEMBL4297588",2021,2003,NA,NA,NA,"Bylvay","Odevixibat","Odevixibat","ENSG00000125255",NA,"Original","Albireo","IBAT inhibitor","Other indication","Pruritus in PFIC","familial intrahepatic cholestasis","MONDO_0017290","EFO_0005653","Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
210,"CHEMBL4297340",2019,NA,2013,NA,NA,"Gallium dotatoc Ga-68","Gallium dotatoc Ga-68","GALLIUMDOTATOCGA-68","ENSG00000180616","ENSG00000145675","Interactor","UIHC PET Imaging Center","Radioactive diagnostic","Other indication","Localization of somatostatin receptor-positive neuroendocrine tumours","neuroendocrine neoplasm","EFO_1001901",NA,"Original","Serious","S,O",TRUE,TRUE,FALSE,FALSE,FALSE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
213,"CHEMBL1743078",2022,NA,2020,NA,NA,"Tzield","Teplizumab","Teplizumab","ENSG00000198851","ENSG00000165025","Interactor","Provention Bio","CD3-targeted antibody","Other indication","Delay onset of type 1 diabetes","type 1 diabetes mellitus","MONDO_0005147",NA,"Original","Not concordant","P,B",TRUE,TRUE,FALSE,FALSE,FALSE,2022,TRUE,2022,TRUE,FALSE,FALSE,FALSE
214,"CHEMBL4208229",2021,1990,2013,1989,1990,"Scemblix","Asciminib","Asciminib","ENSG00000097007","ENSG00000122025,ENSG00000149311,ENSG00000157404","Original","Novartis","ABL/BCR-ABL1  kinase inhibitor","Oncology","Ph+ CML","Blast Phase Chronic Myelogenous Leukemia; BCR-ABL1 Positive","EFO_1000131","EFO_0000339","Original","Serious","P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
216,"CHEMBL3707247",2020,NA,2013,NA,NA,"Zeposia","Ozanimod","OZANIMOD","ENSG00000170989","ENSG00000110848","Interactor","Celgene/Bristol Myers Squibb","S1P receptor modulator","Other indication","Multiple sclerosis","multiple sclerosis","MONDO_0005301",NA,"Original","Serious","S",TRUE,TRUE,FALSE,FALSE,FALSE,2020,TRUE,2020,TRUE,FALSE,FALSE,FALSE
218,"CHEMBL1852688",2021,2014,2001,NA,NA,"Truseltiq","Infigratinib","Infigratinib","ENSG00000160867,ENSG00000068078,ENSG00000066468,ENSG00000077782","ENSG00000066468,ENSG00000002834,ENSG00000039068,ENSG00000065361,ENSG00000068078,ENSG00000077782,ENSG00000096384,ENSG00000099956,ENSG00000102145,ENSG00000106462,ENSG00000107485,ENSG00000123388,ENSG00000124181,ENSG00000124762,ENSG00000127914,ENSG00000136997,ENSG00000139219,ENSG00000145675,ENSG00000147548,ENSG00000160867,ENSG00000165731,ENSG00000168036,ENSG00000168769,ENSG00000177606,ENSG00000178104,ENSG00000179094,ENSG00000179295,ENSG00000179348,ENSG00000184937,ENSG00000197157","Original","BridgeBio","FGFR2 kinase inhibitor","Oncology","FGFR2-mutated bile duct cancer","bile duct cancer","MONDO_0003059",NA,"Original","Serious","P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
219,"CHEMBL3889654",2018,1992,1992,NA,NA,"Vitrakvi","Larotrectinib","LAROTRECTINIB","ENSG00000148053,ENSG00000198400,ENSG00000140538","ENSG00000081237,ENSG00000096384,ENSG00000105976,ENSG00000124181,ENSG00000127329,ENSG00000135333,ENSG00000140538,ENSG00000145675,ENSG00000146648,ENSG00000162733,ENSG00000198400,ENSG00000206503,ENSG00000149177,ENSG00000006125,ENSG00000127022,ENSG00000134259,ENSG00000160691,ENSG00000206052","Original","Loxo Oncology/Bayer","TRKA, TRKB and TRKC inhibitor","Oncology","NTRK-positive solid cancers","salivary gland cancer; soft tissue sarcoma; thyroid cancer","MONDO_0004669,EFO_1001968,MONDO_0002108",NA,"Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
220,"CHEMBL4297841",2021,NA,2015,NA,NA,"Tivdak","Tisotumab vedotin","Tisotumabvedotin","ENSG00000117525,ENSG00000167552,ENSG00000258947,ENSG00000137267,ENSG00000188229,ENSG00000176014,ENSG00000261456,ENSG00000123416,ENSG00000198033,ENSG00000196230,ENSG00000167553,ENSG00000152086,ENSG00000104833,ENSG00000137285,ENSG00000101162,ENSG00000127824","ENSG00000065361,ENSG00000080824,ENSG00000083799,ENSG00000091831,ENSG00000126934,ENSG00000130779,ENSG00000133124,ENSG00000136997,ENSG00000146648,ENSG00000177606,ENSG00000179218,ENSG00000204843","Interactor","Seagen/Genmab","Tissue-factor-directed ADC","Oncology","Cervical cancer","cervical cancer","MONDO_0002974",NA,"Original","Serious","P,A",TRUE,TRUE,FALSE,FALSE,FALSE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
221,"CHEMBL207538",2019,NA,NA,2005,NA,"Zulresso","Brexanolone","BREXANOLONE","ENSG00000094755,ENSG00000109158,ENSG00000186297,ENSG00000022355,ENSG00000145864,ENSG00000166206,ENSG00000182256,ENSG00000011677,ENSG00000268089,ENSG00000102287,ENSG00000113327,ENSG00000163285,ENSG00000151834,ENSG00000145863,ENSG00000163288,ENSG00000187730",NA,"Original","Sage Therapeutics","GABAA-receptor-positive modulator","Other indication","Postpartum depression","postpartum depression","EFO_0007453","MONDO_0002050","Related","Not concordant","P,B",TRUE,FALSE,TRUE,FALSE,FALSE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
223,"CHEMBL4535757",2021,1990,1990,NA,NA,"Lumakras","Sotorasib","Sotorasib","ENSG00000133703","ENSG00000078061,ENSG00000133703,ENSG00000157764,ENSG00000067560,ENSG00000132155,ENSG00000142192,ENSG00000143398","Original","Amgen","KRAS-G12C inhibitor","Oncology","KRASG12C-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
227,"CHEMBL441738",2019,NA,NA,2007,NA,"Scenesse","Afamelanotide","AFAMELANOTIDE","ENSG00000258839",NA,"Original","Clinuvel","Melanocortin 1 receptor agonist","Other indication","Erythropoietic protoporphyria","erythropoietic protoporphyria","MONDO_0001676","EFO_1000752","Related","Serious","P,O,F",TRUE,FALSE,TRUE,FALSE,FALSE,2019,TRUE,2019,FALSE,TRUE,FALSE,FALSE
228,"CHEMBL2103837",2019,1977,1977,NA,NA,"Vyndaqel","Tafamidis","TAFAMIDIS","ENSG00000118271","ENSG00000118271,ENSG00000119614,ENSG00000128272,ENSG00000132016,ENSG00000138207,ENSG00000139372,ENSG00000142192,ENSG00000166595,ENSG00000198959","Original","Pfizer/Foldrx","Transthyretin stabilizer","Other indication","Heart disease caused by ATTR-CM","cardiomyopathy","EFO_0000318",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2019,TRUE,2019,FALSE,FALSE,FALSE,TRUE
229,"CHEMBL2107857",2014,1966,1966,NA,NA,"Myalept","Metreleptin","METRELEPTIN","ENSG00000116678","ENSG00000116678,ENSG00000174697,ENSG00000179295","Original","Amylin","Leptin analogue","Other indication","Leptin deficiency in patients with congenital or acquired generalized lipodystrophy","congenital generalized lipodystrophy","EFO_1000681",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2014,TRUE,2014,FALSE,FALSE,FALSE,TRUE
230,"CHEMBL2108429",2015,NA,NA,2016,NA,"Nucala","Mepolizumab","MEPOLIZUMAB","ENSG00000113525",NA,"Original","GlaxoSmithKline","IL-5 antagonist","Other indication","Serious asthma","Status Asthmaticus","EFO_0008590","MONDO_0004979,MONDO_0004979","Related","Serious","S,F",TRUE,FALSE,TRUE,FALSE,FALSE,2015,TRUE,2015,FALSE,TRUE,FALSE,FALSE
232,"CHEMBL396778",2017,NA,2002,NA,NA,"Xadago","Safinamide","SAFINAMIDE","ENSG00000069535","ENSG00000102466,ENSG00000163050","Interactor","US WorldMeds","MAO-B inhibitor","Other indication","Parkinson disease","Parkinson disease","MONDO_0005180",NA,"Original","Serious","S",TRUE,TRUE,FALSE,FALSE,FALSE,2017,TRUE,2017,TRUE,FALSE,FALSE,FALSE
236,"CHEMBL2108278",2016,1988,NA,NA,NA,"Exondys 51","Eteplirsen","ETEPLIRSEN","ENSG00000198947","ENSG00000101400,NA","Original","Sarepta Therapeutics","ASO designed to target dystrophin pre-mRNA","Other indication","Duchenne muscular dystrophy","Duchenne muscular dystrophy","MONDO_0010679",NA,"Original","Serious","P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2016,TRUE,2016,FALSE,FALSE,FALSE,TRUE
237,"CHEMBL2403108",2014,2005,1990,NA,NA,"Zykadia","Ceritinib","CERITINIB","ENSG00000171094,ENSG00000143924,ENSG00000181163","ENSG00000165731,ENSG00000171094,ENSG00000091831,ENSG00000096384,ENSG00000104408,ENSG00000107882,ENSG00000127329,ENSG00000135679,ENSG00000141510,ENSG00000147889,ENSG00000164362,ENSG00000181163,ENSG00000198900,ENSG00000071894,ENSG00000115163,ENSG00000254093,ENSG00000001626,ENSG00000087586,ENSG00000116030,ENSG00000116478,ENSG00000137203,ENSG00000141456,ENSG00000149177,ENSG00000178999","Original","Novartis","Kinase inhibitor against ALK, IGF1R, insulin receptor and ROS1","Oncology","ALK-positive metastatic NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
241,"CHEMBL1509,CHEMBL1230314",2021,2021,2021,NA,NA,"Nextstellis","Drospirenone, estetrol","Drospirenone,estetrol","ENSG00000151623,ENSG00000082175,ENSG00000091831,ENSG00000140009","ENSG00000091831,ENSG00000091831,ENSG00000104447,ENSG00000132153,ENSG00000135250,ENSG00000135486,ENSG00000138078,ENSG00000143575,ENSG00000155561,ENSG00000158406,ENSG00000162244,ENSG00000167216,ENSG00000171456,ENSG00000171490,ENSG00000197728","Original","Mayne Pharma","Spironolactone and oestrogen analogues","Other indication","To prevent pregnancy","reproductive behaviour measurement","EFO_0007862",NA,"Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
243,"CHEMBL3707382",2017,1977,1977,NA,NA,"Mepsevii","Vestronidase alfa","VESTRONIDASEALFA","ENSG00000169919","ENSG00000169919","Original","Ultragenyx","Recombinant human lysosomal ‚Äö√¢√†‚àö‚â†‚Äö√Ñ√∂‚àö¬¢¬¨√ü-glucuronidase","Other indication","Mucopolysaccharidosis VII","mucopolysaccharidosis type 7","MONDO_0009662",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
244,"CHEMBL1742996",2017,NA,NA,2022,NA,"Siliq","Brodalumab","BRODALUMAB","ENSG00000177663",NA,"Original","Valeant Pharmaceuticals","IL-17RA antagonist","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","EFO_0000676","Related","Not serious","S",TRUE,FALSE,TRUE,FALSE,FALSE,2017,TRUE,2017,FALSE,TRUE,FALSE,FALSE
246,"CHEMBL3707267",2016,2021,NA,NA,NA,"Axumin","Fluciclovine F-18","FLUCICLOVINEF-18","ENSG00000155465,ENSG00000105281,ENSG00000165349",NA,"Original","Blue Earth","Radioactive diagnostic","Other indication","Suspected prostate cancer recurrence","prostate cancer","MONDO_0008315",NA,"Original","Serious","P",TRUE,FALSE,FALSE,FALSE,TRUE,2016,FALSE,2016,FALSE,FALSE,FALSE,FALSE
247,"CHEMBL278623",2017,2009,1966,NA,NA,"Macrilen","Macimorelin","MACIMORELIN","ENSG00000121853","ENSG00000121853,ENSG00000116678","Original","Aeterna Zentaris","Growth hormone secretagogue receptor agonist","Other indication","Diagnosis of adult growth hormone deficiency","short stature due to GHSR deficiency","MONDO_0014403",NA,"Original","Not serious","S,O",TRUE,FALSE,FALSE,FALSE,TRUE,2017,TRUE,2017,FALSE,FALSE,FALSE,TRUE
248,"CHEMBL1770248",2017,NA,NA,2002,NA,"Steglatro","Ertugliflozin","ERTUGLIFLOZIN","ENSG00000140675",NA,"Original","Merck & Co./Pfizer","SGLT2 inhibitor","Other indication","Type 2 diabetes mellitus","type 2 diabetes mellitus","MONDO_0005148","HP_0003076,Orphanet_79161","Related","Not concordant","S",TRUE,FALSE,TRUE,FALSE,FALSE,2017,TRUE,2017,FALSE,TRUE,FALSE,FALSE
250,"CHEMBL189963",2015,NA,NA,2008,2015,"Ibrance","Palbociclib","PALBOCICLIB","ENSG00000135446,ENSG00000110092,ENSG00000105810","ENSG00000110092,ENSG00000179750","Original","Pfizer","CDK4 and CDK6 inhibitor","Oncology","ER-positive, HER2-negative advanced breast cancer","HER2 negative breast carcinoma","EFO_0009780","EFO_0000305","Original","Serious","P,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
251,"CHEMBL4559134",2020,1986,1975,NA,NA,"Retevmo","Selpercatinib","SELPERCATINIB","ENSG00000108091,ENSG00000165731,ENSG00000170759","ENSG00000146648,ENSG00000165731,ENSG00000171094,ENSG00000105568,ENSG00000108091,ENSG00000109670,ENSG00000110395,ENSG00000124181,ENSG00000160867,ENSG00000164305,ENSG00000168610,ENSG00000170759,ENSG00000113575,ENSG00000101266,ENSG00000104695,ENSG00000137076,ENSG00000168002,ENSG00000170027,ENSG00000188191","Original","Eli Lilly/Loxo Oncology","RET kinase inhibitor","Oncology","RET fusion-positive NSCLC and thyroid cancer","non-small cell lung carcinoma; thyroid cancer","EFO_0003060,MONDO_0002108",NA,"Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
252,"CHEMBL2364653",2021,NA,2008,NA,NA,"Saphnelo","Anifrolumab","Anifrolumab","ENSG00000142166","ENSG00000105397,ENSG00000115415","Interactor","AstraZeneca","IFNAR-targeted mAb","Other indication","SLE","systemic lupus erythematosus","MONDO_0007915",NA,"Original","Serious","S,F",TRUE,TRUE,FALSE,FALSE,FALSE,2021,TRUE,2021,TRUE,FALSE,FALSE,FALSE
253,"CHEMBL3301572",2016,1995,1995,NA,NA,"Spinraza","Nusinersen","NUSINERSEN","ENSG00000205571","ENSG00000107290,ENSG00000172062,ENSG00000205571,ENSG00000079805,ENSG00000169057,ENSG00000182004,ENSG00000187191,ENSG00000197386,ENSG00000204410","Original","Biogen/Ionis Pharmaceuticals","ASO designed to target SMN2 pre-mRNA","Other indication","Spinal muscular atrophy","spinal muscular atrophy","EFO_0008525",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2016,TRUE,2016,FALSE,FALSE,FALSE,TRUE
254,"CHEMBL1738797",2015,2005,1975,NA,NA,"Alecensa","Alectinib","ALECTINIB","ENSG00000171094,ENSG00000143924,ENSG00000165731","ENSG00000146648,ENSG00000165731,ENSG00000171094,ENSG00000096384,ENSG00000107882,ENSG00000110395,ENSG00000124181,ENSG00000127329,ENSG00000160867,ENSG00000164305,ENSG00000168610,ENSG00000137076,ENSG00000149177","Original","Roche","ALK inhibitor","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
255,"CHEMBL1614701",2020,NA,NA,2013,NA,"Koselugo","Selumetinib","SELUMETINIB","ENSG00000169032,ENSG00000126934",NA,"Original","AstraZeneca","MEK1/2 kinase inhibitor","Other indication","Neurofibromatosis type 1","neurofibromatosis type 1","MONDO_0018975","EFO_0008514","Related","Serious","P,O,B",TRUE,FALSE,TRUE,FALSE,FALSE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
256,"CHEMBL4594320",2021,1985,NA,NA,NA,"Nexviazyme","Avalglucosidase alfa","Avalglucosidasealfa","ENSG00000171298",NA,"Original","Sanofi","Recombinant alpha-glucosidase","Other indication","Pompe disease","glycogen storage disease II","MONDO_0009290",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
258,"CHEMBL3545110",2017,NA,NA,2008,2015,"Kisqali","Ribociclib","RIBOCICLIB","ENSG00000105810,ENSG00000135446","ENSG00000110092,ENSG00000179750","Interactor","Novartis","CDK4/6 inhibitor","Oncology","HR-positive, HER2-negative breast cancer","HER2 negative breast carcinoma","EFO_0009780","EFO_0000305","Related","Serious","P,B",TRUE,TRUE,TRUE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
259,"CHEMBL2111101",2016,2006,1999,NA,NA,"Nuplazid","Pimavanserin","PIMAVANSERIN","ENSG00000102468","ENSG00000102468,ENSG00000118432,ENSG00000147246,ENSG00000164082","Original","Acadia Pharmaceuticals","Atypical antipsychotic","Other indication","Hallucinations and delusions associated with Parkinson disease psychosis","Parkinson disease; psychosis","MONDO_0005180,EFO_0005407",NA,"Original","Serious","P,B",TRUE,FALSE,FALSE,FALSE,TRUE,2016,FALSE,2016,FALSE,FALSE,FALSE,FALSE
260,"CHEMBL2070241",2019,NA,NA,2015,NA,"Vyleesi","Bremelanotide","BREMELANOTIDE","ENSG00000166603",NA,"Original","Amag","Melanocortin receptor agonist","Other indication","Hypoactive sexual desire disorder","sexual dysfunction","EFO_0004714","EFO_0008343,EFO_0008343","Related","Not serious","S",TRUE,FALSE,TRUE,FALSE,FALSE,2019,TRUE,2019,FALSE,TRUE,FALSE,FALSE
261,"CHEMBL1173055",2016,NA,1991,NA,NA,"Rubraca","Rucaparib","RUCAPARIB","ENSG00000041880,ENSG00000129484,ENSG00000143799","ENSG00000141510,ENSG00000082805,ENSG00000091831,ENSG00000100030,ENSG00000148737,ENSG00000154767,ENSG00000156052,ENSG00000157554,ENSG00000164305,ENSG00000165392,ENSG00000168036,ENSG00000198900,ENSG00000245848,ENSG00000286522,ENSG00000004700,ENSG00000101412,ENSG00000148702,ENSG00000073050,ENSG00000092847,ENSG00000118518,ENSG00000131747,ENSG00000143799,ENSG00000147874,ENSG00000150991,ENSG00000166884,ENSG00000189403,ENSG00000196419,ENSG00000253729","Original","Clovis Oncology","PARP inhibitor","Oncology","BRCA-positive ovarian cancer","ovarian cancer","MONDO_0008170",NA,"Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2016,FALSE,2016,FALSE,FALSE,FALSE,FALSE
262,"CHEMBL2103830",2018,NA,2004,NA,NA,"Tavalisse","Fostamatinib","FOSTAMATINIB","ENSG00000165025","ENSG00000012124,ENSG00000142192,ENSG00000162711","Interactor","Rigel Pharmaceuticals","SYK inhibitor","Other indication","Immune thrombocytopenic purpura","autoimmune thrombocytopenic purpura","EFO_0007160",NA,"Original","Serious","S,O",TRUE,TRUE,FALSE,FALSE,FALSE,2018,TRUE,2018,TRUE,FALSE,FALSE,FALSE
264,"CHEMBL3545367",2019,NA,NA,2003,NA,"Dayvigo","Lemborexant","LEMBOREXANT","ENSG00000121764,ENSG00000137252",NA,"Original","Eisai","Orexin receptor antagonist","Other indication","Insomnia","insomnia","EFO_0004698","EFO_0008568,EFO_0005271","Related","Not serious","S",TRUE,FALSE,TRUE,FALSE,FALSE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
265,"CHEMBL429910",2014,NA,NA,2002,NA,"Farxiga","Dapagliflozin","DAPAGLIFLOZIN","ENSG00000140675",NA,"Original","AstraZeneca","SGLT2 inhibitor","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","HP_0003076,Orphanet_79161","Related","Not concordant","S,F",TRUE,FALSE,TRUE,FALSE,FALSE,2014,TRUE,2014,FALSE,TRUE,FALSE,FALSE
269,"CHEMBL3936761",2019,NA,2004,NA,NA,"Brukinsa","Zanubrutinib","ZANUBRUTINIB","ENSG00000010671","ENSG00000010671,ENSG00000117560","Original","BeiGene","BTK inhibitor","Oncology","Mantle cell lymphoma","mantle cell lymphoma","EFO_1001469",NA,"Original","Serious","P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2019,TRUE,2019,FALSE,FALSE,FALSE,TRUE
270,"CHEMBL3707326",2018,2004,NA,NA,NA,"Crysvita","Burosumab","BUROSUMAB","ENSG00000118972",NA,"Original","Ultragenyx Pharmaceutical/Kyowa Hakko Kirin","FGF23 antibody","Other indication","X-linked hypophosphataemia","Hypophosphatemia","HP_0002148",NA,"Original","Not serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2018,TRUE,2018,FALSE,FALSE,FALSE,TRUE
271,"CHEMBL3545253",2020,NA,1985,NA,NA,"Flortaucipir F-18","Flortaucipir F-18","FLORTAUCIPIRF-18","ENSG00000186868","ENSG00000130203,ENSG00000142192,ENSG00000186868,ENSG00000136717","Original","Eli Lilly","Radioactive diagnostic","Other indication","Imaging, tau in Alzheimer disease","Alzheimer disease","MONDO_0004975",NA,"Original","Serious","P",TRUE,FALSE,FALSE,FALSE,TRUE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
272,"CHEMBL3099695",2020,2005,NA,NA,NA,"Isturisa","Osilodrostat","OSILODROSTAT","ENSG00000160882",NA,"Original","Recordati Rare Diseases","Cortisol synthesis inhibitor","Other indication","Cushing disease","Cushing syndrome","EFO_0003099",NA,"Original","Not concordant","S,O",TRUE,FALSE,FALSE,FALSE,TRUE,2020,TRUE,2020,FALSE,FALSE,FALSE,TRUE
273,"CHEMBL1743041",2018,NA,NA,2015,NA,"Poteligeo","Mogamulizumab","MOGAMULIZUMAB","ENSG00000183813",NA,"Original","Kyowa Hakko Kirin","CCR4 antibody","Oncology","mycosis fungoides or Sezary syndrome","mycosis fungoides","EFO_1001051","MONDO_0015758","Related","Serious","P,O,B",TRUE,FALSE,TRUE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
274,"CHEMBL3989958",2018,2010,2010,NA,NA,"Tibsovo","Ivosidenib","IVOSIDENIB","ENSG00000138413","ENSG00000138413,ENSG00000072062,ENSG00000163513,ENSG00000179218","Original","Agios Pharmaceuticals","IDH1 inhibitor","Oncology","IDH1-mutated AML, Locally Advanced or Metastatic Cholangiocarcinoma (*)","acute myeloid leukemia; cholangiocarcinoma","EFO_0000222,EFO_0005221",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
275,"CHEMBL2105395",2013,NA,NA,NA,NA,"Osphena","Ospemifene","OSPEMIFENE","ENSG00000140009,ENSG00000091831",NA,"Original","Shionogi","Oestrogen receptor modulator","Other indication","Moderate to Serious dyspareunia due to menopause","Dyspareunia","HP_0030016",NA,"Original","Not serious","S",FALSE,FALSE,FALSE,FALSE,FALSE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
277,"CHEMBL571546",2020,NA,2007,NA,NA,"Klisyri","Tirbanibulin","TIRBANIBULIN","ENSG00000197122","ENSG00000174775","Interactor","Athenex","Microtubule inhibitor","Other indication","Actinic keratosis","actinic keratosis","EFO_0002496","EFO_0003784","Related","Not serious","S",TRUE,TRUE,TRUE,FALSE,FALSE,2020,TRUE,2020,TRUE,TRUE,FALSE,FALSE
278,"CHEMBL235668,CHEMBL1129",2015,2000,NA,NA,NA,"Lonsurf","Tipiracil, trifluridine","TIPIRACIL,TRIFLURIDINE","ENSG00000025708,ENSG00000176890",NA,"Original","Taiho","Thymidine phosphorylase inhibitor plus a nucleoside metabolic inhibitor","Oncology","Colorectal cancer","colorectal cancer","EFO_0005842",NA,"Original","Serious","S,F",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
279,"CHEMBL3833384",2022,NA,NA,1996,NA,"Rolvedon","Eflapegrastim","Eflapegrastim","ENSG00000119535",NA,"Original","Spectrum","Leukocyte growth factor","Other indication","Incidence of infection in non-myeloid malignancies, with myelosuppressive drugs","infection","EFO_0000544","Orphanet_169142","Related","Serious","S",TRUE,FALSE,TRUE,FALSE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
281,"CHEMBL1873475",2013,NA,2004,NA,NA,"Imbruvica","Ibrutinib","IBRUTINIB","ENSG00000010671","ENSG00000010671,ENSG00000117560","Original","Pharmacyclics","Bruton's tyrosine kinase inhibitor","Oncology","Mantle cell lymphoma","Mantle cell lymphoma","EFO_1001469",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2013,TRUE,2013,FALSE,FALSE,FALSE,TRUE
283,"CHEMBL3833319",2018,2019,NA,NA,NA,"Yupelri","Revefenacin","REVEFENACIN","ENSG00000133019",NA,"Original","Theravance Biopharma/Mylan","Long-acting muscarinic receptor antagonist","Other indication","COPD","chronic obstructive pulmonary disease","EFO_0000341",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2018,TRUE,2018,FALSE,FALSE,FALSE,TRUE
285,"CHEMBL2338675",2021,1992,1992,NA,NA,"Nulibry","Fosdenopterin","Fosdenopterin","ENSG00000164172","ENSG00000164172","Original","BridgeBio","cPMP","Other indication","MoCD type A","sulfite oxidase deficiency due to molybdenum cofactor deficiency","MONDO_0020480",NA,"Original","Serious","P,O,B",TRUE,FALSE,FALSE,FALSE,TRUE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
286,"CHEMBL514800",2014,NA,NA,2010,NA,"Otezla","Apremilast","APREMILAST","ENSG00000184588,ENSG00000065989,ENSG00000105650,ENSG00000113448",NA,"Original","Celgene","Phosphodiesterase 4 inhibitor","Other indication","Psoriatic arthritis and plaque psoriasis","psoriatic arthritis; psoriasis vulgaris","EFO_0003778,EFO_1001494","EFO_0000676","Related","Serious","S",TRUE,FALSE,TRUE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
287,"CHEMBL3137320",2018,NA,NA,NA,1995,"Talzenna","Talazoparib","TALAZOPARIB","ENSG00000143799,ENSG00000129484","ENSG00000091831","Interactor","Pfizer","PARP inhibitor","Oncology","BRCA-mutated HER2-negative breast cancer","HER2 negative breast carcinoma","EFO_0009780","EFO_0000305","Related","Serious","P",TRUE,TRUE,TRUE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
291,"CHEMBL2108311",2015,1993,NA,NA,NA,"Strensiq","Asfotase alfa","ASFOTASEALFA","ENSG00000162551",NA,"Original","Alexion","Alkaline phosphatase","Other indication","Hypophosphatasia","hypophosphatasia","MONDO_0018570",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
292,"CHEMBL3707227",2016,2017,2020,NA,NA,"Tecentriq","Atezolizumab","ATEZOLIZUMAB","ENSG00000120217","ENSG00000197646","Original","Genentech","PDL1 inhibitor","Oncology","Urothelial carcinoma","urothelial carcinoma","EFO_0008528",NA,"Original","Serious","P,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2016,TRUE,2016,FALSE,FALSE,FALSE,TRUE
293,"CHEMBL3039540",2021,1991,1985,NA,NA,"Aduhelm","Aducanumab","Aducanumab","ENSG00000142192","ENSG00000080815,ENSG00000130203,ENSG00000137642,ENSG00000137845,ENSG00000142192,ENSG00000143801,ENSG00000186868,ENSG00000070808,ENSG00000132535,ENSG00000007047,ENSG00000073060,ENSG00000120885,ENSG00000120899,ENSG00000121653,ENSG00000129219,ENSG00000131042,ENSG00000138613,ENSG00000163879,ENSG00000165916,ENSG00000168077","Original","Biogen/Eisai","Amyloid-beta-targeted mAb","Other indication","Alzheimers disease","Alzheimers disease","MONDO_0004975",NA,"Original","Serious","P,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
295,"CHEMBL3137309",2016,2013,1992,NA,NA,"Venclexta","Venetoclax","VENETOCLAX","ENSG00000171791","ENSG00000029363,ENSG00000087088,ENSG00000100030,ENSG00000141510,ENSG00000171791,ENSG00000198625,ENSG00000030110,ENSG00000141682,ENSG00000153094,ENSG00000123358","Original","AbbVie","BCL-2 inhibitor","Oncology","Chronic lymphocytic leukaemia","chronic lymphocytic leukemia","EFO_0000095",NA,"Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2016,TRUE,2016,FALSE,FALSE,FALSE,TRUE
299,"CHEMBL3301581",2017,NA,1994,NA,NA,"Tymlos","Abaloparatide","ABALOPARATIDE","ENSG00000160801","ENSG00000087494,ENSG00000168036","Interactor","Radius Health","Parathyroid hormone-related protein","Other indication","Osteoporosis","osteoporosis","EFO_0003882",NA,"Original","Not serious","S",TRUE,TRUE,FALSE,FALSE,FALSE,2017,TRUE,2017,TRUE,FALSE,FALSE,FALSE
300,"CHEMBL1083659",2014,NA,NA,2003,NA,"Belsomra","Suvorexant","SUVOREXANT","ENSG00000137252,ENSG00000121764",NA,"Original","Merck & Co.","Orexin-receptor antagonist","Other indication","Insomnia","insomnia","EFO_0004698","EFO_0008568,EFO_0005271","Related","Not serious","S",TRUE,FALSE,TRUE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
301,"CHEMBL3039502",2018,NA,2014,2000,1990,"Copiktra","Duvelisib","DUVELISIB","ENSG00000105851,ENSG00000171608","ENSG00000145675,ENSG00000166501,ENSG00000174775","Interactor","Verastem","PI3K inhibitor","Oncology","CLL, FL and SLL","chronic lymphocytic leukemia; follicular lymphoma","EFO_0000095,MONDO_0018906","EFO_0000183","Related","Serious","P,O,A,F",TRUE,TRUE,TRUE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
302,"CHEMBL3187723",2018,2011,2002,NA,NA,"Mektovi","Binimetinib","BINIMETINIB","ENSG00000169032,ENSG00000126934","ENSG00000132155,ENSG00000157764,ENSG00000078061,ENSG00000100030,ENSG00000108953,ENSG00000102882,ENSG00000109971,ENSG00000137693,ENSG00000141068,ENSG00000142192,ENSG00000166913,ENSG00000172530","Original","Array BioPharma","MEK inhibitor","Oncology","BRAF-mutated melanoma","melanoma","EFO_0000756",NA,"Original","Serious","S,O",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
303,"CHEMBL4297852",2018,NA,1995,NA,NA,"Oxervate","Cenegermin","CENEGERMIN","ENSG00000140538,ENSG00000148053,ENSG00000198400","ENSG00000142192,ENSG00000146648","Interactor","Domp‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ¬¨¬®¬¨¬©","Recombinant NGF","Other indication","Neurotrophic keratitis","keratitis","EFO_0009449",NA,"Original","Not serious","P,O,B,F",TRUE,TRUE,FALSE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
304,"CHEMBL4297610",2022,2010,2010,NA,NA,"Rezlidhia","Olutasidenib","Olutasidenib","ENSG00000138413","ENSG00000138413,ENSG00000072062,ENSG00000163513,ENSG00000179218","Original","Rigel/Forma","IDH1 inhibitor","Oncology","IDH1-mutated AML","acute myeloid leukemia","EFO_0000222",NA,"Original","Serious","S,O",TRUE,FALSE,FALSE,FALSE,TRUE,2022,TRUE,2022,FALSE,FALSE,FALSE,TRUE
306,"CHEMBL1187833,CHEMBL1198857",2013,2019,NA,NA,NA,"Anoro Ellipta","Umeclidinium, vilanterol","UMECLIDINIUM,VILANTEROL","ENSG00000133019,ENSG00000169252","ENSG00000113369,ENSG00000163485,NA","Original","GSK","Anticholinergic and a LABA","Other indication","Chronic obstructive pulmonary disease","chronic obstructive pulmonary disease","EFO_0000341",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
308,"CHEMBL4297770",2018,1977,1977,NA,NA,"Tegsedi","Inotersen","INOTERSEN","ENSG00000118271","ENSG00000118271","Original","Ionis Pharmaceuticals","TTR-directed antisense oligonucleotide","Other indication","Hereditary TTR-mediated amyloidosis","hereditary ATTR amyloidosis","MONDO_0017132",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2018,TRUE,2018,FALSE,FALSE,FALSE,TRUE
310,"CHEMBL4297778",2021,1995,1991,NA,NA,"Zynlonta","Loncastuximab tesirine","Loncastuximabtesirine","ENSG00000177455","ENSG00000211899","Original","ADC Therapeutics","CD19-targeted ADC","Oncology","B-cell lymphoma","B-cell non-Hodgkins lymphoma","EFO_1001938",NA,"Original","Serious","P,O,A",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
311,"CHEMBL4066936",2021,2018,2018,NA,NA,"Verquvo","Vericiguat","Vericiguat","ENSG00000123201,ENSG00000061918,ENSG00000152402,ENSG00000164116","ENSG00000061918,ENSG00000164116","Original","Merck & Co./Bayer","sGC stimulator","Other indication","Chronic heart failure","coronary artery disease","EFO_0001645",NA,"Original","Serious","P,F",TRUE,FALSE,FALSE,FALSE,TRUE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
312,"CHEMBL376359",2013,2012,2012,2012,2012,"Nesina","Alogliptin","ALOGLIPTIN","ENSG00000197635","ENSG00000197635,ENSG00000159224,ENSG00000169248","Original","Takeda","DPP4 inhibitor","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","HP_0003076,Orphanet_79161","Original","Not concordant","S",TRUE,FALSE,FALSE,FALSE,TRUE,2013,TRUE,2013,FALSE,FALSE,FALSE,TRUE
315,"CHEMBL2042122",2013,1991,1985,NA,NA,"Vizamyl","Flutemetamol F-18","FLUTEMETAMOLF-18","ENSG00000142192","ENSG00000080815,ENSG00000130203,ENSG00000137642,ENSG00000137845,ENSG00000142192,ENSG00000143801,ENSG00000186868,ENSG00000070808,ENSG00000132535,ENSG00000007047,ENSG00000073060,ENSG00000120885,ENSG00000120899,ENSG00000121653,ENSG00000128482,ENSG00000129219,ENSG00000131042,ENSG00000138613,ENSG00000139318,ENSG00000163879,ENSG00000165916,ENSG00000168077","Original","GE Healthcare","Radioactive diagnostic agent","Other indication","PET imaging of the brain to estimate beta-amyloid neuritic plaque density in patients who are being evaluated for Alzheimer's disease","neuritic plaque measurement; Alzheimer disease","EFO_0006798,MONDO_0004975",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
320,"CHEMBL2364648",2017,2018,2018,2009,2009,"Tremfya","Guselkumab","GUSELKUMAB","ENSG00000113302,ENSG00000110944","ENSG00000110944,ENSG00000113302,ENSG00000162594","Original","Janssen/Johnson & Johnson","IL-23 blocker","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","EFO_0000676","Original","Not serious","P",TRUE,FALSE,FALSE,FALSE,TRUE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
322,"CHEMBL4582651",2020,2010,1975,NA,NA,"Gavreto","Pralsetinib","PRALSETINIB","ENSG00000170759,ENSG00000165731,ENSG00000108091","ENSG00000146648,ENSG00000165731,ENSG00000171094,ENSG00000105568,ENSG00000108091,ENSG00000109670,ENSG00000110395,ENSG00000124181,ENSG00000160867,ENSG00000164305,ENSG00000168610,ENSG00000170759,ENSG00000113575,ENSG00000104695,ENSG00000137076,ENSG00000168002,ENSG00000170027,ENSG00000188191","Original","Blueprint Medicines/Roche","RET kinase inhibitor","Oncology","RET fusion-positive NSCLC","non-small cell lung carcinoma","EFO_0003060",NA,"Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
325,"CHEMBL2219536",2013,1995,1995,2010,2010,"Kynamro","Mipomersen","MIPOMERSEN","ENSG00000084674","ENSG00000130164,ENSG00000138823","Original","Genzyme","Oligonucleotide inhibitor of apolipoprotein B100 synthesis","Other indication","Homozygous familial hypercholesterolaemia","homozygous familial hypercholesterolemia","MONDO_0018328","EFO_0004611","Original","Serious","S,O",TRUE,FALSE,FALSE,FALSE,TRUE,2013,TRUE,2013,FALSE,FALSE,FALSE,TRUE
327,"CHEMBL4297723",2018,NA,2004,NA,NA,"Libtayo","Cemiplimab","CEMIPLIMAB","ENSG00000188389","ENSG00000120217,ENSG00000179295,ENSG00000197646,ENSG00000006125,ENSG00000121594","Interactor","Regeneron/Sanofi","PD1 antibody","Oncology","CSCC, BCC(*), NSCLC(*)","cutaneous squamous cell carcinoma; basal cell carcinoma; non-small cell lung carcinoma","EFO_1001927,EFO_0004193,EFO_0003060",NA,"Original","Serious","P,B",TRUE,TRUE,FALSE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
333,"CHEMBL4297528",2020,1995,1995,NA,NA,"Evrysdi","Risdiplam","RISDIPLAM","ENSG00000205571","ENSG00000107290,ENSG00000172062,ENSG00000205571,ENSG00000079805,ENSG00000169057,ENSG00000182004,ENSG00000187191,ENSG00000197386,ENSG00000204410","Original","Roche/Genentech","SMN2 splicing modifier","Other indication","Spinal muscular atrophy","spinal muscular atrophy","EFO_0008525",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2020,TRUE,2020,FALSE,FALSE,FALSE,TRUE
336,"CHEMBL2107834",2013,2007,2007,2007,2007,"Adempas","Riociguat","RIOCIGUAT","ENSG00000123201,ENSG00000164116,ENSG00000061918,ENSG00000152402","ENSG00000164116","Original","Bayer","Soluble guanylyl cyclase stimulator","Other indication","Persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension","pulmonary arterial hypertension","EFO_0001361","EFO_0000537","Original","Serious","P,O",TRUE,FALSE,FALSE,FALSE,TRUE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
337,"CHEMBL315985",2013,2006,2007,NA,NA,"Aptiom","Eslicarbazepine","ESLICARBAZEPINE","ENSG00000168356,ENSG00000169432,ENSG00000144285,ENSG00000007314,ENSG00000136546,ENSG00000185313,ENSG00000136531,ENSG00000183873,ENSG00000196876,ENSG00000153253","ENSG00000102466,ENSG00000105711,ENSG00000114279,NA","Original","Sunovion","MOA unknown, but thought to involve voltage-gated sodium channels","Other indication","Partial-onset seizures","Seizure","HP_0001250",NA,"Original","Not concordant","S",TRUE,FALSE,FALSE,FALSE,TRUE,2013,FALSE,2013,FALSE,FALSE,FALSE,FALSE
338,"CHEMBL3833373",2017,2017,NA,NA,NA,"Bavencio","Avelumab","AVELUMAB","ENSG00000120217","ENSG00000197646","Original","Merck KGaA/Pfizer","PDL1-blocking antibody","Oncology","Merkel cell carcinoma","Merkel cell skin cancer","EFO_1001471",NA,"Original","Serious","P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2017,TRUE,2017,FALSE,FALSE,FALSE,TRUE
339,"CHEMBL2108027",2014,1996,NA,1996,NA,"Trulicity","Dulaglutide","DULAGLUTIDE","ENSG00000112164",NA,"Original","Eli Lilly","GLP1-receptor agonist","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","HP_0003076,Orphanet_79161","Original","Not concordant","S",TRUE,FALSE,FALSE,FALSE,TRUE,2014,TRUE,2014,FALSE,FALSE,FALSE,TRUE
340,"CHEMBL2109540",2015,2008,NA,NA,NA,"Praluent","Alirocumab","ALIROCUMAB","ENSG00000169174","ENSG00000130164","Original","Sanofi","PCSK9 inhibitor","Other indication","LDL lowering","low density lipoprotein cholesterol measurement","EFO_0004611",NA,"Original","Not serious","P",TRUE,FALSE,FALSE,FALSE,TRUE,2015,TRUE,2015,FALSE,FALSE,FALSE,TRUE
344,"CHEMBL2103822",2014,NA,NA,2019,NA,"Hetlioz","Tasimelteon","TASIMELTEON","ENSG00000134640,ENSG00000168412",NA,"Original","Vanda","Melatonin-receptor agonist","Other indication","Non-24-hour sleep-wake disorder","sleep-wake disorder","MONDO_0003406","EFO_0008328","Related","Not serious","P,O",TRUE,FALSE,TRUE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
345,"CHEMBL1287853",2019,1995,1995,NA,NA,"Inrebic","Fedratinib","FEDRATINIB","ENSG00000096968,ENSG00000122025","ENSG00000096968,ENSG00000097007,ENSG00000117400,ENSG00000122025,ENSG00000179295","Original","Celgene/BMS","JAK2 and FLT3 inhibitor","Other indication","Myelofibrosis","myelofibrosis","MONDO_0044903",NA,"Original","Serious","P,O",TRUE,FALSE,FALSE,FALSE,TRUE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
346,"CHEMBL1800159",2020,NA,NA,NA,2003,"Orgovyx","Relugolix","RELUGOLIX","ENSG00000109163",NA,"Original","Myovant Sciences","GnRH receptor antagonist","Oncology","Prostate cancer","prostate cancer","MONDO_0008315",NA,"Original","Serious","P",TRUE,FALSE,FALSE,FALSE,TRUE,2020,TRUE,2020,FALSE,FALSE,FALSE,TRUE
349,"CHEMBL3306803",2019,1998,1997,NA,NA,"Caplyta","Lumateperone","LUMATEPERONE","ENSG00000102468,ENSG00000108576,ENSG00000149295","ENSG00000078369,ENSG00000102468,ENSG00000118432,ENSG00000128271,ENSG00000142319,ENSG00000147246,ENSG00000147955,ENSG00000162946,ENSG00000164082,ENSG00000149295","Original","Intra-Cellular Therapies","Atypical antipsychotic","Other indication","Schizophrenia","schizophrenia","MONDO_0005090",NA,"Original","Not concordant","S,F",TRUE,FALSE,FALSE,FALSE,TRUE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
350,"CHEMBL2364638",2019,NA,2018,NA,NA,"Ubrelvy","Ubrogepant","UBROGEPANT","ENSG00000064989","ENSG00000110680","Interactor","Allergan","CGRP receptor antagonist","Other indication","Migraine with or without aura","migraine disorder","MONDO_0005277",NA,"Original","Not serious","S",TRUE,TRUE,FALSE,FALSE,FALSE,2019,TRUE,2019,TRUE,FALSE,FALSE,FALSE
353,"CHEMBL4297750",2022,2013,2011,NA,NA,"Vabysmo","Faricimab","Faricimab","ENSG00000112715,ENSG00000091879","ENSG00000099250,ENSG00000112715","Original","Roche/Genentech","VEGF _ ANG2 bispecific antibody","Other indication","nAMD and DME","age-related macular degeneration","EFO_0001365",NA,"Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
354,"CHEMBL2108724",2017,1996,NA,1996,NA,"Ozempic","Semaglutide","SEMAGLUTIDE","ENSG00000112164",NA,"Original","Novo Nordisk","GLP1 receptor agonist","Other indication","Type 2 diabetes mellitus","type 2 diabetes mellitus","MONDO_0005148","HP_0003076,Orphanet_79161","Original","Not concordant","S",TRUE,FALSE,FALSE,FALSE,TRUE,2017,TRUE,2017,FALSE,FALSE,FALSE,TRUE
355,"CHEMBL3991065",2021,NA,2018,NA,NA,"Qulipta","Atogepant","Atogepant","ENSG00000064989","ENSG00000110680","Interactor","AbbVie","CGRP receptor antagonist","Other indication","Episodic migraine","migraine disorder","MONDO_0005277",NA,"Original","Not serious","S",TRUE,TRUE,FALSE,FALSE,FALSE,2021,TRUE,2021,TRUE,FALSE,FALSE,FALSE
356,"CHEMBL2107333",2013,NA,NA,2019,NA,"Tecfidera","Dimethyl fumarate","DIMETHYLFUMARATE","ENSG00000079999",NA,"Original","Biogen Idec","MOA unknown; activates NRF2 pathway","Other indication","Relapsing forms of multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929","MONDO_0005301","Related","Serious","S",TRUE,FALSE,TRUE,FALSE,FALSE,2013,TRUE,2013,FALSE,TRUE,FALSE,FALSE
357,"CHEMBL2108658",2022,NA,2017,NA,2014,"Imjudo","Tremelimumab","Tremelimumab","ENSG00000163599","ENSG00000145675","Interactor","AstraZeneca","CTLA4-targeted mAb","Oncology","Hepatocellular carcinoma","hepatocellular carcinoma","EFO_0000182","MONDO_0018531","Original","Serious","S,O",TRUE,TRUE,FALSE,FALSE,FALSE,2022,TRUE,2022,TRUE,FALSE,FALSE,FALSE
358,"CHEMBL1743049",2016,2005,1997,NA,NA,"Lartruvo","Olaratumab","OLARATUMAB","ENSG00000134853","ENSG00000100311,ENSG00000113721,ENSG00000124181,ENSG00000146648","Original","Eli Lilly","PDGFRalpha-blocking antibody","Oncology","Soft tissue sarcoma","soft tissue sarcoma","EFO_1001968",NA,"Original","Serious","P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2016,TRUE,2016,FALSE,FALSE,FALSE,TRUE
359,"CHEMBL3833329",2018,NA,2018,NA,NA,"Aimovig","Erenumab","ERENUMAB","ENSG00000064989","ENSG00000110680","Interactor","Amgen/Novartis","CGRP receptor antibody","Other indication","Migraine","migraine disorder","MONDO_0005277",NA,"Original","Not serious","S",TRUE,TRUE,FALSE,FALSE,FALSE,2018,TRUE,2018,TRUE,FALSE,FALSE,FALSE
362,"CHEMBL608533",2017,NA,NA,1979,NA,"Rydapt","Midostaurin","MIDOSTAURIN","ENSG00000163932,ENSG00000115825,ENSG00000166501,ENSG00000171132,ENSG00000163558,ENSG00000184304,ENSG00000065675,ENSG00000126583,ENSG00000027075,ENSG00000067606,ENSG00000154229,ENSG00000128052,ENSG00000122025,ENSG00000157404,ENSG00000134853,ENSG00000113721",NA,"Original","Novartis","FLT3 inhibitor","Oncology","FLT3-positive AML","acute myeloid leukemia, FLT3 internal tandem duplication","MONDO_0100415","EFO_0000222","Related","Serious","P,O,B,F",TRUE,FALSE,TRUE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
363,"CHEMBL3989924",2018,NA,2017,NA,NA,"Lutathera","Lutetium Lu 177 dotatate","LUTETIUMLU177DOTATATE","ENSG00000139874,ENSG00000162009,ENSG00000278195,ENSG00000132671,ENSG00000180616","ENSG00000145675","Interactor","Advanced Accelerator Applications/Novartis","Somatostatin receptor-targeted radiopharmaceutical","Oncology","GEP-NETs","digestive system neuroendocrine neoplasm","MONDO_0024503",NA,"Original","Serious","P,O,F",TRUE,TRUE,FALSE,FALSE,FALSE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
364,"CHEMBL2107869",2015,1982,1982,NA,NA,"Tresiba","Insulin degludec","INSULINDEGLUDEC","ENSG00000171105","ENSG00000145675,ENSG00000254647,ENSG00000169047,ENSG00000171105,ENSG00000197594,ENSG00000075624,ENSG00000081237,ENSG00000106070,ENSG00000135439,ENSG00000178188,ENSG00000179295,ENSG00000185950,ENSG00000196396,ENSG00000124181,ENSG00000140443,ENSG00000149177,ENSG00000153233","Original","Novo Nordisk","Long-acting insulin","Other indication","Diabetes","diabetes mellitus","EFO_0000400",NA,"Original","Not concordant","S",TRUE,FALSE,FALSE,FALSE,TRUE,2015,TRUE,2015,FALSE,FALSE,FALSE,TRUE
365,"CHEMBL2043437",2018,2016,NA,NA,NA,"Daurismo","Glasdegib","GLASDEGIB","ENSG00000128602","ENSG00000185920","Original","Pfizer","Hedgehog pathway inhibitor","Oncology","AML","acute myeloid leukemia","EFO_0000222",NA,"Original","Serious","P,O",TRUE,FALSE,FALSE,FALSE,TRUE,2018,TRUE,2018,FALSE,FALSE,FALSE,TRUE
366,"CHEMBL2107874",2019,2008,1999,NA,NA,"Evenity","Romosozumab","ROMOSOZUMAB","ENSG00000167941","ENSG00000162337,ENSG00000070018","Original","Amgen","Sclerostin inhibitor","Other indication","Osteoporosis","osteoporosis","EFO_0003882",NA,"Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2019,TRUE,2019,FALSE,FALSE,FALSE,TRUE
367,"CHEMBL4594406",2022,2008,1984,NA,NA,"Pluvicto","Lutetium Lu-177 vipivotide tetraxetan","LutetiumLu-177vipivotidetetraxetan","ENSG00000142515","ENSG00000169083","Original","Novartis","PSMA-binding radioligand therapeutic agent","Oncology","PSMA-positive prostate cancer","prostate carcinoma","EFO_0001663",NA,"Original","Serious","P,B",TRUE,FALSE,FALSE,FALSE,TRUE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
368,"CHEMBL3707377,CHEMBL691",2018,NA,NA,NA,2023,"Annovera","Segesterone acetate, ethinyl estradiol","SEGESTERONEACETATE,ETHINYLESTRADIOL","ENSG00000082175,ENSG00000091831","ENSG00000091831,ENSG00000091831","Original","TherapeuticsMD","Progestin and estrogen combined hormonal contraceptive","Other indication","Female contraception","contraception","EFO_0009520",NA,"Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
369,"CHEMBL4297340",2016,NA,2013,NA,NA,"Netspot","Gallium Ga-68 dotatate","GALLIUMGA-68DOTATATE","ENSG00000180616","ENSG00000145675","Interactor","Advanced Accelerator Applications","Radioactive diagnostic","Other indication","Neuroendocrine tumours","neuroendocrine neoplasm","EFO_1001901",NA,"Original","Serious","P,O",TRUE,TRUE,FALSE,FALSE,FALSE,2016,FALSE,2016,FALSE,FALSE,FALSE,FALSE
370,"CHEMBL2103883",2018,1994,1998,NA,NA,"Doptelet","Avatrombopag","AVATROMBOPAG","ENSG00000117400","NA,ENSG00000096968","Original","Dova Pharmaceuticals","Thrombopoietin receptor agonist","Other indication","Thrombocytopenia","thrombocytopenia","HP_0001873",NA,"Original","Not concordant","P",TRUE,FALSE,FALSE,FALSE,TRUE,2018,TRUE,2018,FALSE,FALSE,FALSE,TRUE
371,"CHEMBL2108681",2018,2018,2018,2009,2009,"Ilumya","Tildrakizumab","TILDRAKIZUMAB","ENSG00000110944,ENSG00000113302","ENSG00000110944,ENSG00000113302,ENSG00000162594","Original","Sun Pharma","IL-23 antibody","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","EFO_0000676","Original","Not serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
372,"CHEMBL4204794",2020,1990,1977,NA,NA,"Ayvakit","Avapritinib","AVAPRITINIB","ENSG00000157404,ENSG00000134853","NA,ENSG00000111252,ENSG00000113721,ENSG00000146648,ENSG00000049130","Original","Blueprint Medicines","PDGFRA, PDGFRA mutants and KIT kinase inhibitor","Oncology","GIST with PDGFRA exon 18 mutations","gastrointestinal stromal tumor","MONDO_0011719",NA,"Original","Serious","P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
373,"CHEMBL607400",2016,NA,NA,2006,NA,"Briviact","Brivaracetam","BRIVARACETAM","ENSG00000159164,ENSG00000144285",NA,"Original","UCB","Anticonvulsant with unknown MOA, binds to SV2A","Other indication","Partial-onset seizures","Focal-onset seizure","HP_0007359","HP_0001250","Original","Not concordant","S",TRUE,FALSE,FALSE,FALSE,TRUE,2016,FALSE,2016,FALSE,FALSE,FALSE,FALSE
374,"CHEMBL1743007",2015,NA,NA,2014,NA,"Darzalex","Daratumumab","DARATUMUMAB","ENSG00000004468",NA,"Original","Johnson & Johnson","CD38-directed mAb","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","MONDO_0004095","Related","Serious","P,O,B,A,F",TRUE,FALSE,TRUE,FALSE,FALSE,2015,TRUE,2015,FALSE,TRUE,FALSE,FALSE
378,"CHEMBL2218919",2021,NA,NA,2008,NA,"Lupkynis","Voclosporin","Voclosporin","ENSG00000138814",NA,"Original","Aurinia","Calcineurin inhibitor","Other indication","Lupus nephritis","lupus nephritis","EFO_0005761","MONDO_0007915","Related","Serious","P,F",TRUE,FALSE,TRUE,FALSE,FALSE,2021,TRUE,2021,FALSE,TRUE,FALSE,FALSE
379,"CHEMBL3707348",2017,NA,2004,NA,NA,"Calquence","Acalabrutinib","ACALABRUTINIB","ENSG00000010671","ENSG00000010671,ENSG00000117560","Original","AstraZeneca/Acerta Pharma","BTK inhibitor","Oncology","Mantle cell lymphoma","Mantle cell lymphoma","EFO_1001469",NA,"Original","Serious","P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE,2017,TRUE,2017,FALSE,FALSE,FALSE,TRUE
382,"CHEMBL3701238",2022,NA,NA,2013,NA,"Lytgobi","Futibatinib","Futibatinib","ENSG00000068078,ENSG00000077782,ENSG00000160867,ENSG00000066468",NA,"Original","Taiho Oncology","FGFR kinase inhibitor","Oncology","FGFR2-aberrant intrahepatic cholangiocarcinoma","intrahepatic cholangiocarcinoma","EFO_1001961","EFO_0005221","Related","Serious","P,O,B,A,F",TRUE,FALSE,TRUE,FALSE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
383,"CHEMBL502182",2018,2004,NA,NA,NA,"Orilissa","Elagolix sodium","ELAGOLIXSODIUM","ENSG00000109163",NA,"Original","AbbVie","GnRH receptor antagonist","Other indication","Pain associated with endometriosis","adenomyosis; pain","MONDO_0010888,EFO_0003843",NA,"Original","Not serious","P",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
385,"CHEMBL2103827",2014,NA,1981,NA,NA,"Northera","Droxidopa","DROXIDOPA","ENSG00000169252,ENSG00000170214,ENSG00000043591,ENSG00000120907,ENSG00000274286,ENSG00000184160,ENSG00000188778,ENSG00000150594,ENSG00000171873","ENSG00000171867,ENSG00000185359,ENSG00000197971","Interactor","Lundbeck","Synthetic amino-acid precursor of noradrenaline; MOA unknown","Other indication","Light-headedness in patients with neurogenic orthostatic hypotension","primary orthostatic hypotension","MONDO_0015914",NA,"Original","Not serious","P,O,A,F",TRUE,TRUE,FALSE,FALSE,FALSE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
388,"CHEMBL3833307",2020,NA,NA,2013,NA,"Enspryng","Satralizumab","SATRALIZUMAB","ENSG00000160712,ENSG00000134352",NA,"Original","Roche/Genentech","IL-6R-directed mAb","Other indication","NMOSD","neuromyelitis optica","EFO_0004256","MONDO_0000568","Related","Serious","S,O,B,F",TRUE,FALSE,TRUE,FALSE,FALSE,2020,FALSE,2020,FALSE,FALSE,FALSE,FALSE
389,"CHEMBL3039545",2019,2001,2001,NA,NA,"Reblozyl","Luspatercept","LUSPATERCEPT","ENSG00000105329,ENSG00000092969,ENSG00000119699","ENSG00000049323,ENSG00000076248,ENSG00000105329,ENSG00000105991,ENSG00000138615,ENSG00000151615,ENSG00000163430","Original","Celgene/BMS","Erythroid maturation agent","Other indication","Anaemia in beta-thalassaemia","beta thalassemia; anemia","MONDO_0019402,MONDO_0002280",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2019,FALSE,2019,FALSE,FALSE,FALSE,FALSE
391,"CHEMBL2105759",2018,1998,1995,NA,NA,"Olumiant","Baricitinib","BARICITINIB","ENSG00000096968,ENSG00000162434","ENSG00000096968,ENSG00000100368,ENSG00000134352,ENSG00000162434,ENSG00000065361,ENSG00000115415,ENSG00000168610","Original","Incyte/Eli Lilly","JAK inhibitor","Other indication","Rheumatoid arthritis","rheumatoid arthritis","EFO_0000685",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2018,FALSE,2018,FALSE,FALSE,FALSE,FALSE
392,"CHEMBL2028663",2013,NA,NA,2002,NA,"Tafinlar","Dabrafenib","DABRAFENIB","ENSG00000157764",NA,"Original","GSK","Kinase inhibitor with activity against BRAFV600E, BRAFV600K, BRAFV600D, wild-type BRAF and other kinases","Oncology","Unresectable or metastatic melanoma with BRAF(V600E) mutation as detected by an FDA-approved test","metastatic melanoma","EFO_0002617","EFO_0000756","Related","Serious","S,O,F",TRUE,FALSE,TRUE,FALSE,FALSE,2013,TRUE,2013,FALSE,TRUE,FALSE,FALSE
395,"CHEMBL4297517",2022,1990,1994,NA,NA,"Camzyos","Mavacamten","Mavacamten","ENSG00000092054","ENSG00000134571","Original","Bristol Myers Squibb","Cardiac myosin inhibitor","Other indication","Classes of obstructive HCM (Hypertrophic Obstructive Cardiomyopathy)","hypertrophic cardiomyopathy","EFO_0000538",NA,"Original","Serious","S,O,B",TRUE,FALSE,FALSE,FALSE,TRUE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
398,"CHEMBL1289601",2015,2017,2015,NA,NA,"Lenvima","Lenvatinib","LENVATINIB","ENSG00000037280,ENSG00000128052,ENSG00000102755","ENSG00000037280,ENSG00000096384,ENSG00000110395,ENSG00000111679,ENSG00000128052,ENSG00000145675,ENSG00000197122,ENSG00000112715,ENSG00000149177,ENSG00000158092,ENSG00000160691","Original","Eisai","VEGFR inhibitor","Oncology","Thyroid cancer","thyroid cancer","MONDO_0002108",NA,"Original","Serious","P,O",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
399,"CHEMBL1743062",2014,2011,2011,NA,NA,"Cyramza","Ramucirumab","RAMUCIRUMAB","ENSG00000128052","ENSG00000037280,ENSG00000111679,ENSG00000128052,ENSG00000197122,ENSG00000067225,ENSG00000142798,ENSG00000160691,ENSG00000179776","Original","Eli Lilly","VEGFR2 antagonist","Oncology","Gastric cancer","gastric cancer","MONDO_0001056",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2014,TRUE,2014,FALSE,FALSE,FALSE,TRUE
400,"CHEMBL484785",2016,NA,NA,2010,NA,"Eucrisa","Crisaborole","CRISABOROLE","ENSG00000184588,ENSG00000113448,ENSG00000065989,ENSG00000105650",NA,"Original","Pfizer/Anacor Pharmaceuticals","PDE4 inhibitor","Other indication","Atopic dermatitis","atopic eczema","EFO_0000274","HP_0000964,MONDO_0002406","Related","Not serious","S",TRUE,FALSE,TRUE,FALSE,FALSE,2016,FALSE,2016,FALSE,FALSE,FALSE,FALSE
401,"CHEMBL605846",2014,NA,2019,NA,NA,"Striverdi Respimat","Olodaterol","OLODATEROL","ENSG00000169252","ENSG00000113369,ENSG00000163485","Interactor","Boehringer Ingelheim","Long-acting beta2-adrenoceptor agonist","Other indication","COPD","chronic obstructive pulmonary disease","EFO_0000341",NA,"Original","Serious","S",TRUE,TRUE,FALSE,FALSE,FALSE,2014,TRUE,2014,TRUE,FALSE,FALSE,FALSE
402,"CHEMBL3218576",2017,NA,NA,2002,NA,"Aliqopa","Copanlisib dihydrochloride","COPANLISIB","ENSG00000171608,ENSG00000121879",NA,"Original","Bayer","PI3Kalpha/‚Äö√¢√†‚àö‚â†¬¨¬®‚Äö√Ñ¬¢ inhibitor","Oncology","Follicular lymphoma","follicular lymphoma","MONDO_0018906","EFO_0000183","Related","Serious","P,O,A,F",TRUE,FALSE,TRUE,FALSE,FALSE,2017,FALSE,2017,FALSE,FALSE,FALSE,FALSE
403,"CHEMBL3707226",2016,NA,NA,1995,NA,"Defitelio","Defibrotide sodium","DEFIBROTIDESODIUM","ENSG00000122194",NA,"Original","Gentium","Profibrinolytic","Other indication","Hepatic veno-occlusive disease","hepatic veno-occlusive disease","MONDO_0019514","MONDO_0002405","Related","Serious","P,O,F",TRUE,FALSE,TRUE,FALSE,FALSE,2016,TRUE,2016,FALSE,TRUE,FALSE,FALSE
405,"CHEMBL363392",2021,NA,NA,2020,NA,"Livmarli","Maralixibat","Maralixibat","ENSG00000125255",NA,"Original","Mirum","IBAT inhibitor","Other indication","Pruritus in Alagille syndrome","Alagille syndrome","MONDO_0007318","EFO_0005653","Related","Serious","P,O,B",TRUE,FALSE,TRUE,FALSE,FALSE,2021,TRUE,2021,FALSE,TRUE,FALSE,FALSE
406,"CHEMBL2109624",2019,NA,1982,NA,NA,"Cablivi","Caplacizumab","CAPLACIZUMAB","ENSG00000110799","ENSG00000160323","Interactor","Sanofi/Ablynx","vWF-directed nanobody","Other indication","ATTP","thrombotic thrombocytopenic purpura","MONDO_0018896",NA,"Original","Serious","P,O,F",TRUE,TRUE,FALSE,FALSE,FALSE,2019,TRUE,2019,TRUE,FALSE,FALSE,FALSE
412,"CHEMBL4298211",2021,NA,2012,NA,NA,"Empaveli","Pegcetacoplan","Pegcetacoplan","ENSG00000125730","ENSG00000155659","Interactor","Apellis","Complement protein C3 inhibitor","Other indication","PNH","paroxysmal nocturnal hemoglobinuria","MONDO_0100244",NA,"Original","Serious","P,O,F",TRUE,TRUE,FALSE,FALSE,FALSE,2021,TRUE,2021,TRUE,FALSE,FALSE,FALSE
413,"CHEMBL566315",2016,NA,NA,2000,NA,"Ocaliva","Obeticholic acid","OBETICHOLICACID","ENSG00000012504",NA,"Original","Intercept","FXR agonist","Other indication","Primary biliary cholangitis","primary biliary cirrhosis","EFO_1001486","EFO_0001422","Related","Serious","P,O,A,F",TRUE,FALSE,TRUE,FALSE,FALSE,2016,TRUE,2016,FALSE,TRUE,FALSE,FALSE
414,"CHEMBL2108676",2014,1987,NA,NA,NA,"Vimizim","Elosulfase alfa","ELOSULFASEALFA","ENSG00000141012",NA,"Original","BioMarin","Hydrolytic lysosomal glycosaminoglycan-specific enzyme","Other indication","Mucopolysaccharidosis type IVA","mucopolysaccharidosis type 4A","MONDO_0009659",NA,"Original","Serious","P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE,2014,FALSE,2014,FALSE,FALSE,FALSE,FALSE
416,"CHEMBL4297819",2021,NA,2005,NA,NA,"Besremi","Ropeginterferon alfa-2b","Ropeginterferonalfa-2b","ENSG00000142166,ENSG00000159110","ENSG00000162434,","Interactor","Pharmaessentia","PEGylated interferon alpha-2b","Oncology","Polycythaemia vera","polycythemia vera","EFO_0002429",NA,"Original","Serious","S,O",TRUE,TRUE,FALSE,FALSE,FALSE,2021,FALSE,2021,FALSE,FALSE,FALSE,FALSE
418,"CHEMBL431770",2019,NA,1995,NA,NA,"Nourianz","Istradefylline","ISTRADEFYLLINE","ENSG00000128271","ENSG00000149295","Interactor","Kyowa Kirin","Adenosine receptor antagonist","Other indication","Parkinson disease episodes","Parkinson disease","MONDO_0005180",NA,"Original","Serious","S",TRUE,TRUE,FALSE,FALSE,FALSE,2019,TRUE,2019,TRUE,FALSE,FALSE,FALSE
419,"CHEMBL4298062",2020,1988,NA,NA,NA,"Viltepso","Viltolarsen","VILTOLARSEN","ENSG00000198947","ENSG00000101400,NA","Original","Nippon Shinyaku","Dystrophin splicing modifier","Other indication","Duchenne muscular dystrophy","duchenne muscular dystrophy","MONDO_0010679",NA,"Original","Serious","P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE,2020,TRUE,2020,FALSE,FALSE,FALSE,TRUE
421,"CHEMBL2028019",2015,1997,1997,NA,NA,"Vraylar","Cariprazine","CARIPRAZINE","ENSG00000151577,ENSG00000149295","ENSG00000078369,ENSG00000118432,ENSG00000128271,ENSG00000142319,ENSG00000147955,ENSG00000162946,ENSG00000149295,NA","Original","Forest","Atypical antipsychotic","Other indication","Schizophrenia and bipolar 1 disorder","Schizophrenia; bipolar disorder","MONDO_0005090,MONDO_0004985",NA,"Original","Serious","S",TRUE,FALSE,FALSE,FALSE,TRUE,2015,FALSE,2015,FALSE,FALSE,FALSE,FALSE
424,"CHEMBL3707229",2021,2011,NA,2021,NA,"Tezspire","Tezepelumab","Tezepelumab","ENSG00000145777",NA,"Original","Astrazeneca/Amgen","TSLP-targeted mAb","Other indication","Serious asthma","asthma","MONDO_0004979","EFO_0004842","Original","Serious","P",TRUE,FALSE,FALSE,FALSE,TRUE,2021,TRUE,2021,FALSE,FALSE,FALSE,TRUE
425,"CHEMBL3990044,CHEMBL2108738",2022,NA,2004,NA,NA,"Opdualag","Relatlimab, nivolumab","Relatlimab,nivolumab","ENSG00000089692,ENSG00000188389","ENSG00000120217,ENSG00000179295,ENSG00000197646,ENSG00000006125","Interactor","Bristol Myers Squibb","LAG3-targeted mAb plus PD1-targeted mAb","Oncology","Melanoma","melanoma","EFO_0000756",NA,"Related","Serious","P,O,F",TRUE,FALSE,TRUE,FALSE,FALSE,2022,FALSE,2022,FALSE,FALSE,FALSE,FALSE
